Fungicidal mixtures containing pyrazole derivatives

Abstract

1. A fungicidal composition comprising: (a) a compound of Formula 1, including all geometric and stereoisomers, tautomers, iV-oxides, and salts thereof; [Case 1] TIFF2023517942000074.tif49170 (In the formula, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , m and n are as defined in this disclosure) and (b) at least one additional fungicidal compound. Also disclosed is a method for controlling plant diseases caused by fungal plant pathogens, comprising applying to a plant or part thereof, or to a plant seed, a fungicidally effective amount of a compound of Formula 1, its A-oxide, or salt (e.g., as a component of the above composition). Also disclosed is a composition comprising (a) at least one compound selected from the compounds of Formula 1, its A-oxide, and salt, above, and at least one invertebrate pest control compound or agent.

Description

[Technical Field]

[0001] The present invention relates to certain pyrazoles, their N-oxides, salts, and mixtures and compositions containing such halomethyl ketone and hydrate derivatives, and methods of using such halomethyl ketone and hydrate derivatives and mixtures and compositions thereof as fungicides. [Background technology]

[0002] Control of plant diseases caused by fungal plant pathogens is crucial in achieving high crop efficiency. Plant disease damage to ornamental plants, vegetables, field, cereal, and fruit crops can cause significant losses in productivity, thereby resulting in increased costs to consumers. In addition to being highly destructive in many cases, plant diseases can be difficult to control and can develop resistance to commercially available fungicides. While many products are available on the market for these purposes, there remains a need for new fungicidal compounds that are more effective, less costly, less toxic, environmentally safer, or have different sites of action. In addition to the introduction of new fungicides, fungicide combinations are often used to promote disease control, broaden the spectrum of control, and delay resistance development. Furthermore, certain unusual fungicide combinations demonstrate greater-than-additive (i.e., synergistic) effects to provide commercially important levels of plant disease control. It is recognized in the art that the benefits of a particular fungicide combination vary, depending on factors such as the specific plant species and the plant disease being treated, and whether the plant is treated before or after infection with a fungal plant pathogen. Therefore, new advantageous combinations are needed to provide a variety of options for best meeting specific plant disease control needs. Such combinations have now been discovered.

[0003] PCT Patent Publications WO 2018 / 052838, WO 2013 / 192126, WO 2012 / 031061 and WO 2010 / 101973 disclose fungicidal pyrazoles and their use in agriculture. PCT Patent Publication WO 2019 / 020981 discloses pyrazole, isothiazole and isoxazole derivatives and their use in agriculture. Summary of the Invention [Means for solving the problem]

[0004] The present invention provides a fungicidal composition (i.e., combination) comprising: (a) Formula 1: [ka] (In the formula, R 1 is a C1-C2 alkyl, R 2 is cyano, halogen, C1-C2 alkyl or C1-C2 haloalkyl, R 3 is halogen or methyl, Each R 4 are independently halogen, cyano, nitro, C1-C3 alkyl, C1-C3 alkoxy, C1-C3 haloalkoxy, C2-C6 alkenyloxy, C2-C6 alkynyloxy, C2-C6 cyanoalkoxy, C2-C6 alkoxyalkyl or C2-C6 alkoxyalkoxy; Each R 5 are independently halogen, C1-C3 alkyl, C2-C6 alkoxyalkyl, C1-C3 alkoxy, C1-C3 haloalkoxy, C2-C6 alkenyloxy, C2-C6 alkynyloxy, C2-C6 cyanoalkoxy or C2-C6 alkoxyalkoxy; m and n are each independently 0, 1, 2, or 3; R 6 is H; or R6a C1-C3 alkyl or C1-C3 haloalkyl, each optionally substituted with up to two substituents independently selected from: amino, C2-C4 alkenyl, C2-C4 alkynyl, C3-C6 cycloalkyl, CH(=O), S(=O)2OM, S(=O) u R 7 , (C=W)R 8 OR 9 and Each R 6a are independently cyano, C3-C6 cycloalkyl, C1-C3 alkoxy, C1-C3 haloalkoxy, C1-C3 alkylthio, C1-C3 alkylsulfinyl, or C1-C3 alkylsulfonyl; M is K or Na; u is 0, 1 or 2; R 7 is C1-C3 alkyl or C1-C3 haloalkyl, W is O or S; R 8 is C1-C3 alkyl, C2-C4 alkoxyalkyl, C2-C4 alkylaminoalkyl, C3-C6 dialkylaminoalkyl, C1-C3 alkoxy, C1-C3 alkylthio or C2-C4 alkylthioalkyl, R 9 is H; or R 9a C1-C3 alkyl or C1-C3 haloalkyl, each optionally substituted with up to two substituents independently selected from: 10 and Each R 9a are independently cyano, C3-C6 cycloalkyl, C1-C3 alkoxy, C1-C3 haloalkoxy, C1-C3 alkylthio, C1-C3 alkylsulfinyl, or C1-C3 alkylsulfonyl, and R 10is C1-C3 alkyl, C2-C4 alkoxyalkyl, C2-C4 alkylaminoalkyl, C3-C6 dialkylaminoalkyl, C1-C3 alkoxy, C1-C3 alkylthio, or C2-C4 alkylthioalkyl) at least one compound selected from the group consisting of the compounds of formula (I) (including all stereoisomers), N-oxides and salts thereof; (b) at least one additional fungicidal compound; and with the proviso that the compound of formula 1 comprises 4-(2,6-difluoro-4-methoxyphenyl)-N-(2,4-difluoro-6-nitrophenyl)-1,3-dimethyl-1H-pyrazol-5-amine, 4-(2-chloro-4-fluorophenyl)-1,3-dimethyl-N-(2-nitrophenyl)-1H-pyrazol-5-amine, 4-(2-chloro-4-fluorophenyl)-N-(2,4-difluoro-6-nitrophenyl)-1,3-dimethyl-1H-pyrazol-5-amine, 4-(2-chloro-4-fluorophenyl)-3-ethyl-1-methyl-N-(2-nitrophenyl)-1H-pyrazol-5-amine, 4-(2-chloro-4-fluorophenyl)-1-methyl-N-(2-nitrophenyl)-3-(trifluoromethyl)-1H-pyrazol-5-amine, 4-(2,6-difluoro-4-methoxyphenyl)-N-(2-methoxy-6-nitrophenyl)-1,3-dimethyl-1H-pyrazol-5-amine, 4-(2-chloro-4-fluorophenyl)-N-(2-methoxy-6-nitrophenyl)-1,3-dimethyl-1H-pyrazol-5-amine, N-(2-chloro-6-nitrophenyl)-4-(2,6-difluoro-4-methoxyphenyl)-1,3-dimethyl-1H-pyrazol-5-amine, N-(2-chloro-3-fluoro-6-nitrophenyl)-4-(2,6-difluoro-4-methoxyphenyl)-1,3-dimethyl-1H-pyrazol-5-amine, 4-(2-chloro-4-fluorophenyl)-1,3-dimethyl-N-(2-methyl-6-nitrophenyl)-1H-pyrazol-5-amine, N-(2-bromo-4-fluoro-6-nitrophenyl)-4-(2-chloro-4-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine, 4-(2-chloro-4-fluorophenyl)-N-(4-methoxy-2-nitrophenyl)-1,3-dimethyl-1H-pyrazol-5-amine, 4-(2,6-difluoro-4-methoxyphenyl)-N-(4-fluoro-2-nitrophenyl)-1,3-dimethyl-1H-pyrazol-5-amine, 4-(2,6-difluoro-4-methoxyphenyl)-N-(4-methoxy-2-nitrophenyl)-1,3-dimethyl-1H-pyrazol-5-amine, N-(4-chloro-2-nitrophenyl)-4-(2,6-difluoro-4-methoxyphenyl)-1,3-dimethyl-1H-pyrazol-5-amine, 4-(2,6-difluoro-4-methoxyphenyl)-1,3-dimethyl-N-[2-nitro-4-(2-propyn-1-yloxy)phenyl]-1H-pyrazol-5-amine, 4-(2,6-difluoro-4-methoxyphenyl)-1,3-dimethyl-N-[2-nitro-4-(2-propen-1-yloxy)phenyl]-1H-pyrazol-5-amine, N-(4-bromo-2-nitrophenyl)-4-(2,6-difluoro-4-methoxyphenyl)-1,3-dimethyl-1H-pyrazol-5-amine, N-(4-chloro-2-fluoro-6-nitrophenyl)-4-(2,6-difluoro-4-methoxyphenyl)-1,3-dimethyl-1H-pyrazol-5-amine, 3-chloro-4-(2-chloro-4-fluorophenyl)-N-(2,4-difluoro-6-nitrophenyl)-1-methyl-1H-pyrazol-5-amine, 4-(2,6-difluoro-4-methoxyphenyl)-1,3-dimethyl-N-[4-methyl-2-nitrophenyl]-1H-pyrazol-5-amine, 4-(2-chloro-4-fluorophenyl)-1,3-dimethyl-N-(4-methyl-2-nitrophenyl)-1H-pyrazol-5-amine, and N-(4-bromo-2-fluoro-6-nitrophenyl)-4-(2,6-difluoro-4-methoxyphenyl)-1,3-dimethyl-1H-pyrazol-5-amine provided that the antiseptic composition (i.e., combination) is not

[0005] The present invention also relates to compositions comprising (a) at least one compound selected from the compounds of Formula 1 above, N-oxides and salts thereof, and at least one invertebrate pest control compound or agent.

[0006] The present invention also relates to a composition comprising one of the above compositions comprising component (a) and at least one additional component selected from the group consisting of surfactants, solid diluents, and liquid diluents.

[0007] The present invention also relates to a method for controlling plant diseases caused by fungal plant pathogens, comprising applying to the plant or part thereof or to the seeds of the plant a fungicidally effective amount of one of the compositions described above.

[0008] The method may also be described as a method of protecting a plant or a plant seed from disease caused by a fungal plant pathogen, comprising applying to the plant (or a portion thereof) or plant seed (either directly or through the environment (e.g., growth medium) of the plant or plant seed) a fungicidally effective amount of one of the compositions.

[0009] The present invention also relates to compounds of formula 1 above or N-oxides or salts thereof. DETAILED DESCRIPTION OF THE INVENTION

[0010] As used herein, the terms "comprise," "including," "include," "including," "having," "having," "containing," "containing," "featuring," or any variation thereof, are intended to include a non-exclusive inclusion subject to any limitations expressly indicated. For example, a composition, mixture, process, method, article, or device that includes a list of elements is not necessarily limited to only those elements and may also include other elements not expressly listed or inherent to such composition, mixture, process, method, article, or device.

[0011] The transitional phrase "consisting of" excludes any unspecified element, step, or ingredient. In claims, when a claim is closed to encompass substances different from those recited, apart from impurities, it is usually relevant thereto. When the phrase "consisting of" appears in a clause in the body of a claim rather than immediately following the preamble, it limits only the elements recited in that clause and does not exclude other elements from the claim as a whole.

[0012] The transitional phrase "consisting essentially of" is used to define a composition, method, or apparatus that includes materials, steps, features, ingredients, or elements in addition to those literally disclosed, provided that these additional materials, steps, features, ingredients, or elements do not materially affect the basic and novel characteristics of the claimed invention. The term "consisting essentially of" occupies a neutral position between "comprising" and "consisting of."

[0013] It should be readily understood that where applicants have defined the invention or any portion thereof with open-ended terms such as "comprising," the statement should be construed as also describing such inventions using the terms "consisting essentially of" or "consisting of" (unless otherwise stated).

[0014] Furthermore, unless expressly stated to the contrary, "or" refers to an inclusive "or" and not an exclusive "or." For example, the condition "A or B" is satisfied by any one of the following: A is true (or exists) and B is false (or does not exist), A is false (or does not exist) and B is true (or exists), and both A and B are true (or exist).

[0015] Furthermore, the indefinite articles "a" and "an" preceding an element or component of the invention are intended to be open-ended regarding the number of instances (i.e., occurrences) of that element or component. Thus, "a" and "an" should be read to include one or at least one, and such singular form of that element or component also includes the plural, unless it is clear that the number means singular.

[0016] The term "agriculture" refers to the production of agricultural crops such as food and fiber, and includes the growing of maize or corn, soybeans and other legumes, rice, grains (e.g., wheat, oats, barley, rye and rice), leafy vegetables (e.g., lettuce, cabbage and other greens), fruit vegetables (e.g., tomatoes, peppers, eggplant, crucifers and cucurbits), potatoes, sweet potatoes, grapes, cotton, fruit trees (e.g., pome fruits, stone fruits and citrus fruits), small fruit trees (e.g., berries and cherries), and other specialty crops (e.g., canola, sunflowers and olives).

[0017] The term "non-agricultural" refers to non-crop crops such as horticultural crops (e.g., ornamental plants not grown in greenhouses, nurseries, or fields), residential, agricultural, commercial, and industrial structures, turf (e.g., turf farms, pastures, golf courses, lawns, athletic fields, etc.), wood products, storage products, silviculture and vegetation management, public health (i.e., humans) and animal health (e.g., domesticated animals, e.g., pets, livestock, and poultry, non-domesticated animals such as wildlife) uses.

[0018] The term "crop vigor" refers to the rate of growth or biomass deposition of a crop plant. "Increased vigor" refers to an increase in growth or biomass deposition in a crop plant when compared to an untreated control crop plant. The term "crop yield" refers to the harvest of crop material, both in terms of quantity and quality, obtained after harvesting the crop plant. "Increased crop yield" refers to an increase in crop yield when compared to an untreated control crop plant.

[0019] The term "biologically effective amount" refers to an amount of a biologically active compound (e.g., a compound of Formula 1) sufficient to produce a desired biological effect upon application (i.e., contact) to the fungi to be controlled or their environment, or to the plant, seed or locus of the plant in which the plant grows (e.g., growth medium) to protect the plant from damage by fungal disease or for other desired effect (e.g., increased plant vigor).

[0020] As referred to in this disclosure and claims, "plants" include members of the Kingdom Plantae, particularly Spermatopsida, in all life stages, including seedlings (e.g., germinating seeds that grow into seedlings) and mature, reproductive growth stages (e.g., plants that produce flowers and seeds). Plant parts include geotropic members that typically grow below the surface of the growing medium (e.g., soil), such as rhizomes, tubers, bulbs, and corms, and above the surface of the growing medium (e.g., soil), such as leaves (including stems and leaves), flowers, fruits, and seeds.

[0021] As referred to herein, the term "seedling", used alone or in combination, means a young plant developing from the germ of a seed.

[0022] As referred to herein, the term "broadleaf" used alone or in terms such as "broadleaf crops" means dicotyledonous or dicotyledonous plants, the term being used to describe a group of angiosperms characterized by an embryo with two cotyledons.

[0023] As referred to in this disclosure, the terms "fungal pathogen" and "fungal plant pathogen" include pathogens of the phyla Ascomycota, Basidiomycota, and Zygomycota, as well as fungus-like Oomycota, which are causative agents of a wide spectrum of plant diseases of economically important ornamentals, turf, vegetables, field, grain, and fruit crops. In the context of this disclosure, "protecting plants from disease" or "controlling plant diseases" includes preventative action (interruption of the fungal cycle of infection, colonization, symptom development, and sporulation) and / or therapeutic action (inhibition of colonization of plant host tissue).

[0024] As used herein, the term "mode of action" (MOA), as defined by the Fungicide Resistance Action Committee (FRAC), is used to distinguish fungicides by their biochemical mechanism of action in the biosynthetic pathway of plant pathogens and their risk of resistance. FRAC-defined MOA include: (A) nucleic acid metabolism, (B) cytoskeleton and motor proteins, (C) respiration, (D) amino acid and protein synthesis, (E) signal transduction, (F) lipid synthesis or transport and membrane integrity or function, (G) membrane sterol biosynthesis, (H) cell wall biosynthesis, (I) cell wall melanin synthesis, (P) host plant defense induction, (U) unknown MOA, (M) chemicals with multi-site activity, and (BM) biologics with multiple MOA. Each mechanism of action (i.e., letters A-BM) contains one or more subgroups (e.g., A includes subgroups A1, A2, A3, and A4) based on individual confirmed target sites of action or, if the exact target site is unknown, based on cross-resistance profiles within the group or with respect to other groups. Each of these subgroups (e.g., A1, A2, A3, and A4) is assigned a FRAC code (number and / or letter). For example, the FRAC code for subgroup A1 is 4. Additional information regarding target sites and FRAC codes can be obtained, for example, from publicly available databases provided by FRAC.

[0025] As used herein, the term "cross-resistance" refers to the phenomenon that occurs when a pathogen develops resistance to one fungicide and simultaneously becomes resistant to one or more other fungicides, which are typically, but not always, in the same chemical class, have the same target site of action, or are detoxifiable by the same mechanism.

[0026] Generally, when a molecular fragment (i.e., a group) is represented by a series of atomic symbols (e.g., C, H, N, O, and S), the implied point of attachment is readily recognized by one of ordinary skill in the art. In some cases herein, particularly when alternative points of attachment are possible, the point of attachment may be explicitly indicated by a hyphen ("-"). For example, "-NCS" indicates that the point of attachment is the nitrogen atom (i.e., isothiocyanato, not thiocyanato).

[0027] As used herein, the term "alkylating agent" refers to a compound in which a carbon-containing group is attached through a carbon atom to a leaving group, e.g., a halide or sulfonate, which is displaceable by attachment of a nucleophile to said carbon atom. Unless otherwise indicated, the term "alkylation" does not limit the carbon-containing group to alkyl, and the carbon-containing group in an alkylating agent may be, for example, R 5 These include the various carbon-bonded substituents specified for

[0028] In the above description, the term "alkyl," whether used alone or in compound terms such as "alkylthio" or "haloalkyl," includes straight-chain or branched alkyls, such as methyl, ethyl, n-propyl, and i-propyl, or the various butyl, pentyl, or hexyl isomers. "Alkenyl" includes straight-chain or branched alkenes, such as ethenyl, 1-propenyl, 2-propenyl, and the various butenyl, pentenyl, and hexenyl isomers. "Alkenyl" also includes polyenes, such as 1,2-propadienyl and 2,4-hexadienyl. "Alkynyl" includes straight-chain or branched alkynes, such as 1-propynyl, 2-propynyl, and the various butynyl, pentynyl, and hexynyl isomers. "Alkynyl" can also include moieties consisting of multiple triple bonds, such as 2,5-hexadiynyl.

[0029] "Alkoxy" includes, for example, methoxy, ethoxy, n-propyloxy, i-propyloxy, and the different butoxy, pentoxy, and hexyloxy isomers. "Alkoxyalkyl" indicates alkoxy substitution on alkyl. Examples of "alkoxyalkyl" include CHOCH, CHOCHCH, CHCHOCH, CHCHCHOCH, CHCHCHCHOCH, and CHCHOCHCH. "Alkenyloxy" includes straight-chain or branched alkenyl attached to and linked through an oxygen atom. Examples of "alkenyloxy" include HC=CHCHO, (CH)C=CHCHO, CHCH=CHCHO, CHCH=C(CH)CHO, and CH=CHCHCHO. "Alkynyloxy" includes straight-chain or branched alkynyl attached to and linked through an oxygen atom. Examples of "alkynyloxy" include HC≡CCH2O, CH3C≡CCH2O, and CH3C≡CCH2CH2O. "Alkoxyalkoxy" indicates alkoxy substitution on another alkoxy moiety. Examples of "alkoxyalkoxy" include CH3OCH2O, CH3OCH2O, and CH3CH2OCH2O.

[0030] "Alkylthio" includes branched or straight-chain alkylthio moieties such as methylthio, ethylthio, and the different propylthio isomers. "Alkylthioalkyl" indicates alkylthio substitution on alkyl. Examples of "alkylthioalkyl" include CH3SCH2, CH3SCH2CH2, CH3CH2SCH2, and CH3CH2SCH2CH2. "Alkylsulfinyl" includes both enantiomers of alkylsulfinyl groups. Examples of "alkylsulfinyl" include CH3S(=O), CH3CH2S(=O), CH3CH2CH2S(=O), and (CH3)2CHS(=O). Examples of "alkylsulfonyl" include CH3S(=O), CH3CH2S(=O), CH3CH2CH2S(=O)2, and (CH3)2CHS(=O).

[0031] "Alkylaminoalkyl" denotes an alkylamino substitution on alkyl. Examples of "alkylaminoalkyl" include CH3NHCH2, CH3NHCH2CH2, CH3CH2NHCH2, CH3CH2CH2CH2NHCH2, and CH3CH2NHCH2CH2. Examples of "dialkylaminoalkyl" include (CH3)2NCH2, (CH3CH2)2NCH2CH2, and CH3CH2(CH3)NCH2CH2.

[0032] The term "cycloalkyl" refers to a saturated carbocyclic ring of 3 to 6 carbon atoms joined together by single bonds. Examples of "cycloalkyl" include cyclopropyl, cyclobutyl, cyclopentyl, and cyclohexyl. The term "cycloalkylalkyl" refers to cycloalkyl substitution on an alkyl group. Examples of "cycloalkylalkyl" include cyclopropylmethyl, cyclopentylethyl, and other cycloalkyl moieties attached to straight-chain or branched alkyl groups.

[0033] The term "halogen", when used alone or in compound terms such as "haloalkyl" or in descriptions such as "alkyl substituted with halogen", includes fluorine, chlorine, bromine, or iodine. Furthermore, when used in compound terms such as "haloalkyl" or in descriptions such as "alkyl substituted with halogen", the alkyl may be partially or fully substituted with halogen atoms, which may be the same or different. Examples of "haloalkyl" or "alkyl substituted with halogen" include F3C, ClCH2, CF3CH2, and CF3CCl2. Terms such as "haloalkoxy" are defined analogously to the term "haloalkyl". Examples of "haloalkoxy" include CF3O, CCl3CHO, F2CHCH2CHO, and CF3CHO.

[0034] "Cyanoalkoxy" refers to an alkyloxy group substituted with one cyano group. Examples of "cyanoalkoxy" include NCCH2O, NCCH2CH2O, and CH3CH(CN)CH2O.

[0035] The total number of carbon atoms in a substituent is indicated by the prefix "C i ~C j " where i and j are numbers from 1 to 6. For example, C1-C3 alkylsulfonyl refers to methylsulfonyl through propylsulfonyl, C2 alkoxyalkyl refers to CHOCH2, C3 alkoxyalkyl refers to, for example, CHOCHCH2CH2 or CHCH2OCH2, and C4 alkoxyalkyl refers to the various isomers of an alkyl group substituted with an alkoxy group containing a total of 4 carbon atoms, examples include CHCH2CH2OCH2 and CHCH2OCH2CH2.

[0036] The term "unsubstituted" in reference to a group such as a ring means that the group has no substituents other than its one or more bonds to the remainder of Formula 1. The term "optionally substituted" means that the number of substituents can be zero. Unless otherwise specified, an optionally substituted group can be substituted with as many optional substituents as possible, accommodated by replacing hydrogen atoms with non-hydrogen substituents on any available carbon or nitrogen atom. Generally, the number of optional substituents (if present) ranges from 1 to 3. As used herein, the term "optionally substituted" is used interchangeably with the phrase "substituted or unsubstituted" or the term "(un)substituted."

[0037] The number of optional substituents may be limited by expressed limits. For example, the phrase "R 6a "Optionally substituted with up to two substituents independently selected from" means that there can be 0, 1 or 2 substituents.

[0038] Substituents with subscripts indicating that the number of substituents can vary (e.g., (R 4 ) m When a compound is substituted by R , unless otherwise specified, the substituents are independently selected from the group of defined substituents. When various groups are shown to be optionally attached at a position (e.g., m can be 0 (R 4 ) m ), hydrogen may be present in a position not listed in the definitions of the various groups.

[0039] The naming of substituents in this disclosure uses accepted terminology that achieves conciseness in accurately conveying chemical structures to those of skill in the art. For the sake of brevity, locant descriptors may be omitted. In some cases herein, substituents (e.g., R 4 and R 5 ) attachment points are indicated by locant numbers which may differ from the Chemical Abstracts naming system if the difference does not affect the meaning.

[0040] The compounds of the present invention may exist as one or more stereoisomers. Stereoisomers are isomers that have identical constitution but differ in the spatial arrangement of their atoms, including enantiomers, diastereomers, cis- and trans-isomers (also known as geometric isomers), and atropisomers. Atropisomers result from restricted rotation around a single bond, and the high barrier to rotation allows for the isolation of the isomeric species. Those skilled in the art will recognize that one stereoisomer may be more reactive and / or exhibit advantageous effects when enriched or separated from other stereoisomers. In addition, those skilled in the art know methods for separating, enriching, and / or selectively preparing such stereoisomers. For a comprehensive discussion of all aspects of stereoisomerism, see Ernest L. Eliel and Samuel H. Wilen, Stereochemistry of Organic Compounds, John Wiley & Sons, 1994.

[0041] The compounds of the present invention may exist as one or more conformers due to restricted rotation about the amide bond (e.g., C(=O)-N) in Formula 1. The present invention also includes mixtures of conformers. In addition, the present invention also includes compounds enriched in one conformer relative to another.

[0042] This invention includes all stereoisomers, structural isomers and mixtures thereof in all proportions as well as isotopic forms such as deuterated compounds.

[0043] Those skilled in the art will understand that not all nitrogen-containing heterocycles can form N-oxides because the nitrogen requires an available lone pair of electrons to be oxidized to the oxide. Those skilled in the art will recognize those nitrogen-containing heterocycles that can form N-oxides. Those skilled in the art will also recognize that tertiary amines can form N-oxides. Synthetic methods for preparing N-oxides of heterocycles and tertiary amines will be well known to those skilled in the art, including the oxidation of heterocycles and tertiary amines using peroxyacids such as peracetic acid and m-chloroperbenzoic acid (MCPBA), hydrogen peroxide, alkyl hydroperoxides such as t-butyl hydroperoxide, sodium perborate, and dioxiranes such as dimethyldioxirane. These methods for preparing N-oxides have been widely described and reviewed in the literature, see, for example, the following references: T.L.G. Ilchrist, Comprehensive Organic Synthesis, vol. 7, pp. 748-750 (S.V. Ley, Ed., Pergamon Press); M. Tisler and B. Stanovnik, Comprehensive Heterocyclic Chemistry, vol. 3, pp. 18-20, A.J. Boulton and A. McKillop, Eds., Pergamon Press; M.R. Grimmett and B.R.T. Keene, Advances in Heterocyclic Chemistry, vol. 43, pp. 149-161, A.R.Katrittzky, Eds., Academic Press; M. Tisler and B. Stanovnik, Advances in Heterocyclic Chemistry, vol. 9, pp. 285-291, A.R.Katrittzky and A.J.Boulton, Eds., Academic Press. Press; and GWHCheeseman and ESGWerstiuk, Advances in Heterocyclic Chemistry, vol. 22, pp. 390-392, ARKatritzky and AJ Boulton, Eds., Academic Press.

[0044] Those skilled in the art will recognize that salts of compounds share biological utility with their corresponding non-salt forms because, under environmental and physiological conditions, salts are in equilibrium with their corresponding non-salt forms. Thus, a wide variety of salts of compounds of Formula 1 are useful for controlling plant diseases caused by fungal plant pathogens (i.e., suitable as pesticides). Salts of compounds of Formula 1 include, for example, acid addition salts with inorganic or organic acids such as hydrobromic acid, hydrochloric acid, nitric acid, phosphoric acid, sulfuric acid, acetic acid, butyric acid, fumaric acid, lactic acid, maleic acid, malonic acid, oxalic acid, propynoic acid, salicylic acid, tartaric acid, 4-toluenesulfonic acid, or valeric acid. When compounds of Formula 1 contain an acidic residue, such as a carboxylic acid, salts also include those formed with organic or inorganic bases, such as pyridine, triethylamine, or ammonia, or amides, hydrides, hydroxides, or carbonates of sodium, potassium, lithium, calcium, magnesium, or barium. Thus, the present invention includes compounds selected from Formula 1, their N-oxides and pesticide-suitable salts.

[0045] Compounds selected from Formula 1, their stereoisomers, N-oxides, and salts typically exist in more than one form; therefore, Formula 1 encompasses all crystalline and amorphous forms of the compounds represented by Formula 1. Amorphous forms include solid embodiments, such as waxes and gums, as well as liquid embodiments, such as solutions and melts. Crystalline forms include embodiments that represent a substantially single crystal type and embodiments that represent a mixture of polymorphs (i.e., multiple crystalline types). The term "polymorph" refers to a specific crystalline form of a compound that can crystallize in various crystalline forms, which have different molecular arrangements and / or conformations in the crystal lattice. Multiple polymorphs can have the same chemical composition, but they can also differ in composition due to the presence or absence of co-crystallized water or other molecules that may be weakly or strongly bound in the lattice. Polymorphs can differ in chemical, physical, and biological properties, such as crystal shape, density, hardness, color, chemical stability, melting point, hygroscopicity, suspendability, dissolution rate, and biological availability. Those skilled in the art will appreciate that a particular polymorph of the compound represented by Formula 1 may exhibit advantageous effects (e.g., suitability in preparing useful formulations, improved biological performance) compared to other polymorphs or mixtures of polymorphs of the same compound represented by Formula 1. The preparation and isolation of a particular polymorph of the compound represented by Formula 1 can be achieved by methods known to those skilled in the art, such as, for example, crystallization using selected solvents and temperatures.

[0046] As described in the Summary of the Invention, aspects of the present invention relate to compositions comprising (a) at least one compound selected from Formula 1, N-oxides and salts thereof, and (b) at least one additional fungicidal compound. More particularly, component (b) is: (b1) methyl benzimidazole carbamate (MBC) fungicide; (b2) dicarboximide fungicides, (b3) demethylation inhibitor (DMI) fungicides; (b4) phenylamide (PA) fungicides; (b5) amine / morpholine fungicides, (b6) phospholipid biosynthesis inhibitor fungicides, (b7) succinate dehydrogenase inhibitor (SDHI) fungicides; (b8) hydroxy(2-amino-)pyrimidine fungicides, (b9) anilinopyrimidine (AP) fungicides; (b10) N-phenylcarbamate fungicides, (b11) Quinone outside inhibitor (QoI) fungicides; (b12) phenylpyrrole (PP) fungicide; (b13) azanaphthalene fungicides, (b14) cell peroxidation inhibitor bactericide, (b15) melanin biosynthesis inhibitor-reductase (MBI-R) fungicides; (b16a) melanin biosynthesis inhibitor-dehydratase (MBI-D) fungicides; (b16b) Melanin biosynthesis inhibitor-polyketide synthase (MBI-P) fungicides, (b17) ketoreductase inhibitor (KRI) fungicides; (b18) squalene-epoxidase inhibitor fungicides, (b19) polyoxin fungicides, (b20) phenylurea fungicides, (b21) quinone inside inhibitor (QiI) fungicides; (b22) benzamide and thiazolecarboxamide fungicides, (b23) enopyranuronic acid antibiotic disinfectant, (b24) hexopyranosyl antibiotic fungicides, (b25) glucopyranosyl antibiotics: protein synthesis bactericides, (b26) glucopyranosyl antibiotic fungicides, (b27) cyanoacetamide oxime fungicides, (b28) carbamate fungicides, (b29) oxidative phosphorylation uncoupling fungicides, (b30) organotin fungicides, (b31) carboxylic acid fungicides, (b32) heterocyclic aromatic compound fungicides, (b33) phosphonate fungicides, (b34) phthalamic acid fungicides, (b35) benzotriazine fungicides, (b36) benzene-sulfonamide fungicides, (b37) pyridazinone fungicides, (b38) thiophene-carboxamide fungicides, (b39) Complex I NADH oxidoreductase inhibitor fungicide, (b40) carboxylic acid amide (CAA) fungicides, (b41) tetracycline antibiotic fungicides, (b42) thiocarbamate fungicides, (b43) benzamide fungicides, (b44) microbial disinfectants; (b45) quinone outside inhibitor, stigmatellin binding (QoSI) fungicides, (b46) plant extract fungicides, (b47) cyanoacrylate fungicides, (b48) polyene fungicides, (b49) oxysterol binding protein inhibitor (OSBPI) fungicides; (b50) aryl-phenyl-ketone fungicides, (b51) host plant defense-inducing fungicides, (b52) multi-site active fungicides; (b53) Biological agents with multiple mechanisms of action; (b54) Fungicides other than the fungicides of component (a) and components (b1) to (b53), and salts of compounds (b1) to (b54) is selected from the group consisting of:

[0047] Of note are embodiments in which component (b) comprises at least one fungicidal compound from each of two different groups selected from (b1) through (b54).

[0048] "Methyl benzimidazole carbamate (MBC) fungicide (b1)" (FRAC code 1) inhibits mitosis by binding to β-tubulin during microtubule assembly. Inhibition of microtubule assembly can disrupt cell division, intracellular transport, and cellular structure. Methyl benzimidazole carbamate fungicides include benzimidazole and thiophanate fungicides. Benzimidazoles include benomyl, carbendazim, fuberidazole, and thiabendazole. Thiophanates include thiophanate and thiophanate-methyl.

[0049] "Dicarboximide fungicides (b2)" (FRAC code 2) inhibit mitogen-activated protein (MAP) / histidine kinase in osmotic signaling. Examples include chlozolinate, dimethaclon, iprodione, procymidone, and vinclozolin.

[0050] "Demethylation inhibitor (DMI) fungicides (b3)" (FRAC code 3) (sterol biosynthesis inhibitors (SBI): Class I) inhibit the C14 demethylase involved in sterol production. Sterols, such as ergosterol, are required for membrane structure and function and are therefore essential for the development of functional cell walls. Exposure to these fungicides therefore results in the overgrowth and eventual death of susceptible fungi. DMI fungicides are divided into several chemical classes: piperazines, pyridines, pyrimidines, imidazoles, triazoles, and triazolinethiones. Piperazines include triforine. Pyridines include buthiobate, pyrifenox, pyrisoxazole, and (αS)-[3-(4-chloro-2-fluorophenyl)-5-(2,4-difluorophenyl)-4-isoxazolyl]-3-pyridineemethanol. Pyrimidines include fenarimol, nuarimol, and triarimo. Imidazoles include econazole, imazalil, oxpoconazole, pefurazoate, prochloraz and triflumizole.Triazoles include azaconazole, bitertanol, bromuconazole, cyproconazole, difenoconazole, diniconazole (including diniconazole-M), epoxiconazole, etaconazole, fenbuconazole, fluquinconazole, flusilazole, flutriafol, hexaconazole, imibenconazole, ipconazole, ipfentrifluconazole, mefentrifluconazole, metconazole, myclobutanil, penconazole, propiconazole, quinconazole, simeconazole, tebuconazole, tetraconazole, triadimefon, triadimenol, triticonazole, uniconazole, uniconazole-P, α-(1-chlorocyclopropyl)-α-[2-(2-methylpropyl)-2-methyl ... Triazolinethiones include prothioconazole. Biochemical investigations have shown that all of the above fungicides are DMI fungicides, as described by KH Kuck et al. in Modern Selective Fungicides - Properties, Applications and Mechanisms of Action, H. Lyr (Ed.), Gustav Fischer Verlag: New York, 1995, pp. 205-258.

[0051] "Phenylamide (PA) fungicides (b4)" (FRAC code 4) are specific inhibitors of RNA polymerase in Oomycete fungi. Susceptible fungi exposed to these fungicides exhibit a reduced ability to incorporate uridine into rRNA. Exposure to this class of fungicide inhibits the growth and development of susceptible fungi. Phenylamide fungicides include acylalanine, oxazolidinone, and butyrolactone fungicides. Acylalanines include benalaxyl, benalaxyl-M (also known as chiralaxyl), furalaxyl, metalaxyl, and metalaxyl-M (also known as mefenoxam). Oxazolidinones include oxadixyl. Butyrolactones include ofurace.

[0052] "Amine / morpholine fungicides (b5)" (FRAC code 5) (SBI: class II) target two sites in the sterol biosynthetic pathway, Δ 8 →Δ 7 Isomerase and Δ 14 They inhibit reductase. Sterols, such as ergosterol, are required for membrane structure and function and are therefore essential for the development of functional cell walls. Therefore, exposure to these fungicides results in the overgrowth and eventual death of susceptible fungi. Amine / morpholine fungicides (also known as non-DMI sterol biosynthesis inhibitors) include morpholine, piperidine, and spiroketal-amine fungicides. Morpholines include aldimorph, dodemorph, fenpropimorph, tridemorph, and trimorphamide. Piperidines include fenpropidin and piperaline. Spiroketal amines include spiroxamine.

[0053] "Phospholipid biosynthesis inhibitor fungicides (b6)" (FRAC code 6) inhibit fungal growth by affecting the biosynthesis of phospholipids. Phospholipid biosynthesis inhibitor fungicides include phosphorothiolate fungicides and dithiolane fungicides. Phosphorothiolates include edifenphos, iprobenfos, and pyrazophos. Dithiolanes include isoprothiolane.

[0054] "Succinate dehydrogenase inhibitor (SDHI) fungicides (b7)" (FRAC code 7) inhibit the respiration of complex II fungi by blocking succinate dehydrogenase, a key enzyme in the Krebs cycle (TCA cycle). When respiration is inhibited, fungi are unable to produce ATP, resulting in impaired growth and reproduction. SDHI fungicides include phenylbenzamide, phenyloxoethylthiophenamide, pyridinylethylbenzamide, furancarboxamide, oxathiinecarboxamide, thiazolecarboxamide, pyrazole-4-carboxamide, N-cyclopropyl-N-benzyl-pyrazolecarboxamide, N-methoxy-(phenyl-ethyl)-pyrazolecarboxamide, pyridinecarboxamide, and pyrazinecarboxamide fungicides. Phenylbenzamides include benodanil, flutolanil, and mepronil. Phenyloxoethylthiophenamides include isofetamide. Pyridinylethylbenzamides include fluopyram. Furancarboxamides include fenfuram. Oxathiincarboxamides include carboxin and oxycarboxin. Thiazolecarboxamides include thifluzamide. Pyrazole-4-carboxamides include benzovindiflupyr, bixafen, fluveneteram (tentative name, registration number 1676101-39-5), fluindapyr, fluxapyroxad, furametpyr, inpirfluxam, isopyrazam, penflufen, penthiopyrad, pyrapropoin (tentative name, registration number 1803108-03-3), sedaxane, and N-[2-(2,4-dichlorophenyl)-2-methoxy-1-methylethyl]-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide. N-cyclopropyl-N-benzyl-pyrazolecarboxamides include isoflucipram. N-methoxy-(phenylethyl)-pyrazolecarboxamides include pydiflumetofen. Pyridinecarboxamides include boscalid. Pyrazinecarboxamides include pyraziflumide.

[0055] "Hydroxy-(2-amino-)pyrimidine fungicides (b8)" (FRAC code 8) inhibit nucleic acid synthesis by inhibiting adenosine deaminase. Examples include bupirimate, dimethirimol, and ethirimol.

[0056] "Anilinopyrimidine (AP) fungicides (b9)" (FRAC code 9) are proposed to inhibit the biosynthesis of the amino acid methionine and the secretion of hydrolytic enzymes that lyse plant cells upon infection. Examples include cyprodinil, mepanipyrim, and pyrimethanil.

[0057] "N-phenylcarbamate fungicides (b10)" (FRAC code 10) inhibit mitosis by binding to beta-tubulin and disrupting microtubule assembly. Inhibition of microtubule assembly can disrupt cell division, intracellular transport, and cellular structure. Examples include diethofencarb.

[0058] Quinone outside inhibitor (QoI) fungicides (b11) (FRAC code 11) inhibit complex III of fungal mitochondrial respiration by affecting ubiquinol oxidase. The oxidation of ubiquinol is inhibited at the "quinone outside" (Qo) site of the cytochrome bc1 complex present in the inner mitochondrial membrane of fungi. Inhibiting mitochondrial respiration prevents normal growth and development of fungi. Quinone outside inhibitor fungicides include methoxyacrylate, methoxyacetamide, methoxycarbamate, oximinoacetate, oximinoacetamide, and dihydrodioxazine fungicides (collectively known as strobilurin fungicides), as well as oxazolidinedione, imidazolinone, and benzylcarbamate fungicides. Methoxyacrylates include azoxystrobin, cumoxystrobin, enoxastrobin (also known as enestrobin), flufenoxystrobin, picoxystrobin, and pyraoxystrobin. Methoxyacetamides include mandestrobin. Methoxycarbamates include pyraclostrobin, pyrametostrobin, and triclopyricarb. Oximinoacetates include kresoxim-methyl and trifloxystrobin. Oximinoacetamides include dimoxystrobin, phenaminestrobin, metominostrobin, and orysastrobin. Dihydrodioxazines include fluoxastrobin. Oxazolidinediones include famoxadone. Imidazolinones include fenamidone. Benzylcarbamates include pyribencarb.

[0059] "Phenylpyrrole (PP) fungicides (b12)" (FRAC code 12) are fungicides that inhibit MAP / histidine kinases involved in osmotic signaling in fungi. Fenpiclonil and fludioxonil are examples of this class of fungicides.

[0060] "Azanaphthalene fungicides (b13)" (FRAC code 13) are proposed to inhibit signal transduction by an unknown mechanism. They have been shown to interfere with germination and / or appressorium formation of fungi that cause powdery mildew diseases. Azanaphthalene fungicides include aryloxyquinolines and quinazolinones. Aryloxyquinolines include quinoxyfen. Quinazolinones include proquinazide.

[0061] "Cellular peroxidation inhibitor fungicides (b14)" (FRAC code 14) have been proposed to inhibit lipid peroxidation, which affects fungal membrane synthesis. Members of this class, such as etridiazole, may also affect other biological processes, such as respiration and melanin biosynthesis. Cellular peroxidation fungicides include aromatic hydrocarbon and 1,2,4-thiadiazole fungicides. Aromatic hydrocarbon fungicides include biphenyl, chloroneb, dicloran, quintozene, tecnazene, and tolclofos-methyl. 1,2,4-thiadiazoles include etridiazole.

[0062] "Melanin biosynthesis inhibitor-reductase (MBI-R) fungicides (b15)" (FRAC code 16.1) inhibit the naphthal reduction step of melanin biosynthesis. Melanin is necessary for infection of host plants by some fungi. Melanin biosynthesis inhibitor-reductase fungicides include isobenzofuranone, pyrroloquinolinone, and triazolobenzothiazole fungicides. Isobenzofuranones include phthalides. Pyrroloquinolinones include pyroquilon. Triazolobenzothiazoles include tricyclazole.

[0063] "Melanin biosynthesis inhibitor-dehydratase (MBI-D) fungicides (b16a)" (FRAC code 16.2) inhibit scytalone dehydratase in melanin biosynthesis. Melanin is required for host plant infection by some fungi. Melanin biosynthesis inhibitor-dehydratase fungicides include cyclopropanecarboxamide, carboxamide, and propionamide fungicides. Cyclopropanecarboxamides include carpropamid. Carboxamides include diclocymet. Propionamides include fenoxanil.

[0064] "Melanin biosynthesis inhibitor-polyketide synthase (MBI-P) fungicides (b16b)" (FRAC code 16.3) are compounds that inhibit polyketide synthase in melanin biosynthesis. Melanin is required for infection of host plants by some fungi. Melanin biosynthesis inhibitor-polyketide synthase fungicides include trifluoroethylcarbamate fungicides. Trifluoroethylcarbamate fungicides include tolprocarb.

[0065] "Ketoreductase inhibitor (KRI) fungicides (b17)" (FRAC code 17) inhibit 3-ketoreductase during C4-demethylation in sterol production. Ketoreductase inhibitor fungicides (also known as sterol biosynthesis inhibitors (SBI): Class III) include hydroxyanilides and aminopyrazolinones. Hydroxyanilids include fenhexamid. Aminopyrazolinones include fenpyrazamine. Quinofumelin (tentative name, registration number 861647-84-9) and ipflufenoquin (tentative name, registration number 1314008-27-9) are also considered to be ketoreductase inhibitor fungicides.

[0066] "Squalene-epoxidase inhibitor fungicides (b18)" (FRAC code 18) (SBI: Class IV) inhibit squalene epoxidase in the sterol biosynthetic pathway. Sterols, such as ergosterol, are required for membrane structure and function and are therefore essential for the development of functional cell walls. Therefore, exposure to these fungicides results in the overgrowth and eventual death of susceptible fungi. Squalene epoxidase inhibitor fungicides include thiocarbamate fungicides and allylamine fungicides. Thiocarbamates include pyributicarb. Allylamines include naftifine and terbinafine.

[0067] "Polyoxin fungicides (b19)" (FRAC code 19) inhibit chitin synthase. Examples include polyoxins.

[0068] "Phenylurea fungicides (b20)" (FRAC code 20) are proposed to affect cell division. Examples include pencycuron.

[0069] Quinone inside inhibitor (QiI) fungicides (b21) (FRAC code 21) inhibit complex III of fungal mitochondrial respiration by affecting ubiquinone reductase. The reduction of ubiquinone is prevented at the "quinone inside" (Qi) site of the cytochrome bc1 complex present in the inner mitochondrial membrane of fungi. By inhibiting mitochondrial respiration, they disrupt the normal growth and development of fungi. Quinone inside inhibitor fungicides include cyanoimidazoles, sulfamoyltriazoles, and picolinamide fungicides. Cyanoimidazoles include cyazofamid. Sulfamoyltriazoles include amisulbrom. Picolinamides include fenpicoxamid (registration number 517875-34-2).

[0070] "Benzamide and thiazolecarboxamide fungicides (b22)" (FRAC code 22) inhibit mitosis by binding to beta-tubulin and disrupting microtubule assembly. Inhibition of microtubule assembly can disrupt cell division, intracellular transport, and cellular structure. Benzamides include toluamides such as zoxamide. Thiazolecarboxamides include ethylaminothiazolecarboxamides such as ethaboxam.

[0071] "Enopyranuronic acid antibiotic fungicides (b23)" (FRAC code 23) are those that inhibit fungal growth by affecting protein biosynthesis. Examples include blasticidin-S.

[0072] "Hexopyranosyl antibiotic fungicides (b24)" (FRAC code 24) are those that inhibit fungal growth by affecting phospholipid biosynthesis. Examples include kasugamycin.

[0073] "Glucopyranosyl antibiotics: protein synthesis fungicides (b25)" (FRAC code 25) are compounds that inhibit fungal growth by affecting protein biosynthesis. Examples include streptomycin.

[0074] "Glucopyranosyl antibiotic fungicides (b26)" (FRAC code U18, formerly FRAC code 26, reclassified as U18) are proposed to inhibit trehalase and inositol biosynthesis. Examples include validamycin.

[0075] "Cyanoacetamide oxime fungicides (b27)" (FRAC code 27) includes cymoxanil.

[0076] "Carbamate fungicides (b28)" (FRAC code 28) are considered multisite inhibitors of fungal growth. They are proposed to disrupt the synthesis of fatty acids in the cell membrane and subsequently disrupt the membrane's permeability. Iodocarb, propamacarb, and prothiocarb are examples of this class of fungicides.

[0077] "Oxidative phosphorylation uncoupling fungicides (b29)" (FRAC code 29) inhibit fungal respiration by blocking oxidative phosphorylation. Inhibiting respiration prevents normal growth and development of fungi. This class includes dinitrophenyl crotonates such as binapacryl, meptyldinocap, and dinocap, and 2,6-dinitroanilines such as fluazinam.

[0078] "Organotin fungicides (b30)" (FRAC code 30) inhibit adenosine triphosphate (ATP) synthesis in the oxidative phosphorylation pathway. Examples include fentin acetate, fentin chloride, and fentin hydroxide.

[0079] "Carboxylic acid fungicides (b31)" (FRAC code 31) inhibit fungal growth by acting on deoxyribonucleic acid (DNA) topoisomerase type II (gyrase). Examples include oxolinic acid.

[0080] "Heteroaromatic fungicides (b32)" (FRAC code 32) are proposed for affecting DNA / ribonucleic acid (RNA) synthesis. Heteroaromatic fungicides include isoxazoles and isothiazolones. Isoxazoles include hymexazole, and isothiazolones include octhilinone.

[0081] "Phosphonate fungicides (b33)" (FRAC code P07, formerly FRAC code 33, reclassified as P07) includes phosphorous acid and its various salts (including fosetylaluminium).

[0082] "Phthalamic acid fungicides (b34)" (FRAC code 34) includes tecloftalam.

[0083] "Benzotriazine fungicides (b35)" (FRAC code 35) includes triazoxide.

[0084] "Benzenesulfonamide fungicides (b36)" (FRAC code 36) includes flusulfamide.

[0085] "Pyridazinone fungicides (b37)" (FRAC code 37) includes diclomedine.

[0086] "Thiophene-carboxamide fungicides (b38)" (FRAC code 38) are proposed to affect ATP production. Examples include silthiofam.

[0087] "Complex I NADH oxidoreductase inhibitor fungicides (b39)" (FRAC code 39) inhibit electron transport in mitochondria and include pyrimidine amines such as diflumetrim, pyrazole-5-carboxamides such as tolfenpyrad, and quinazolines such as fenazaquin.

[0088] "Carboxylic acid amide (CAA) fungicides (b40)" (FRAC code 40) inhibit cellulose synthetase, preventing the growth of and killing target fungi. Carboxylic acid amide fungicides include cinnamic acid amide, carbamic acid valinamide, and mandelic acid amide fungicides. Cinnamic acid amides include dimethomorph, flumorph, and pyrimorph. Carbamic acid valinamides include benthiavalicarb, benthiavalicarb-isopropyl, iprovalcarb, and cinnamic acid amides. Bu and Mandelamides include mandipropamide, N-[2-[4-[[3-(4-chlorophenyl)-2-propyn-1-yl]oxy]-3-methoxyphenyl]ethyl]-3-methyl-2-[(methylsulfonyl)amino]butanamide, and N-[2-[4-[[3-(4-chlorophenyl)-2-propyn-1-yl]oxy]-3-methoxyphenyl]ethyl]-3-methyl-2-[(ethylsulfonyl)amino]butanamide.

[0089] "Tetracycline antibiotic fungicides (b41)" (FRAC code 41) are those that inhibit fungal growth by affecting protein synthesis. Examples include oxytetracycline.

[0090] "Thiocarbamate fungicides (b42)" (FRAC code M12, formerly FRAC code 42, reclassified to M12) includes metasulfocarb.

[0091] "Benzamide fungicides (b43)" (FRAC code 43) inhibit fungal growth by delocalizing spectrin-like proteins. Examples include pyridinylmethylbenzamides such as fluopicolide and fluopimomide.

[0092] "Microbicides (b44)" (FRAC code BM02, formerly FRAC code 44 but reclassified to BM02) disrupt the cell membranes of fungal pathogens. Microbicides include Bacillus species, such as Bacillus amyloliquefaciens strains AP-136, AP-188, AP-218, AP-219, AP-295, QST713, FZB24, F727, MB1600, D747, and TJ100 (also known as strain 1 BE; known from EP 2962568), and the bactericidal lipopeptides they produce.

[0093] "Quinone outside inhibitor, stigmatellin-binding (QoSI) fungicides (b45)" (FRAC code 45) inhibit complex III mitochondrial respiration in fungi by affecting ubiquinone reductase at the "quinone outside" (Qo) site, the stigmatellin-binding subsite, of the cytochrome bc1 complex. Inhibition of mitochondrial respiration prevents normal growth and development of fungi. QoSI fungicides include triazolopyrimidylamines, such as ametocladine.

[0094] "Plant extract fungicides (b46)" (FRAC code 46) cause cell membrane disruption. Plant extract fungicides include terpene hydrocarbons, terpene alcohols and terpene phenols, such as extracts from Melaleuca alternifolia (tea tree), and vegetable oils (mixtures), such as eugenol, geraniol, and thymol.

[0095] "Cyanoacrylate fungicide (b47)" (FRAC code 47) binds to the myosin motor domain and affects motor activity and actin assembly. Cyanoacrylates include fungicides such as Fenamacryl.

[0096] "Polyene fungicides (b48)" (FRAC code 48) bind to ergosterol, the main membrane sterol, causing destruction of fungal cell membranes. Examples include natamycin (pimaricin).

[0097] "Oxysterol-binding protein inhibitor (OSBPI) fungicides (b49)" (FRAC code 49) bind to oxysterol-binding proteins of oomycetes and inhibit zoospore release, zoospore motility, and sporangial germination. Oxysterol-binding fungicides include piperidinylthiazole isoxazolines such as oxathiapiprolin and fluoxapiprolin.

[0098] "Aryl-phenyl-ketone fungicides (b50)" (FRAC code 50, formerly FRAC code U8, reclassified to 50) inhibit the growth of fungal mycelia. Aryl phenyl ketone fungicides include benzophenones such as metrafenone and benzoylpyridines such as pyriophenone.

[0099] "Host plant defense-inducing fungicides (b51)" induce the defense mechanisms of host plants. Host plant defense-inducing fungicides include benzothiadiazoles (FRAC code P01), benzisothiazoles (FRAC code P02), thiadiazolecarboxamides (FRAC code P03), polysaccharides (FRAC code P04), plant extracts (FRAC code P05), microorganisms (FRAC code P06), and phosphonate fungicides (FRAC code P07, see (b33) above). Benzisothiazoles include acibenzolar-S-methyl. Benzisothiazoles include probenazole. Thiadiazolecarboxamides include tiadinil and isotianil. Polysaccharides include laminarin. Plant extracts include extracts from Reynoutria sachalinensis (giant knotweed). The microorganisms included the cell walls of Bacillus mycoides isolate J and Saccharomyces cerevisiae strain LAS117.

[0100] "Multi-site active fungicides (b52)" are fungicides that inhibit fungal growth through multiple sites of action and have contact / preventive activity. Multi-site active fungicides include copper fungicides (FRAC code M01), sulfur fungicides (FRAC code M02), dithiocarbamate fungicides (FRAC code M03), phthalimide fungicides (FRAC code M04), chloronitrile fungicides (FRAC code M05), sulfamide fungicides (FRAC code M06), multi-site contact guanidine fungicides (FRAC code M07), triazine fungicides (FRAC code M08), quinone fungicides (FRAC code M09), quinoxaline fungicides (FRAC code M10), maleimide fungicides (FRAC code M11), and thiocarbamate (FRAC code M12, see (b42) above) fungicides. Copper fungicides are typically inorganic compounds containing copper in the copper(II) oxidation state; examples include copper oxychloride, copper sulfate, and copper hydroxide (including compositions such as Bordeaux's mixture (tribasic copper sulfate)). Sulfur fungicides are inorganic chemicals containing rings or chains of sulfur atoms; examples include elemental sulfur. Dithiocarbamate fungicides are fungicides containing a dithiocarbamate molecular moiety; examples include ferbam, mancozeb, maneb, metiram, propineb, thiram, zinc thiazole, zineb, and ziram. Phthalimide fungicides contain a phthalimide molecular moiety; examples include folpet, captan, and captafol. Chloronitrile fungicides contain aromatic rings substituted with chloro and cyano; examples include chlorothalonil. Sulfamide fungicides include dichlofluanid and trifluanid. Multi-site contact guanidine fungicides include guazatine, iminooctadine albesilate, and iminooctadine triacetate. Triazine fungicides include anilazine, quinone fungicides include dithianon, quinoxaline fungicides include quinomethionate (also known as thinomethionate), and maleimide fungicides include fluoroimide.

[0101] "Biological products with multiple modes of action (b53)" include agents of biological origin that exhibit multiple modes of action without evidence of a dominant mode of action. This class of fungicides includes polypeptide (lectin), phenol, sesquiterpene, tritepenoid and coumarin fungicides (FRAC code BMO1), such as extracts from cotyledons of lupine plantlets. This class also includes momomicron fungicides (FRAC code BMO2, see above (b44)).

[0102] "Fungicides other than those of components (a) and (b1) through (b53); (b54)" includes certain fungicides whose mechanism of action may be unknown. These include (b54.1) "phenyl-acetamide fungicides" (FRAC code U06), (b54.2) "guanidine fungicides" (FRAC code U12), (b54.3) "thiazolidine fungicides" (FRAC code U13), (b54.4) "pyrimidinone-hydrazone fungicides" (FRAC code U14), (b54.5) "4-quinolyl acetate fungicides" (FRAC code U16), (b54.6) "tetrazolyl oxime fungicides" (FRAC code U17), and "glucopyranosyl antibiotic fungicides" (FRAC code U18; see (b26) above). Phenylacetamides include cyflufenamid. Guanidines include dodine. Thiazolidinedione includes fluthianil, pyrimidinone hydrazone includes ferimzone, 4-quinolyl acetate includes tebufloquine, and tetrazolyl oxime includes picarbutrazox.

[0103] The (b54) class includes bethoxadin, diclobenthiazox (tentative name, registration number 957144-77-3), dipimethitron (tentative name, registration number 16114-35-5), flometoquin, neoasozine (iron methanearsonate), pyrrolnitrin, tolnifanide (registration number 304911-98-6), N'-[4-[4-chloro-3-(trifluoromethyl)phenoxy]-2,5-dimethyl-phenyl]-N-ethyl-N-methylmethanimidamide, 5-fluoro-2-[(4-fluorophenyl)methoxy]-4-pyrimidinamine, and 4-fluoro-phenyl N-[1-[[[1-(4-cyanophenyl)ethyl]sulfonyl]methyl]propyl]carbamate.

[0104] Additional "fungicides other than those of classes (1) to (54)" whose mechanism of action may be unknown or cannot yet be classified include fungicidal compounds selected from components (b54.7) to (b54.12) below.

[0105] Ingredient (54.7) relates to (1S)-2,2-bis(4-fluorophenyl)-1-methylethyl N-[[3-(acetyloxy)-4-methoxy-2-pyridinyl]carbonyl]-L-alaninate (tentative name florylpicoxamide, registration number 1961312-55-9), which is believed to be a quinone inside inhibitor (QiI) fungicide (FRAC code 21) that inhibits complex III mitochondrial respiration in fungi.

[0106] Ingredient (54.8) relates to 1-[2-[[[1-(4-chlorophenyl)-1H-pyrazol-3-yl]oxy]methyl]-3-methylphenyl]-1,4-dihydro-4-methyl-5H-tetrazol-5-one (tentative name Methyltetraprole, registration number 1472649-01-6), which is considered to be a quinone outside inhibitor (QoI) fungicide (FRAC code 45) that inhibits complex III mitochondrial respiration in fungi and is effective against QoI-resistant strains.

[0107] Ingredient (54.9) relates to 3-chloro-4-(2,6-difluorophenyl)-6-methyl-5-phenylpyridazine (provisional name pyridaclomethyl, registration number 1358061-55-8), which is believed to be a tubulin polymerization promoter and provides antifungal activity against fungal species belonging to the Ascomycota and Basidiomycota phyla.

[0108] Ingredient (54.10) relates to (4-phenoxyphenyl)methyl 2-amino-6-methyl-pyridine-3-carboxylate (provisional name: aminopyrifen, registration number 1531626-08-0), which is thought to inhibit the GWT-1 protein in glycosylphosphatidylinositol-anchor biosynthesis in Neurospora crassa.

[0109] The component (b54.11) is given by the formula b54.11 [ka] (In the formula, R b1 and R b3 are each independently a halogen; and R b2 is H, halogen, C1-C3 alkyl, C1-C3 haloalkyl, or C3-C6 cycloalkyl) The present invention relates to the compound

[0110] Examples of compounds of formula b54.11 include (b54.11a) methyl N-[[5-[1-(2,6-difluoro-4-formylphenyl)-1H-pyrazol-3-yl]-2-methylphenyl]methyl]carbamate, (b54.11b) methyl N-[[5-[1-(4-cyclopropyl-2,6-dichlorophenyl)-1H-pyrazol-3-yl]-2-methylphenyl]methyl]carbamate, (b54.11c) methyl N-[[5-[1-(4-chloro-2,6-difluorophenyl)-1H-pyrazol-3-yl]-2-methylphenyl]methyl]carbamate, (b 54.11d) methyl N-[[5-[1-(4-cyclopropyl-2,6-difluorophenyl)-1H-pyrazol-3-yl]-2-methylphenyl]methyl]carbamate, (b54.11e) methyl N-[[5-[1-[2,6-difluoro-4-(1-methylethyl)phenyl]-1H-pyrazol-3-yl]-2-methylphenyl]methyl]carbamate and (b54.11f) methyl N-[[5-[1-[2,6-difluoro-4-(trifluoromethyl)phenyl]-1H-pyrazol-3-yl]-2-methylphenyl]methyl]carbamate. Compounds of formula b54.11, their use as fungicides and methods for their preparation are generally known, see, for example, PCT Patent Publications WO 02008 / 124092, WO 2014 / 066120 and WO 2020 / 097012.

[0111] Methyl The component (b54.12) is the formula b54.12 [ka] (In the formula, R b4 teeth, [ka] and R b6 is a C2-C4 alkoxycarbonyl or a C2-C4 haloalkylaminocarbonyl, L is CH2 or CH2O, where the atom on the right is attached to the phenyl ring in formula b54.12; R b5 teeth, [ka] and R b7 is a C1-C3 alkyl, where the wavy bond indicates that the adjacent double bond is in the (Z)- or (E)-configuration or a mixture thereof. The present invention relates to the compound

[0112] Examples of compounds of formula b54.12 are (b54.12a) N-(2,2,2-trifluoroethyl)-2-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-4-oxazolecarboxamide, (b54.12b) ethyl 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenoxy]methyl]-1H-pyrazole-4-carboxamide, carboxylate, (b54.12c) ethyl 1-[[4-[[(1Z)-2-ethoxy-3,3,3-trifluoro-1-propen-1-yl]oxy]phenyl]methyl]-1H-pyrazole-4-carboxylate, and (b54.12d) ethyl 1-[[4-[[2-(trifluoromethyl)-1,3-dioxolan-2-yl]methoxy]phenyl]methyl]-1H-pyrazole-4-carboxylate. Compounds of formula b54.12, their use as fungicides and methods for their preparation are generally known, see, for example, PCT Patent Publications WO 2008 / 187553 and WO 2020 / 056090.

[0113] Embodiments of the invention described in the Summary of the Invention include those described below. In the following embodiments, Formula 1 includes its stereoisomers, N-oxides, and salts, and references to "compounds of Formula 1" include the definitions of the substituents defined in the Summary of the Invention, unless further defined in the embodiments.

[0114] Embodiment 1. In Formula 1, R 1 A composition comprising components (a) and (b) as described in the Summary of the Invention, wherein

[0115] Embodiment 2. In Formula 1, R 1 A composition comprising components (a) and (b) as described in the Summary of the Invention, wherein

[0116] Embodiment 3.R 2 A composition comprising components (a) and (b) as described in the Summary of the Invention (herein, in Formula 1) or Embodiment 1 or 2, wherein is cyano, halogen, or C1-C2 alkyl.

[0117] Embodiment 4.R 2 A composition comprising components (a) and (b) as described in the Summary of the Invention (herein, in Formula 1) or Embodiment 1 or 2, wherein is cyano, Br, Cl, F, C1-C2 alkyl, or C1-C2 haloalkyl.

[0118] Embodiment 5.R 2 is cyano, Br, Cl, F, C1-C2 alkyl, or halomethyl.

[0119] Embodiment 6.R 2 is cyano, Br, Cl, F, C1-C2 alkyl, or CF3.

[0120] Embodiment 7.R 2 is cyano, Br, Cl, F, or C1-C2 alkyl.

[0121] Embodiment 8.R 2 is cyano or C1-C2 alkyl.

[0122] Embodiment 9.R 2 is C1-C2 alkyl.

[0123] Embodiment 10.R2 is cyano or methyl.

[0124] Embodiment 11.R 2 is methyl.

[0125] Embodiment 12.R 2 is Br, Cl, or methyl.

[0126] Embodiment 13.R 3 A composition comprising components (a) and (b) as described in the Summary of the Invention (herein, in Formula 1) or any one of Embodiments 1-12, wherein is halogen or methyl.

[0127] Embodiment 13a.R 3 is a halogen.

[0128] Embodiment 13b.R 3 is Br, Cl, F, or methyl.

[0129] Embodiment 14.R 3 is Br, Cl, or F.

[0130] Embodiment 15.R 3 is Cl or F.

[0131] Embodiment 16.R 3 The composition of embodiment 15, wherein is Cl.

[0132] Embodiment 17.R 3 is F.

[0133] Embodiment 18.R 3 is Cl, F, or methyl.

[0134] Embodiment 19.R3 is Cl or methyl.

[0135] Embodiment 20.R 3 is methyl.

[0136] Embodiment 21. Each R 4 is independently halogen, cyano, C1-C2 alkyl, C1-C2 alkoxy, C1-C2 haloalkoxy, C2-C4 alkenyloxy, C2-C4 alkynyloxy, C2-C4 cyanoalkoxy, C2-C4 alkoxyalkyl, or C2-C4 alkoxyalkoxy.

[0137] Embodiment 22. Each R 4 is independently halogen, cyano, methyl, methoxy, halomethoxy, C2-C4 alkenyloxy, C2-C4 alkynyloxy, C2-C4 cyanoalkoxy, C2-C4 alkoxyalkyl, or C2-C4 alkoxyalkoxy.

[0138] Embodiment 23. Each R 4 is independently halogen, cyano, methyl, methoxy, halomethoxy, C2-C4 alkenyloxy, C2-C4 alkynyloxy, or C2-C4 cyanoalkoxy.

[0139] Embodiment 24. Each R 4 is independently halogen, cyano, methyl, methoxy, halomethoxy, or C2-C4 cyanoalkoxy.

[0140] Embodiment 25. Each R 4 is independently halogen, cyano, methyl, or methoxy.

[0141] Embodiment 25a. Each R 4is independently halogen, cyano, or methoxy.

[0142] Embodiment 25b. Each R 4 is independently halogen, cyano, or methyl.

[0143] Embodiment 26. Each R 4 is independently Br, Cl, F, cyano, methyl, or methoxy.

[0144] Embodiment 27. Each R 4 is independently Br, Cl, F, cyano, or methoxy.

[0145] Embodiment 28. Each R 4 is independently Cl, F, cyano, or methoxy.

[0146] Embodiment 29. Each R 4 is independently Br, Cl, or F.

[0147] Embodiment 30. Each R 4 is independently Cl or F.

[0148] Embodiment 31. Each R 4 The composition of embodiment 30, wherein is Cl. Embodiment 32. Each R 4 is F.

[0149] Embodiment 33. Each R 4 A composition comprising components (a) and (b) as described in the Summary of the Invention (herein, in Formula 1) or any one of Embodiments 1-32, wherein

[0150] Embodiment 34. Each R 4is independently a halogen.

[0151] Embodiment 35. Each R 4 is independently Br, Cl, or F or cyano.

[0152] Embodiment 36. A composition comprising components (a) and (b) as described in the Summary of the Invention (herein, in Formula 1) or any one of Embodiments 1-35, wherein m is 0, 1, or 2.

[0153] Embodiment 37. The composition of embodiment 36, wherein m is 1 or 2.

[0154] Embodiment 38. The composition of embodiment 37, wherein m is 1.

[0155] Embodiment 39. The composition of embodiment 38, wherein m is 2.

[0156] Embodiment 40. Each R 5 is independently halogen, C1-C2 alkyl, C2-C4 alkoxyalkyl, C1-C2 alkoxy, C1-C2 haloalkoxy, C2-C4 alkenyloxy, C2-C4 alkynyloxy, C2-C4 cyanoalkoxy, or C2-C4 alkoxyalkoxy.

[0157] Embodiment 41. Each R 5 is independently halogen, methyl, methoxy, halomethoxy, C2-C4 alkenyloxy, C2-C4 alkynyloxy, or C2-C4 cyanoalkoxy.

[0158] Embodiment 42. Each R 5 is independently halogen, methyl, methoxy, halomethoxy, C2-C4 alkenyloxy, or C2-C4 cyanoalkoxy.

[0159] Embodiment 43. Each R 5 is independently halogen, methyl, methoxy, halomethoxy, or C2-C4 cyanoalkoxy.

[0160] Embodiment 44. Each R 5 is independently halogen, methyl, or methoxy.

[0161] Embodiment 45. Each R 5 is independently Br, Cl, F, methyl, or methoxy.

[0162] Embodiment 46. Each R 5 is independently Br, Cl, F, or methoxy.

[0163] Embodiment 46a. Each R 5 is independently Br, Cl, or F.

[0164] Embodiment 47. Each R 5 is independently Cl, F, or methoxy.

[0165] Embodiment 48. Each R 5 is independently Cl or F.

[0166] Embodiment 49. Each R 5 is independently Br, Cl, F, or methyl.

[0167] Embodiment 50. Each R 5 is independently F or methyl.

[0168] Embodiment 51. Each R 5 is F.

[0169] Embodiment 52. The composition of Formula 1 or any one of Embodiments 1-51, wherein n is 0, 1, or 2.

[0170] Embodiment 53. The composition of embodiment 52, wherein n is 1 or 2.

[0171] Embodiment 54. The composition of embodiment 53, wherein n is 1.

[0172] Embodiment 55. The composition of embodiment 53, wherein n is 2.

[0173] Embodiment 56.R 6 but H; or R 6a C1-C3 alkyl or C1-C3 haloalkyl, each optionally substituted with up to one substituent selected from: amino, C2-C3 alkenyl, C2-C3 alkynyl, cyclopropyl, CH(=O), S(=O)2OM, S(=O) u R 7 , (C=W)R 8 OR 9 A composition comprising components (a) and (b) as described in the Summary of the Invention (herein, in Formula 1) or any one of Embodiments 1 to 55, wherein

[0174] Embodiment 57.R 6 but H; or R 6a C1-C3 alkyl or C1-C3 haloalkyl, each optionally substituted with up to one substituent selected from: cyclopropyl, S(=O)2OM, S(=O) u R 7 , (C=W)R 8 OR 9 57. The composition of embodiment 56, wherein

[0175] Embodiment 58.R 6 but H; or R 6a C1-C2 alkyl or C1-C2 haloalkyl, each optionally substituted with up to one substituent selected from: u R 7 OR9 58. The composition of embodiment 57, wherein

[0176] Embodiment 59.R 6 but H; or R 6a The composition of embodiment 58, wherein the alkyl, alkyl group, or haloalkyl group is C1-C2 alkyl or C1-C2 haloalkyl, each optionally substituted with up to one substituent selected from:

[0177] Embodiment 60.R 6 is H, C1-C2 alkyl, or C1-C2 haloalkyl.

[0178] Embodiment 61.R 6 is H, methyl, or halomethyl.

[0179] Embodiment 62.R 6 is H, methyl, or trifluoromethyl.

[0180] Embodiment 63.R 6 is H or methyl.

[0181] Embodiment 64.R 6 is H.

[0182] Embodiment 65. Each R 6a is independently cyano, C3-C6 cycloalkyl, or C1-C3 alkoxy.

[0183] Embodiment 66. Each R 6a is independently cyano, cyclopropyl, or methoxy.

[0184] Embodiment 67. Each R 6a is independently cyano or cyclopropyl.

[0185] Embodiment 68. A composition comprising components (a) and (b) as described in the Summary of the Invention (herein, in Formula 1) or any one of Embodiments 1 through 58, wherein u is 0.

[0186] Embodiment 69.R 7 A composition comprising components (a) and (b) as described in the Summary of the Invention (herein, in Formula 1) or any one of Embodiments 1-58, wherein is methyl or halomethyl.

[0187] Embodiment 70. A composition comprising components (a) and (b) as described in the Summary of the Invention (herein, in Formula 1) or any one of Embodiments 1-57, wherein W is O.

[0188] Embodiment 71.R 8 A composition comprising components (a) and (b) as described in the Summary of the Invention (herein, in Formula 1) or any one of Embodiments 1-57, wherein is C1-C3 alkyl, C1-C3 alkoxy, or C1-C3 alkylthio.

[0189] Embodiment 72.R 8 is methyl, ethyl, methoxy, ethoxy, methylthio, or ethylthio.

[0190] Embodiment 73.R 8 is methyl, methoxy, or methylthio.

[0191] Embodiment 74.R 9 but H; or R 9a C1-C3 alkyl or C1-C3 haloalkyl, each optionally substituted with up to one substituent selected from: 10 A composition comprising components (a) and (b) as described in the Summary of the Invention (herein, in Formula 1) or any one of Embodiments 1-58, wherein

[0192] Embodiment 75.R 9 but H; or R9a The composition of embodiment 74, wherein the alkyl, alkyl group, or haloalkyl group is C1-C2 alkyl or C1-C2 haloalkyl, each optionally substituted with up to one substituent selected from:

[0193] Embodiment 76. Each R 9a is independently cyano, C-C cycloalkyl, or C-C alkoxy.

[0194] Embodiment 77. Each R 9a is independently cyano, cyclopropyl, or methoxy.

[0195] Embodiment 78. Each R 9a is independently cyano or cyclopropyl.

[0196] Embodiment 79.R 10 A composition comprising components (a) and (b) as described in the Summary of the Invention (herein, in Formula 1) or any one of Embodiments 1-78, wherein is C1-C3 alkyl, C1-C3 alkoxy, or C1-C3 alkylthio.

[0197] Embodiment 80.R 10 is methyl, ethyl, methoxy, ethoxy, methylthio, or ethylthio.

[0198] Embodiment 81.R 10 is methyl, methoxy, or methylthio.

[0199] Embodiment 82. m is 1, and R 4 is at the 4-position (or para) relative to the bond of the phenyl ring to the remainder of Formula 1.

[0200] Embodiment 83. m is 1, and R 4 is at the 6-position (or ortho-position) relative to the attachment of the phenyl ring to the remainder of Formula 1.

[0201] Embodiment 84. m is 1, and R 4 is at the 4-position (or para) relative to the bond of the phenyl ring to the remainder of Formula 1, or m is 1, and R 4 A composition comprising components (a) and (b) as described in the Summary of the Invention (herein, in Formula 1) or any one of Embodiments 1-81, wherein:

[0202] Embodiment 85. m is 2 and 1 R 4 A composition comprising components (a) and (b) as described in the Summary of the Invention (herein, in Formula 1) or any one of Embodiments 1-81, wherein one is at the 4-position (or para-position) and the other is at the 6-position (or ortho-position) relative to the attachment of the phenyl ring to the remainder of Formula 1).

[0203] Embodiment 86. m is 1, and R 4 is at the 4-position (or para) relative to the bond of the phenyl ring to the remainder of Formula 1, or m is 1, and R 4 is at the 6-position (or ortho-position), or m is 2, and one R 4 A composition comprising components (a) and (b) as described in the Summary of the Invention (herein, in Formula 1) or any one of Embodiments 1-81, wherein one is at the 4-position (or para position) and the other is at the 6-position (or ortho position).

[0204] In embodiment 86a.m, 1 and R 4 is at the 4-position (or para) relative to the bond of the phenyl ring to the remainder of Formula 1, or m is 2 and one R 4 87. The composition of embodiment 86, wherein one is at the 4-position (or para position) and the other is at the 6-position (or ortho position).

[0205] Embodiment 87. n is 1, and R 5 is at the 4-position (or para) relative to the attachment of the nitrilino ring to the remainder of Formula 1.

[0206] Embodiment 88. n is 1, and R 5 is at the 6-position (or ortho-position) relative to the attachment of the nitrilino ring to the remainder of Formula 1.

[0207] Embodiment 89. n is 2 and 1 R 5 A composition comprising components (a) and (b) as described in the Summary of the Invention (herein, in Formula 1) or any one of Embodiments 1-86a, wherein one is at the 4-position (or para) and the other is at the 6-position (or ortho) relative to the attachment of the nitrilino ring to the remainder of Formula 1.

[0208] In an embodiment 90, n is 1, and R 5 is in the 4-position (or para-position) relative to the attachment of the nitrilino ring to the remainder of Formula 1, or n is 1, and R 5 is in the 6th position (or ortho position), or n is 2 and one R 5 A composition comprising components (a) and (b) as described in the Summary of the Invention (herein, in Formula 1) or any one of Embodiments 1-86a, wherein one is at the 4-position (or para position) and the other is at the 6-position (or ortho position).

[0209] Embodiment 91. m and n are each 1, and R 4 is in the 4-position (or para) relative to the attachment of the phenyl and nitroanilino rings to the remainder of Formula 1, and R 5 is at the 6-position (or ortho-position), or m is 1, and R4 is at the 4-position (or para position), and n is 2, and one R 5 is at the 4-position (or para-position) and the other is at the 6-position (or ortho-position), or m and n are each 1, and R 4 is in 4th place (or para place) and R 5 is at the 4-position (or para-position), or m is 2, and one R 4 is at the 4-position (or para position) and the other is at the 6-position (or ortho position), and n is 1, and R 5 is at the 6-position (or ortho-position).

[0210] Embodiment 92. m and n are each 1, and R 4 is in the 4-position (or para) relative to the attachment of the phenyl and nitroanilino rings to the remainder of Formula 1, and R 5 is at the 6-position (or ortho-position), or m is 1, and R 4 is at the 4-position (or para position), and n is 2, and one R 5 is at the 4-position (or para position) and the other is at the 6-position (or ortho position), m is 2, and one R 4 is at the 4-position (or para position) and the other is at the 6-position (or ortho position), and n is 1, and R 5 is at the 6-position (or ortho-position).

[0211] Embodiment 93. m and n are each 1, and R 4 is in the 4-position (or para) relative to the attachment of the phenyl and nitroanilino rings to the remainder of Formula 1, and R 5 is at the 6-position (or ortho-position), or m is 1, and R 4 is at the 4-position (or para position), and n is 2, and one R 5 93. The composition of embodiment 92, wherein one is at the 4-position (or para position) and the other is at the 6-position (or ortho position).

[0212] Embodiment 94. m and n are each 1, and R 4 is in 4th place (or para place) and R 5 is at the 6-position (or ortho-position).

[0213] Embodiment 95. m is 1, and R 4 is at the 4-position (or para position), and n is 2, and one R 5 94. The composition of embodiment 93, wherein one is at the 4-position (or para position) and the other is at the 6-position (or ortho position).

[0214] Embodiment 96. A composition comprising components (a) and (b) as described in the Summary of the Invention or any one of Embodiments 1 through 95, wherein component (a) does not comprise an N-oxide of a compound of Formula 1.

[0215] Embodiment 97. Component (a) is 4-(2-bromo-4,6-difluorophenyl)-N-(2-fluoro-6-nitrophenyl)-1,3-dimethyl-1H-pyrazol-5-amine (compound 1), 3-chloro-4-[5-[(2-chloro-4-fluoro-6-nitrophenyl)amino]-1,3-dimethyl-1H-pyrazol-4-yl]benzonitrile (compound 18), N-(2-chloro-4-fluoro-6-nitrophenyl)-4-(2-chloro-4-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine (compound 19), 4-(2-chloro-6-fluorophenyl)-N-(2-fluoro-4-methoxy-6-nitrophenyl)-1,3-dimethyl-1H-pyrazol-5-amine (compound 23), 4-(2,4-difluorophenyl)-N-(2-fluoro-4-methoxy-6-nitrophenyl)-1,3-dimethyl-1H-pyrazol-5-amine (compound 57), 4-(2-bromo-4-fluorophenyl)-N-(2-fluoro-6-nitrophenyl)-1,3-dimethyl-1H-pyrazol-5-amine (compound 60), 4-(2-chloro-4,6-difluorophenyl)-N-(2-fluoro-6-nitrophenyl)-1,3-dimethyl-1H-pyrazol-5-amine (compound 68), 4-(2-chloro-4-fluorophenyl)-N-(2-fluoro-6-nitrophenyl)-3-ethyl-1-methyl-1H-pyrazol-5-amine (compound 72), N-(2-chloro-4-fluoro-6-nitrophenyl)-4-(2-chloro-4-methoxyphenyl)-1,3-dimethyl-1H-pyrazol-5-amine (compound 73), 4-(2-chloro-4-fluorophenyl)-N-(2-fluoro-4-methyl-6-nitrophenyl)-1,3-dimethyl-1H-pyrazol-5-amine (compound 93), 4-(2-chloro-4-fluorophenyl)-N-(4-fluoro-2-nitrophenyl)-1,3-dimethyl-1H-pyrazol-5-amine (compound 111), 4-(2-chloro-4-fluorophenyl)-N-(2-fluoro-6-nitrophenyl)-1,3-dimethyl-1H-pyrazol-5-amine (compound 112), 4-(2,4-difluorophenyl)-N-(2-fluoro-6-nitrophenyl)-1,3-dimethyl-1H-pyrazol-5-amine (compound 118), N-(4-chloro-2-fluoro-6-nitrophenyl)-4-(2-chloro-4-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine (Compound 121) and 3-chloro-4-[5-[(2-fluoro-4-methyl-6-nitrophenyl)amino]-1,3-dimethyl-1H-pyrazol-4-yl]benzonitrile (Compound 127) A composition comprising components (a) and (b) as described in the Summary of the Invention or any one of Embodiments 1-95, comprising a compound selected from the group consisting of:

[0216] Embodiment 98. The composition of embodiment 97, wherein component (a) comprises a compound selected from the group consisting of compounds 1, 19, 57, 60, 68, 72, 93, 112, 121 and 127.

[0217] Embodiment 99. The composition of embodiment 98, wherein component (a) comprises a compound selected from the group consisting of compounds 68, 72, and 112.

[0218] Embodiment 100. The composition of embodiment 99, wherein component (a) comprises compound 68.

[0219] Embodiment 101. The composition of embodiment 99, wherein component (a) comprises compound 72.

[0220] Embodiment 102. The composition of embodiment 99, wherein component (a) comprises compound 112.

[0221] Embodiment 103. A composition comprising components (a) and (b) as described in the Summary of the Invention or any one of Embodiments 1-99, wherein component (a) is 4-(2-chloro-4,6-difluorophenyl)-N-(2-fluoro-6-nitrophenyl)-1,3-dimethyl-1H-pyrazol-5-amine.

[0222] Embodiment 104. A composition comprising components (a) and (b) as described in the Summary of the Invention or any one of Embodiments 1-99, wherein component (a) is 4-(2-chloro-4-fluorophenyl)-N-(2-fluoro-6-nitrophenyl)-3-ethyl-1-methyl-1H-pyrazol-5-amine.

[0223] Embodiment 105. A composition comprising components (a) and (b) as described in the Summary of the Invention or any one of Embodiments 1-99, wherein component (a) is 4-(2-chloro-4-fluorophenyl)-N-(2-fluoro-6-nitrophenyl)-1,3-dimethyl-1H-pyrazol-5-amine.

[0224] Embodiment 106. A composition according to any preceding embodiment, wherein component (b) comprises at least two fungicidal compounds, and when component (b) consists of a binary combination of two fungicidal compounds (wherein one of the fungicidal compounds is cyproconazole, difenoconazole, epoxiconazole, flutriafol, metconazole, prothioconazole, or tebuconazole), the other fungicidal compound is other than azoxystrobin, benzovindiflupyr, bixafen, boscalid, fluopyram, fluindapyr, fluxapyroxad, isopyrazam, kresoxim-methyl, penthiopyrad, picoxystrobin, proquinazide, pyraclostrobin, quinoxyfen, sedaxane, or trifloxystrobin.

[0225] Embodiment 107. The composition of embodiment 106, wherein component (b) comprises at least two fungicidal compounds, and when component (b) consists of a binary combination of two fungicidal compounds, one of the fungicidal compounds is cyproconazole, difenconazole, epoxiconazole, flutriafol, prothioconazole or tebuconazole, and the other fungicidal compound is other than azoxystrobin, benzovindiflupyr, bixafen, fluindapyr, fluxapyroxad, isopyrazam, picoxystrobin, pyraclostrobin or trifloxystrobin.

[0226] Embodiment 108. The composition of embodiment 107, wherein (b) comprises at least two fungicidal compounds, and where component (b) consists of a binary combination of two fungicidal compounds, one of the fungicidal compounds is cyproconazole, difenconazole, epoxiconazole, flutriafol, prothioconazole or tebuconazole, and the other fungicidal compound is other than azoxystrobin, benzovindiflupyr, bixafen, fluindapyr, fluxapyroxad, picoxystrobin, pyraclostrobin or trifloxystrobin.

[0227] Embodiments of the present invention, including embodiments 1-108 above and any other embodiments described herein, can be combined in any manner, and the explanations of variables in the embodiments apply not only to compositions comprising a compound of Formula 1 and at least one other fungicidal compound, but also to compositions comprising a compound of Formula 1 and at least one invertebrate pest control compound or agent, to compounds of Formula 1 and compositions thereof, and to starting compounds and intermediate compounds useful in preparing compounds of Formula 1. Furthermore, embodiments of the present invention, including embodiments 1-108 above and any other embodiments described herein and any combination thereof, relate to methods of the present invention. Accordingly, of note as a further embodiment is (a) a composition disclosed above comprising at least one compound selected from the compound of Formula 1 above, its N-oxides and salts, and at least one invertebrate pest control compound or agent.

[0228] Combinations of embodiments 1 to 108 are exemplified below.

[0229] Embodiment A. A composition comprising components (a) and (b) as described in the Summary of the Invention, wherein component (a) comprises a compound of Formula 1 or a salt thereof, wherein: R 1 is methyl, R 2 is cyano, halogen or C1-C2 alkyl, R 3 is a halogen, Each R 4 are independently halogen, cyano, methyl, methoxy, halomethoxy, C2-C4 alkenyloxy, C2-C4 alkynyloxy or C2-C4 cyanoalkoxy; Each R 5 are independently halogen, methyl, methoxy, halomethoxy, C2-C4 alkenyloxy, C2-C4 alkynyloxy, or C2-C4 cyanoalkoxy; R 6 is H; or R 6aC1-C2 alkyl or C1-C2 haloalkyl, each optionally substituted with up to one substituent selected from: u R 7 OR 9 and R 6a is cyano, C3-C6 cycloalkyl or C1-C3 alkoxy, R 7 is methyl or halomethyl, R 9 is H; or R 9a and R 9a is cyano, C3-C6 cycloalkyl, or C1-C3 alkoxy.

[0230] Embodiment B. In Formula 1: R 2 is methyl or ethyl, R 3 is Br, Cl or F, Each R 4 are independently halogen, cyano, methyl or methoxy; m is 1, and R 4 is at the 4-position (or para-position), or m is 1, and R 4 is at the 6-position (or ortho-position), or m is 2, and one R 4 is in the 4th position (or para position) and the other is in the 6th position (or ortho position), Each R 5 are independently halogen, methyl or methoxy; n is 1, and R 5 is at the 4-position (or para-position), or n is 1, and R 5 is at the 6-position (or ortho-position), or n is 2, and one R 5 is in the 4th position (or para position) and the other is in the 6th position (or ortho position), R 6The composition of embodiment B, wherein is H or methyl.

[0231] Embodiment C. In Formula 1: R 2 is methyl, Each R 4 is independently Br, Cl, F, cyano or methoxy; Each R 5 is independently Br, Cl, F, methyl or methoxy; R 6 The composition of embodiment B, wherein is H.

[0232] Embodiment D. In Formula 1: Each R 4 is independently Br, Cl or F; Each R 5 is independently Br, Cl, F or methoxy; m and n are each 1, and R 4 is in 4th place (or para place) and R 5 is at the 6-position (or ortho-position), or m is 1, and R 4 is at the 4-position (or para position), and n is 2, and one R 5 is at the 4-position (or para-position) and the other is at the 6-position (or ortho-position), or m is 2 and one R 4 is at the 4-position (or para position) and the other is at the 6-position (or ortho position), and n is 1, and R 5 The composition of embodiment C, wherein: is at the 6-position (or ortho-position).

[0233] Embodiment E. In Formula 1: R 4 is Cl or F, Each R 5 is independently Cl, F or methoxy; m and n are each 1, and R 4 is in 4th place (or para place) and R 5 is at the 6-position (or ortho-position), or m is 1, and R 4is at the 4-position (or para position), and n is 2, and one R 5 The composition of embodiment D, wherein one is at the 4-position (or para position) and the other is at the 6-position (or ortho position).

[0234] Embodiment F. A composition comprising components (a) and (b) as described in the Summary of the Invention, wherein component (a) comprises a compound of Formula 1 or a salt thereof, wherein: R 1 is a C1-C2 alkyl, R 2 is cyano, halogen, C1-C2 alkyl or C1-C2 haloalkyl, R 3 is halogen or methyl, Each R 4 are independently halogen, cyano, nitro, C1-C3 alkyl, C1-C3 haloalkoxy, C2-C6 alkenyloxy, C2-C6 alkynyloxy, C2-C6 cyanoalkoxy, C2-C6 alkoxyalkyl or C2-C6 alkoxyalkoxy; Each R 5 are independently halogen, C1-C3 alkyl, C2-C6 alkoxyalkyl, C1-C3 alkoxy, C1-C3 haloalkoxy, C2-C6 alkenyloxy, C2-C6 alkynyloxy, C2-C6 cyanoalkoxy, or C2-C6 alkoxyalkoxy, provided that at least one R 5 is selected from halogens; m and n are each independently 1, 2, or 3; R 6 is H; or R 6a C1-C3 alkyl or C1-C3 haloalkyl, each optionally substituted with up to two substituents independently selected from: amino, C2-C4 alkenyl, C2-C4 alkynyl, C3-C6 cycloalkyl, CH(=O), S(=O)2OM, S(=O) u R 7 , (C=W)R 8 OR 9 and Each R 6aare independently cyano, C3-C6 cycloalkyl, C1-C3 alkoxy, C1-C3 haloalkoxy, C1-C3 alkylthio, C1-C3 alkylsulfinyl, or C1-C3 alkylsulfonyl; M is K or Na; u is 0, 1 or 2; R 7 is C1-C3 alkyl or C1-C3 haloalkyl, W is O or S; R 8 is C1-C3 alkyl, C2-C4 alkoxyalkyl, C2-C4 alkylaminoalkyl, C3-C6 dialkylaminoalkyl, C1-C3 alkoxy, C1-C3 alkylthio or C2-C4 alkylthioalkyl, R 9 is H; or R 9a C1-C3 alkyl or C1-C3 haloalkyl, each optionally substituted with up to two substituents independently selected from: 10 and Each R 9a are independently cyano, C3-C6 cycloalkyl, C1-C3 alkoxy, C1-C3 haloalkoxy, C1-C3 alkylthio, C1-C3 alkylsulfinyl, or C1-C3 alkylsulfonyl, and R 10 is C1-C3 alkyl, C2-C4 alkoxyalkyl, C2-C4 alkylaminoalkyl, C3-C6 dialkylaminoalkyl, C1-C3 alkoxy, C1-C3 alkylthio or C2-C4 alkylthioalkyl, However, the compound of formula 1 is N-(2-bromo-4-fluoro-6-nitrophenyl)-4-(2-chloro-4-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine, or 3-chloro-4-(2-chloro-4-fluorophenyl)-N-(2,4-difluoro-6-nitrophenyl)-1-methyl-1H-pyrazol-5-amine provided that the composition is not

[0235] Embodiment G. In Formula 1: R 1 is methyl, R 2 is cyano, halogen or C1-C2 alkyl, R 3 is a halogen, Each R 4 are independently halogen, cyano, methyl, C1-C2 alkoxy or C1-C2 haloalkoxy; m is 1, and R 4 is at the 4-position (or para-position), or m is 1, and R 4 is at the 6-position (or ortho-position), or m is 2, and one R 4 is in the 4th position (or para position) and the other is in the 6th position (or ortho position), Each R 5 are independently halogen, methyl, methoxy, halomethyl, C2-C4 alkenyloxy, or C2-C4 cyanoalkoxy; n is 1, and R 5 is at the 4-position (or para-position), or n is 1, and R 5 is at the 6-position (or ortho-position), or n is 2, and one R 5 is in the 4th position (or para position) and the other is in the 6th position (or ortho position), R 6 The composition of embodiment F, wherein is H or methyl.

[0236] Embodiment H. In Formula 1: R 2 is methyl, Each R 4 is independently Br, Cl, F, cyano or methoxy; Each R 5 is independently Br, Cl, F, methyl or methoxy; R 6 The composition of embodiment G, wherein is H.

[0237] Embodiment I. In Formula 1: R 4 is Br, Cl or F, Each R 5 is independently Br, Cl, F or methoxy; m and n are each 1, and R 4 is in 4th place and R 5 is at the 6-position, or m is 1, and R 4 is at the 4-position, and n is 2, and one R 5 The composition of embodiment H, wherein one is at the 4-position and the other is at the 6-position.

[0238] Embodiment JR 4 is Cl or F, Each R 5 The composition of embodiment I, wherein is independently Cl, F, or methoxy.

[0239] Embodiment K. The composition of any one of Embodiments A-J, wherein component (a) comprises a compound selected from the group consisting of Compound 1, Compound 18, Compound 19, Compound 23, Compound 57, Compound 60, Compound 68, Compound 72, Compound 73, Compound 93, Compound 111, Compound 112, Compound 121, and Compound 127.

[0240] Embodiment L. The composition of embodiment K wherein component (a) comprises a compound selected from the group consisting of compound 68, compound 72, and compound 112.

[0241] Embodiment M. The composition of embodiment L wherein component (a) comprises compound 112.

[0242] Embodiment B1. The composition described in the Summary of the Invention wherein component (b) comprises (b1) at least one compound selected from methyl benzimidazole carbamate fungicides, such as benomyl, carbendazim, fuberidazole thiabendazole, thiophanate, and thiophanate methyl (including but not limited to the compositions of any one of Embodiments 1 through 108 and A through M).

[0243] Embodiment B2. The composition described in the Summary of the Invention wherein component (b) comprises (b2) at least one compound selected from a dicarboximide fungicide, such as chlozolinate, dimethachlon, iprodione, procymidone, and vinclozolin (including but not limited to the compositions of any one of Embodiments 1 through 108 and A through M).

[0244] Embodiment B3. Component (b) is (b3) triforine, buthiobate, pyrifenox, pyrisoxazole, fenarimol, nuarimol, triarimol, econazole, imazalil, oxpoconazole, pefurazoate, prochloraz, triflumizole, azaconazole, bitertanol, bromuconazole, cyproconazole, difenoconazole, diniconazole (including diniconazole-M), epoxiconazole, etaconazole, fenbuconazole, fluquinconazole, flusilazole, flutriafol, hexaconazole, ibuprofen, li ... A composition described in the Summary of the Invention (including but not limited to any one of embodiments 1-108 and A-M) comprising at least one compound selected from a demethylation inhibitor fungicide such as mibenconazole, ipconazole, mefentrifluconazole, metconazole, myclobutanil, penconazole, propiconazole, ipfentrifluconazole, quinconazole, simeconazole, tebuconazole, tetraconazole, triadimefon, triadimenol, triticonazole, uniconazole, and uniconazole-P.

[0245] Embodiment B4. The composition described in the Summary of the Invention wherein component (b) comprises (b4) at least one compound selected from phenylamide fungicides such as metalaxyl, metalaxyl-M, benalaxyl, benalaxyl-M, furalaxyl, oblace, and oxadixyl (including but not limited to the compositions of any one of Embodiments 1 through 108 and A through M).

[0246] Embodiment B5. The composition described in the Summary of the Invention wherein component (b) comprises (b5) at least one compound selected from aldimorph, dodemorph, fenpropimorph, tridemorph, trimorphamide, fenpropidin, piperaline, and spiroxamine, and other amine / morpholine fungicides (including but not limited to the compositions of any one of Embodiments 1-108 and A-M).

[0247] Embodiment B6. The composition described in the Summary of the Invention wherein component (b) comprises (b6) at least one compound selected from phospholipid biosynthesis inhibitor fungicides, such as edifenphos, iprobenfos, pyrazophos, and isoprothiolane (including but not limited to the compositions of any one of Embodiments 1-108 and A-M).

[0248] Embodiment B7. The composition described in the Summary of the Invention (including but not limited to the compositions of any one of Embodiments 1-108 and A-M) wherein component (b) comprises (b7) at least one compound selected from succinate dehydrogenase inhibitor fungicides such as benodanil, flutolanil, mepronil, isofetamide, fluopyram, fenfuram, carboxin, oxycarboxin, thifluzamide, benzovindiflupyr, bixafen, fluindapyr, fluxapyroxad, furametpyr, inpirfluxam, isopyrazam, penflufen, penthiopyrad, pyrapropoin, sedaxane, fluventeram, isofulcipram, pydiflumetofen, boscalid, and pyraziflumid.

[0249] Embodiment B8. The composition described in the Summary of the Invention wherein component (b) comprises (b8) at least one compound selected from hydroxy(2-amino-)pyrimidine fungicides, such as bupirimate, dimethirimol, and ethirimol (including but not limited to the compositions of any one of Embodiments 1 through 108 and A through M).

[0250] Embodiment B9. The composition described in the Summary of the Invention wherein component (b) comprises (b9) at least one compound selected from anilinopyrimidine fungicides, such as cyprodinil, mepanipyrim, and pyrimethanil (including but not limited to the compositions of any one of Embodiments 1 through 108 and A through M).

[0251] Embodiment B10. The composition described in the Summary of the Invention wherein component (b) includes at least one compound selected from (b10) an N-phenylcarbamate fungicide, such as diethofencarb (including but not limited to the compositions of any one of Embodiments 1 through 108 and A through M).

[0252] Embodiment B11. The composition described in the Summary of the Invention wherein component (b) comprises (b11) at least one compound selected from quinone outside inhibitor fungicides such as azoxystrobin, cumoxystrobin, enoxastrobin, flufenoxystrobin, picoxystrobin, pyraoxystrobin, mandestrobin, pyraclostrobin, pyrametostrobin, triclopyricarb, kresoxim-methyl, trifloxystrobin, dimoxystrobin, phenaminestrobin, metominostrobin, orysastrobin, fluoxastrobin, famoxadone, fenamidone, and pyribencarb (including but not limited to the compositions of any one of Embodiments 1-108 and A-M).

[0253] Embodiment B12. The composition described in the Summary of the Invention wherein component (b) comprises (b12) at least one compound selected from phenylpyrrole fungicidal compounds, such as fenpiclonil and fludioxonil (including but not limited to the compositions of any one of Embodiments 1-108 and A-M).

[0254] Embodiment B13. The composition described in the Summary of the Invention wherein component (b) comprises (b13) at least one compound selected from azanaphthalene fungicides, such as quinoxyfen and proquinazide (including but not limited to the compositions of any one of Embodiments 1 through 108 and A through M).

[0255] Embodiment B14. The composition described in the Summary of the Invention (including but not limited to the compositions of any one of Embodiments 1-108 and A-M) wherein component (b) comprises (b14) at least one compound selected from cellular peroxidation inhibitor fungicides such as biphenyl, chloroneb, dicloran, quintozene, tecnazene, tolclofos-methyl, and etridiazole.

[0256] Embodiment B15. The composition of the Summary of the Invention wherein component (b) comprises (b15) at least one compound selected from melanin biosynthesis inhibitor-reductase fungicides, such as phthalide, pyroquilon, and tricyclazole (including but not limited to the compositions of any one of Embodiments 1-108 and A-M).

[0257] Embodiment B16a. The composition of the Summary of the Invention wherein component (b) comprises at least one compound selected from (b16a) a melanin biosynthesis inhibitor-dehydratase fungicide, such as carpropamid, diclocymet, and fenoxanil (including but not limited to the compositions of any one of Embodiments 1-108 and A-M).

[0258] Embodiment B16b. The composition described in the Summary of the Invention (including but not limited to the compositions of any one of Embodiments 1-108 and A-M) wherein component (b) comprises at least one compound selected from (b16b) a melanin biosynthesis inhibitor-polyketide synthase fungicide, such as tolprocarb.

[0259] Embodiment B17. The composition described in the Summary of the Invention wherein component (b) comprises (b17) at least one compound selected from ketoreductase inhibitor fungicides, such as fenhexamid, fenpyrazamine, quinofumelin, and ipflufenoquin (including but not limited to the compositions of any one of Embodiments 1-108 and A-M).

[0260] Embodiment B18. The composition described in the Summary of the Invention (including but not limited to the compositions of any one of Embodiments 1-108 and A-M) wherein component (b) comprises at least one compound selected from (b18) squalene-epoxidase inhibitor fungicides, such as pyributicarb, naftifine, and terbinafine.

[0261] Embodiment B19. The composition described in the Summary of the Invention wherein component (b) comprises at least one compound selected from (b19) a polyoxin fungicide, such as a polyoxin (including but not limited to the compositions of any one of Embodiments 1 through 108 and A through M).

[0262] Embodiment B20. The composition described in the Summary of the Invention (including but not limited to the compositions of any one of Embodiments 1 through 108 and A through M) wherein component (b) comprises at least one compound selected from (b20) a phenylurea fungicide, such as pencycuron.

[0263] Embodiment B21. The composition described in the Summary of the Invention (including but not limited to the compositions of any one of Embodiments 1-108 and A-M) wherein component (b) comprises (b21) at least one compound selected from quinone inside inhibitor fungicides, such as cyazofamid, amisulbrom, and fenpicoxamid (Registration No. 517875-34-2).

[0264] Embodiment B22. The composition described in the Summary of the Invention wherein component (b) comprises (b22) at least one compound selected from benzamide and thiazolecarboxamide fungicides, such as zoxamide and ethaboxam (including but not limited to the compositions of any one of Embodiments 1 through 108 and A through M).

[0265] Embodiment B23. The composition described in the Summary of the Invention (including but not limited to the compositions of any one of Embodiments 1-108 and A-M) wherein component (b) comprises at least one compound selected from (b23) an enopyranuronic acid antibiotic fungicide, such as blasticidin-S.

[0266] Embodiment B24. The composition described in the Summary of the Invention wherein component (b) comprises at least one compound selected from (b24) a hexopyranosyl antibiotic fungicide, such as kasugamycin (including but not limited to the compositions of any one of Embodiments 1-108 and A-M).

[0267] Embodiment B25. The composition described in the Summary of the Invention (including but not limited to the compositions of any one of Embodiments 1-108 and A-M) wherein component (b) comprises at least one compound selected from (b25) a glucopyranosyl antibiotic, such as streptomycin; a protein synthetic bactericide.

[0268] Embodiment B26. The composition described in the Summary of the Invention (including but not limited to the compositions of any one of Embodiments 1-108 and A-M) wherein component (b) comprises at least one compound selected from (b26) a glucopyranosyl antibiotic, such as validamycin; trehalase; and an inositol biosynthesis fungicide.

[0269] Embodiment B27. The composition described in the Summary of the Invention wherein component (b) includes at least one compound selected from (b27) a cyanoacetylamidoxime fungicide, such as cymoxanil (including but not limited to the compositions of any one of Embodiments 1 through 108 and A through M).

[0270] Embodiment B28. The composition described in the Summary of the Invention wherein component (b) comprises (b28) at least one compound selected from carbamate fungicides, such as propamacarb, prothiocarb, and iodocarb (including but not limited to the compositions of any one of Embodiments 1 through 108 and A through M).

[0271] Embodiment B29. The composition described in the Summary of the Invention (including but not limited to the compositions of any one of Embodiments 1-108 and A-M) wherein component (b) comprises (b29) at least one compound selected from oxidative phosphorylation uncoupling fungicides, such as fluazinam, binapacryl, meptyldinocap, and dinocap.

[0272] Embodiment B30. The composition described in the Summary of the Invention (including but not limited to the compositions of any one of Embodiments 1-108 and A-M) wherein component (b) comprises (b30) at least one compound selected from organotin fungicides, such as fentin acetate, fentin chloride, and fentin hydroxide.

[0273] Embodiment B31. The composition described in the Summary of the Invention wherein component (b) includes at least one compound selected from (b31) a carboxylic acid fungicide, such as oxolinic acid (including but not limited to the compositions of any one of Embodiments 1-108 and A-M).

[0274] Embodiment B32. The composition described in the Summary of the Invention wherein component (b) comprises (b32) at least one compound selected from hymexazole and heterocyclic aromatic fungicides, such as octhilinone (including but not limited to the compositions of any one of Embodiments 1 through 108 and A through M).

[0275] Embodiment B33. The composition of the Summary of the Invention wherein component (b) comprises at least one compound selected from (b33) phosphonate fungicides, such as phosphorous acid and its various salts, including fosetyl aluminum (including but not limited to the compositions of any one of Embodiments 1 through 108 and A through M).

[0276] Embodiment B34. The composition described in the Summary of the Invention (including but not limited to the compositions of any one of Embodiments 1 through 108 and A through M) wherein component (b) comprises at least one compound selected from (b34) a phthalate fungicide, such as tecloftalam.

[0277] Embodiment B35. The composition described in the Summary of the Invention (including but not limited to the compositions of any one of Embodiments 1 through 108 and A through M) wherein component (b) comprises at least one compound selected from (b35) a benzotriazine fungicide, such as triazoxide.

[0278] Embodiment B36. The composition described in the Summary of the Invention (including but not limited to the compositions of any one of Embodiments 1-108 and A-M) wherein component (b) comprises at least one compound selected from (b36) a benzenesulfonamide fungicide, such as flusulfamide.

[0279] Embodiment B37. The composition described in the Summary of the Invention wherein component (b) includes at least one compound selected from (b37) a pyridazinone fungicide, such as diclomedine (including but not limited to the compositions of any one of Embodiments 1 through 108 and A through M).

[0280] Embodiment B38. The composition described in the Summary of the Invention wherein component (b) includes at least one compound selected from (b38) a thiophenecarboxamide fungicide, such as silthiofam (including but not limited to the compositions of any one of Embodiments 1 through 108 and A through M).

[0281] Embodiment B39. The composition described in the Summary of the Invention (including but not limited to the compositions of any one of Embodiments 1-108 and A-M) wherein component (b) comprises (b39) at least one compound selected from Complex I NADH oxidoreductase inhibitor fungicides, such as diflumetrim, tolfenpyrad, and fenazaquin.

[0282] Embodiment B40. Component (b) is (b40) dimethomorph, benthiavalicarb, benthiavalicarb-isopropyl, iprovalicarb, valifenalate, mandipropamide, flumol F and Pirimol Funa A composition described in the Summary of the Invention (including but not limited to the compositions of any one of Embodiments 1-108 and A-M) comprising at least one compound selected from any carboxylic acid amide fungicide.

[0283] Embodiment B41. The composition described in the Summary of the Invention wherein component (b) comprises (b41) at least one compound selected from a tetracycline antibiotic fungicide, such as oxytetracycline (including but not limited to the compositions of any one of Embodiments 1-108 and A-M).

[0284] Embodiment B42. The composition described in the Summary of the Invention wherein component (b) includes at least one compound selected from (b42) a thiocarbamate fungicide, such as metasulfocarb (including but not limited to the compositions of any one of Embodiments 1 through 108 and A through M).

[0285] Embodiment B43. The composition described in the Summary of the Invention wherein component (b) comprises (b43) at least one compound selected from a benzamide fungicide, such as fluopicolide, fluopimomide, and the like (including but not limited to the compositions of any one of Embodiments 1-108 and A-M).

[0286] Embodiment B44. A composition described in the Summary of the Invention (including but not limited to any one of embodiments 1-108 and A-M), wherein component (b) comprises (b44) at least one compound selected from microbial bactericides, such as Bacillus amyloliquefaciens strains QST713, FZB24, MB1600, D747, F727, TJ100 (also known as strain 1 BE; known from EP 2962568), and bactericidal lipopeptides produced therefrom.

[0287] Embodiment B45. The composition described in the Summary of the Invention (including but not limited to the compositions of any one of Embodiments 1-108 and A-M) wherein component (b) comprises at least one compound selected from (b45) a quinone outside inhibitor such as ametoclazine, a stigmatellin-binding fungicide.

[0288] Embodiment B46. A composition described in the Summary of the Invention (including but not limited to the compositions of any one of Embodiments 1-108 and A-M) wherein component (b) comprises (b46) at least one compound selected from plant extract fungicides such as Melaleuca alternifolia, eugenol, geraniol, and thymol.

[0289] Embodiment B47. The composition described in the Summary of the Invention (including but not limited to the compositions of any one of Embodiments 1 through 108 and A through M) wherein component (b) includes at least one compound selected from (b47) a cyanoacrylate fungicide, such as fenamacryl.

[0290] Embodiment B48. The composition of the Summary of the Invention wherein component (b) comprises (b48) at least one compound selected from a polyene fungicide, such as natamycin (including but not limited to the compositions of any one of Embodiments 1 through 108 and A through M).

[0291] Embodiment B49. The composition described in the Summary of the Invention (including but not limited to the compositions of any one of Embodiments 1-108 and A-M) wherein component (b) comprises at least one compound selected from (b49) oxysterol binding protein inhibitor fungicides, such as oxathiapiprolin and fluoxapiprolin.

[0292] Embodiment B50. The composition of the Summary of the Invention wherein component (b) comprises (b50) at least one compound selected from aryl-phenyl-ketone fungicides, such as metrafenone and pyriophenone (including but not limited to the compositions of any one of Embodiments 1 through 108 and A through M).

[0293] Embodiment B51. The composition described in the Summary of the Invention (including but not limited to the compositions of any one of Embodiments 1-108 and A-M) wherein component (b) comprises (b51) at least one compound selected from host plant defense inducer fungicides such as acibenzolar-S-methyl, probenazole, tiadinil, isotianil, laminarin, extracts from Reynoutria sachalinensis and Bacillus mycoides isolate J, and cell wall of Saccharomyces cerevisiae strain LAS117.

[0294] Embodiment B52. The composition described in the Summary of the Invention (including but not limited to compositions of any one of Embodiments 1-108 and A-M) wherein component (b) comprises (b52) at least one compound selected from copper oxychloride, copper sulfate, copper hydroxide, Bordeaux composition (tribasic copper sulfate), elemental sulfur, ferbam, mancozeb, maneb, metiram, propineb, thiram, zinc thiazole, zineb, ziram, folpet, captan, captafol, chlorothalonil, dichlofluanid, torifluanid, guazatine, iminoctadine albesilate, iminoctadine triacetate, anilazine, dithianon, quinomethionate, and multi-site active fungicides such as fluoroimides.

[0295] Embodiment B53. The composition described in the Summary of the Invention (including but not limited to the compositions of any one of Embodiments 1-108 and A-M) wherein component (b) comprises at least one compound selected from biological fungicides having multiple modes of action, such as (b53) extracts from cotyledons of lupine plantlets.

[0296] Embodiment B54. The component (b) is (b54) cyflufenamid, bethoxadin, neoazodine, pyrrolnitrin, tebufloquine, dodine, fluthianil, ferimzone, picarbutrazox, diclobenthiazox (Registration No. 957144-77-3), dipimethitron (Registration No. 16114-35-5), flometoquin, tolnifanide (Registration No. 304911-98-6), N'-[4-[4-chloro-3-(trifluoromethyl)phenoxy]-2,5-dimethylphenyl]- The composition described in the Summary of the Invention (including the compositions of any one of Embodiments 1 through 108 and A through M) comprises at least one compound selected from a fungicide other than the fungicides of component (a) and components (b1) through (b53), such as N-ethyl-N-methylmethanimidamide, 5-fluoro-2-[(4-fluorophenyl)methoxy]-4-pyrimidinamine, and 4-fluorophenyl N-[1-[[[1-(4-cyanophenyl)ethyl]sulfonyl]methyl]propyl]carbamate (XR-539).

[0297] Embodiment B55. The composition described in the Summary of the Invention (including but not limited to compositions of any one of Embodiments 1 through 108 and A through M) wherein component (b) comprises (1S)-2,2-bis(4-fluorophenyl)-1-methylethyl N-[[3-(acetyloxy)-4-methoxy-2-pyridinyl]carbonyl]-L-alaninate (tentatively named flurylpicoxamide).

[0298] Embodiment B56. The composition described in the Summary of the Invention wherein component (b) comprises 1-[2-[[[1-(4-chlorophenyl)-1H-pyrazol-3-yl]oxy]methyl]-3-methylphenyl]-1,4-dihydro-4-methyl-5H-tetrazol-5-one (tentative name: Methyltetraprole) (including but not limited to compositions of any one of Embodiments 1 through 108 and A through M).

[0299] Embodiment B57. The composition described in the Summary of the Invention (including but not limited to the compositions of any one of Embodiments 1 through 108 and A through M) wherein component (b) comprises 3-chloro-4-(2,6-difluorophenyl)-6-methyl-5-phenylpyridazine (tentatively named pyridaclomethyl).

[0300] Embodiment B58. The composition described in the Summary of the Invention (including but not limited to the compositions of any one of Embodiments 1 through 108 and A through M) wherein component (b) comprises (4-phenoxyphenyl)methyl 2-amino-6-methyl-pyridine-3-carboxylate (tentative name: aminopyrifen).

[0301] Embodiment B59. A composition described in the Summary of the Invention (including, but not limited to, the compositions of any one of Embodiments 1-108 and A-M) wherein component (b) comprises at least one compound selected from (b54.11) (i.e., Formula b54.11).

[0302] The component (b54.11) is given by the formula b54.11 [ka] (In the formula, R b1 and R b3 are each independently a halogen; R b2 is H, halogen, C1-C3 alkyl, C1-C3 haloalkyl, or C3-C6 cycloalkyl) The present invention relates to the compound

[0303] Embodiment B60. Component (b) is selected from the group consisting of methyl N-[[5-[1-(2,6-difluoro-4-formylphenyl)-1H-pyrazol-3-yl]-2-methylphenyl]methyl]carbamate, methyl N-[[5-[1-(4-cyclopropyl-2,6-dichlorophenyl)-1H-pyrazol-3-yl]-2-methylphenyl]methyl]carbamate, methyl N-[[5-[1-(4-chloro-2,6-difluorophenyl)-1H-pyrazol-3-yl]-2-methylphenyl]methyl]carbamate, methyl N-[[5-[1-(4-cyclopropyl The composition of embodiment B59 comprising at least one fungicidal compound selected from the group consisting of methyl N-[[5-[1-[2,6-difluoro-4-(1-methylethyl)phenyl]-1H-pyrazol-3-yl]-2-methylphenyl]methyl]carbamate, methyl N-[[5-[1-[2,6-difluoro-4-(trifluoromethyl)phenyl]-1H-pyrazol-3-yl]-2-methylphenyl]methyl]carbamate and methyl N-[5-[1-[2,6-difluoro-4-(trifluoromethyl)phenyl]-1H-pyrazol-3-yl]-2-methylphenyl]methyl]carbamate.

[0304] Embodiment B60b. The composition of embodiment B60 wherein component (b) comprises at least one fungicidal compound selected from the group consisting of methyl N-[[5-[1-(4-cyclopropyl-2,6-dichlorophenyl)-1H-pyrazol-3-yl]-2-methylphenyl]methyl]carbamate, methyl N-[[5-[1-(4-chloro-2,6-difluorophenyl)-1H-pyrazol-3-yl]-2-methylphenyl]methyl]carbamate, methyl N-[[5-[1-[2,6-difluoro-4-(1-methylethyl)phenyl]-1H-pyrazol-3-yl]-2-methylphenyl]methyl]carbamate and methyl N-[[5-[1-[2,6-difluoro-4-(trifluoromethyl)phenyl]-1H-pyrazol-3-yl]-2-methylphenyl]methyl]carbamate.

[0305] Embodiment B61. A composition described in the Summary of the Invention (including, but not limited to, the compositions of any one of Embodiments 1-108 and A-M) wherein component (b) comprises at least one compound selected from (b54.12) (i.e., Formula b54.12).

[0306] The component (b54.12) is the formula b54.12 [ka] (In the formula, R b4 teeth, [ka] and R b6 is a C2-C4 alkoxycarbonyl or a C2-C4 haloalkylaminocarbonyl, L is CH2 or CH2O, where the atom on the right is attached to the phenyl ring in formula b54.12; R b5 teeth, [ka] and R b7 is a C1-C3 alkyl, where the wavy bond indicates that the adjacent double bond is in the (Z)- or (E)-configuration or a mixture thereof. The present invention relates to the compound

[0307] Embodiment B62. The composition of embodiment B61, wherein component (b) comprises at least one fungicidal compound selected from the group consisting of N-(2,2,2-trifluoroethyl)-2-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-4-oxazolecarboxamide, ethyl 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenoxy]methyl]-1H-pyrazole-4-carboxylate, ethyl 1-[[4-[[(1Z)-2-ethoxy-3,3,3-trifluoro-1-propen-1-yl]oxy]phenyl]methyl]-1H-pyrazole-4-carboxylate, and ethyl 1-[[4-[[2-(trifluoromethyl)-1,3-dioxolan-2-yl]methoxy]phenyl]methyl]-1H-pyrazole-4-carboxylate.

[0308] Embodiment B62b. The composition of embodiment B62 wherein component (b) comprises at least one fungicidal compound selected from the group consisting of N-(2,2,2-trifluoroethyl)-2-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-4-oxazolecarboxamide and ethyl 1-[[4-[[(1Z)-2-ethoxy-3,3,3-trifluoro-1-propen-1-yl]oxy]phenyl]methyl]-1H-pyrazole-4-carboxylate.

[0309] Embodiment B63. The compound (b) is selected from the group consisting of azoxystrobin, benzovindiflupyr, boscalid (nicobifen), bixafen, bromuconazole, carbendazim, chlorothalonil, copper hydroxide, cyflufenamid, cyproconazole, difenoconazole, dimoxystrobin, epoxiconazole, famoxadone, fenbuconazole, fenpropidin, fenpropimorph, fluindapyr, flusilazole, flutriafol, fluxapyroxad, hexaconazole, ipconazole, kresoximmethyl, manzate, metconazole azole, metominostrobin, metrafenone, myclobutanil, penconazole, penthiopyrad, picoxystrobin, prochloraz, propiconazole, proquinazid, prothioconazole, pydiflumetofen, pyraclostrobin, pyrametostrobin, pyroxystrobin, pyriophenone, quinoxyfen, tebuconazole, trifloxystrobin, triticonazole, methyl N-[[5-[1-(4-cyclopropyl-2,6-dichlorophenyl)-1H-pyrazol-3-yl]-2-methylphenyl]methyl]carba mate, methyl N-[[5-[1-(4-chloro-2,6-difluorophenyl)-1H-pyrazol-3-yl]-2-methylphenyl]methyl]carbamate, methyl N-[[5-[1-[2,6-difluoro-4-(1-methylethyl)phenyl]-1H-pyrazol-3-yl]-2-methylphenyl]methyl]carbamate, methyl N-[[5-[1-[2,6-difluoro-4-(trifluoromethyl)phenyl]-1H-pyrazol-3-yl]-2-methylphenyl]methyl]carbamate, N-(2,2,2-trifluoro A composition described in the Summary of the Invention (including, but not limited to, any one of Embodiments 1 through 108 and A through M) comprising at least one fungicidal compound (fungicide) selected from the group consisting of ethyl)-2-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-4-oxazolecarboxamide and ethyl 1-[[4-[[(1Z)-2-ethoxy-3,3,3-trifluoro-1-propen-1-yl]oxy]phenyl]methyl]-1H-pyrazole-4-carboxylate.

[0310] Embodiment B64. Component (b) is azoxystrobin, benzovindiflupyr, bixafen, chlorothalonil, copper hydroxide, cyflufenamid, cyproconazole, difenoconazole, dimoxystrobin, epoxiconazole, famoxadone, fenpropidin, fenpropimorph, fluindapyr, flusilazole, flutriafol, fluxapyroxad, kresoximmethyl, manzate, metconazole, metominostrobin, metrafenone, micropig nil, penthiopyrad, picoxystrobin, propiconazole, proquinazid, prothioconazole, pydiflumetofen, pyraclostrobin, pyrametostrobin, pyroxystrobin, pyriophenone, quinoxyfen, tebuconazole, trifloxystrobin, triticonazole, methyl N-[[5-[1-(4-cyclopropyl-2,6-dichlorophenyl)-1H-pyrazol-3-yl]-2-methylphenyl]methyl]carbamate, methyl N-[[5 -[1-(4-chloro-2,6-difluorophenyl)-1H-pyrazol-3-yl]-2-methylphenyl]methyl]carbamate, methyl N-[[5-[1-[2,6-difluoro-4-(1-methylethyl)phenyl]-1H-pyrazol-3-yl]-2-methylphenyl]methyl]carbamate, methyl N-[[5-[1-[2,6-difluoro-4-(trifluoromethyl)phenyl]-1H-pyrazol-3-yl]-2-methylphenyl]methyl]carbamate The composition of embodiment B63, comprising at least one compound selected from the group consisting of ethyl 1-[[4-[[(1Z)-2-ethoxy-3,3,3-trifluoro-1-propen-1-yl]oxy]phenyl]methyl]-1H-pyrazole-4-carboxylate, N-(2,2,2-trifluoroethyl)-2-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-4-oxazolecarboxamide, and ethyl 1-[[4-[[(1Z)-2-ethoxy-3,3,3-trifluoro-1-propen-1-yl]oxy]phenyl]methyl]-1H-pyrazole-4-carboxylate.

[0311] Embodiment B65. The embodiment B65 in which component (b) is selected from the group consisting of azoxystrobin, benzovindiflupyr, bixafen, chlorothalonil, copper hydroxide, cyproconazole, difenoconazole, epoxiconazole, fenpropidin, fenpropimorph, fluindapyr, flutriafol, fluxapyroxad, manzate, metominostrobin, picoxystrobin, prothioconazole, pydiflumetofen, pyraclostrobin, tebuconazole, trifloxystrobin, methyl N-[[5-[1-(4-cyclopropyl-2,6-dichlorophenyl)-1H-pyrazol-3-yl]-2-methylphenyl]methyl]carbamate, methyl N-[[5-[1-(4-chloro-2,6-difluorophenyl)-1H-pyrazol-3-yl]-2-methylphenyl]methyl]carbamate, methyl N-[[5 The composition of embodiment B64 comprising at least one compound selected from the group consisting of -[1-[2,6-difluoro-4-(1-methylethyl)phenyl]-1H-pyrazol-3-yl]-2-methylphenyl]methyl]carbamate, methyl N-[[5-[1-[2,6-difluoro-4-(trifluoromethyl)phenyl]-1H-pyrazol-3-yl]-2-methylphenyl]methyl]carbamate, N-(2,2,2-trifluoroethyl)-2-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-4-oxazolecarboxamide, and ethyl 1-[[4-[[(1Z)-2-ethoxy-3,3,3-trifluoro-1-propen-1-yl]oxy]phenyl]methyl]-1H-pyrazole-4-carboxylate.

[0312] Embodiment B66. The composition of Embodiment B65 wherein component (b) comprises at least one compound selected from the group consisting of azoxystrobin, benzovindiflupyr, bixafen, chlorothalonil, copper hydroxide, cyproconazole, epoxiconazole, fenpropidin, fenpropimorph, fluindapyr, flutriafol, fluxapyroxad, manzate, metominostrobin, picoxystrobin, prothioconazole, pydiflumetofen, pyraclostrobin, tebuconazole, trifloxystrobin.

[0313] Of note, in the composition of any one of the embodiments described herein, including any of embodiments 1-108, A-M, and B1-B66, references to Formula 1 include salts thereof, but not N-oxides thereof, and thus the phrase "a compound of Formula 1" can be replaced with the phrase "a compound of Formula 1 or a salt thereof." In this noted composition, component (a) comprises a compound of Formula 1 or a salt thereof.

[0314] Also of note as an embodiment are disinfectant compositions of the present invention comprising a disinfectant-effective amount of the composition of any of Embodiments 1-108, A-M, and B1-B66, and at least one additional component selected from the group consisting of surfactants, solid diluents, and liquid diluents.

[0315] Embodiments of the present invention further include a method of controlling plant diseases caused by fungal plant pathogens, comprising applying to a plant or part thereof, or to a plant seed or seedling (e.g., as a composition comprising the formulation components described herein) a fungicidally effective amount of the composition of any one of Embodiments 1-108, A-M, and B1-B66. Embodiments of the present invention also include a method of protecting a plant or plant seed from disease caused by a fungal pathogen, comprising applying to the plant or plant seed a fungicidally effective amount of the composition of any one of Embodiments 1-108, A-M, and B1-B66.

[0316] Some embodiments of the present invention involve controlling or protecting against plant diseases that primarily affect the leaves of plants, and / or involve applying the compositions of the present invention to the leaves of the plants (i.e., to the plants instead of the seeds). Preferred methods of use include those that include the preferred compositions described above, and diseases that are particularly effectively controlled include plant diseases caused by fungal plant pathogens. The fungicide combinations used in accordance with the present invention can promote disease control and delay resistance development.

[0317] The method embodiment further includes:

[0318] Embodiment C1. A method for protecting a plant from a disease selected from rust, powdery mildew, and Septoria disease, comprising applying to the plant a fungicidally effective amount of a composition comprising components (a) and (b) as described in the Summary of the Invention or any one of Embodiments 1-108.

[0319] Embodiment C2. The method of Embodiment C1 wherein the disease is rust and component (b) of the composition comprises at least one fungicidal compound selected from (b3) demethylation inhibitor (DMI) fungicides, (b5) amine / morpholine fungicides, (b7) succinate dehydrogenase inhibitor fungicides, (b11) quinone outside inhibitor (QoI) fungicides, (b13) methyl benzimidazole carbamate fungicides, and (b52) multi-site active fungicides.

[0320] Embodiment C3. The method of embodiment C2, wherein component (b) of the composition comprises at least one fungicidal compound selected from (b3) a demethylation inhibitor (DMI) fungicide, (b7) a succinate dehydrogenase inhibitor fungicide, and (b11) a quinone outside inhibitor (QoI) fungicide.

[0321] Embodiment C4. The method of embodiment C3, wherein component (b) of the composition comprises at least one fungicidal compound selected from (b3) demethylation inhibitor (DMI) fungicides, (b7) succinate dehydrogenase inhibitor fungicides, and (b11) quinone extrinsic inhibitors (QoIs).

[0322] Embodiment C5. The method of any one of Embodiments C1-C4, wherein component (b) of the composition comprises at least one fungicidal compound selected from the group consisting of azoxystrobin, benzovindiflupyr, bixafen, cyproconazole, difenoconazole, epoxiconazole, fenpropimorph, florylpicoxamide, fluindapyr, flutriafol, fluxapyroxad, inpirfluxam, isoflucipram, mefentrifluconazole, metominostrobin, picoxystrobin, prothioconazole, pydiflumetofen, pyraclostrobin, tebuconazole, and trifloxystrobin.

[0323] Embodiment C6. The method of embodiment C5, wherein component (b) of the composition comprises at least one fungicidal compound selected from the group consisting of azoxystrobin, benzovindiflupyr, cyproconazole, epoxiconazole, fluindapyr, fluxapyroxad, metominostrobin, picoxystrobin, prothioconazole, pyraclostrobin, tebuconazole, and trifloxystrobin.

[0324] Embodiment C7. The method of any one of Embodiments C2 to C6, wherein the disease is Asian soybean rust caused by Phakopsora pachyrhizi.

[0325] Embodiment C8. The method of any one of embodiments C2 to C6, wherein the disease is wheat leaf rust caused by Puccinia recondita.

[0326] Embodiment C9. The method of embodiment C1, wherein the disease is powdery mildew disease and component (b) of the composition comprises at least one fungicidal compound selected from (b3) demethylation inhibitor (DMI) fungicides, (b11) quinine external inhibitor (QoI) fungicides, (b13) azanaphthalene fungicides, and (b52) multi-site active fungicides.

[0327] Embodiment C10. The method of embodiment C9, wherein component (b) of the composition comprises at least one fungicidal compound selected from (b3) demethylation inhibitor (DMI) fungicides, (b11) quinone external inhibitor (QoI) fungicides, and (b52) multi-site active fungicides.

[0328] Embodiment C11. The method of embodiments C9 and C10, wherein component (b) of the composition comprises at least one fungicidal compound selected from the group consisting of azoxystrobin, chlorothalonil, copper sulfate, cyproconazole, difenoconazole, epoxiconazole, fenpropimorph, florylpicoxamide, flutriafol, mancozeb, mefentrifluconazole, metominostrobin, picoxystrobin, prothioconazole, pyraclostrobin, tebuconazole, and trifloxystrobin.

[0329] Embodiment C12. The method of Embodiment C11 wherein component (b) of the composition comprises at least one fungicidal compound selected from the group consisting of cyproconazole, difenoconazole, epoxiconazole, prothioconazole, and tebuconazole.

[0330] Embodiment C13. The method of Embodiment C10 wherein component (b) of the composition comprises at least one fungicidal compound selected from (b3) a DMI fungicide.

[0331] Embodiment C14. The method of Embodiment C13 wherein component (b) of the composition comprises at least one fungicidal compound selected from the group consisting of cyproconazole, difenoconazole, and prothioconazole.

[0332] Embodiment C15. The method of Embodiment C10 wherein component (b) of the composition comprises at least one fungicidal compound selected from (b11) Qol fungicides.

[0333] Embodiment C16. The method of Embodiment C15 wherein component (b) of the composition comprises at least one fungicidal compound selected from the group consisting of azoxystrobin, picoxystrobin, and pyraclostrobin.

[0334] Embodiment C17. The method of any one of embodiments C9 to C16, wherein the disease is wheat powdery mildew caused by Erysiphe graminis.

[0335] Embodiment C18. The method of embodiment C1, wherein the disease is Septoria disease and component (b) of the composition comprises at least one fungicidal compound selected from (b3) a demethylation inhibitor (DMI) fungicide and (b11) a quinine external inhibitor (QoI) fungicide.

[0336] Embodiment C19. The method of embodiment C18, wherein component (b) of the composition comprises at least one fungicidal compound selected from the group consisting of azoxystrobin, cyproconazole, difenoconazole, epoxiconazole, fenpropimorph, florylpicoxamide, flutriafol, mefentrifluconazole, metominostrobin, picoxystrobin, prothioconazole, pyraclostrobin, tebuconazole, and trifloxystrobin.

[0337] Embodiment C20. The method of Embodiment C19 wherein component (b) of the composition comprises at least one fungicidal compound selected from the group consisting of epoxiconazole and fenpropimorph.

[0338] Embodiment C21. The method of any one of Embodiments C18 to C20, wherein the disease is wheat leaf blight caused by Zymoseptoria tritici.

[0339] Embodiment C22. The method of embodiment C1, wherein the disease is Botrytis disease and component (b) of the composition comprises at least one fungicidal compound selected from (b11) a quinone external inhibitor (QoI) fungicide and (b52) a multi-site active fungicide.

[0340] Embodiment C23. The method of Embodiment C22 wherein component (b) of the composition comprises at least one fungicidal compound selected from the group consisting of azoxystrobin, chlorothalonil, florylpicoxamide, mancozeb, metominostrobin, picoxystrobin, pyraclostrobin, and trifloxystrobin.

[0341] Embodiment C24. The method of Embodiment C23 wherein component (b) of the composition comprises at least one fungicidal compound selected from the group consisting of azoxystrobin and chlorothalonil.

[0342] Embodiment C25. The method of any one of Embodiments C1 through C24 wherein components (a) and (b) are applied in synergistically effective amounts (and in a synergistic ratio relative to one another).

[0343] Of note are embodiments that are counterparts of embodiments C1 to C25 with respect to a method of controlling plant diseases caused by fungal plant pathogens, comprising applying to a plant or part thereof a fungicidally effective amount of a fungicidal composition of the present invention.

[0344] As noted in the Summary of the Invention, the present invention also relates to compounds of Formula 1, or N-oxides or salts thereof. It is also noted that embodiments of the present invention, including embodiments 1-108, also relate to compounds of Formula 1.

[0345] The present invention provides a fungicidal composition comprising a compound of Formula 1 (including all stereoisomers, N-oxides and salts thereof) and at least one other fungicide. Notable embodiments of such compositions are those comprising a compound corresponding to any of the compound embodiments described above.

[0346] The present invention provides a disinfectant composition comprising (i.e., a disinfectant-effective amount of) a compound of Formula 1 (including all stereoisomers, N-oxides and salts thereof) and at least one additional component selected from the group consisting of surfactants, solid diluents and liquid diluents. Notable embodiments of such compositions are those comprising a compound corresponding to any of the compound embodiments described above.

[0347] The present invention provides a method for controlling plant diseases caused by fungal plant pathogens, comprising applying to a plant or part thereof or to plant seeds a fungicidally effective amount of a compound of Formula 1 (including all stereoisomers, N-oxides and salts thereof). Of note among such method embodiments are those comprising applying a fungicidally effective amount of a compound corresponding to any of the compound embodiments described above. Of particular note are embodiments in which the compound is applied as a composition of the invention.

[0348] Of note is the compound of formula 1A (including all geometric and stereoisomers), its N-oxides, hydrates and salts, Formula 1: [ka] (In the formula, R 2 is cyano, halogen or C1-C2 alkyl, R 3 is a halogen, R 4a and R 4b are each independently H or halogen, provided that at least one is halogen; R 5a and R 5b are each independently H, halogen, methyl, or methoxy, provided that at least one is halogen; However, R 3 is Cl and R 4a is F and R 4b When is H, R 5ais H, Br, Cl, I, methyl or methoxy) as well as agricultural compositions containing them and their use as fungicides.

[0349] Embodiment A1.R 2 is methyl or ethyl, R 3 is Br, Cl or F, R 4a and R 4b are each independently H, Br, Cl, or F; R 5a and R 5b are each independently H, Br, Cl, F or methyl.

[0350] Embodiment B1.R 2 is methyl, R 4a is Cl or F, R 4b is H, Cl or F, R 5a is H, Cl, F or methyl, R 5b A compound according to embodiment A1, wherein is H or F.

[0351] Also of note is a fungicidal composition comprising a fungicidally effective amount of a compound of Formula 1A (including all geometric and stereoisomers, N-oxides, and salts thereof) or any one of the counterpart embodiments that are embodiment counterparts to Embodiments 1-107 and Embodiments A-M, and at least one additional component selected from the group consisting of a surfactant, a solid diluent, and a liquid diluent. Also of note is a method for controlling plant diseases caused by fungal plant pathogens, comprising applying to a plant or part thereof or a plant seed a fungicidally effective amount of a compound of Formula 1A (including all geometric and stereoisomers, N-oxides, and salts thereof) or any one of the counterpart embodiments. Of particular note is an embodiment in which the compound of Formula 1A is applied as a composition of the invention.

[0352] Compounds of Formula 1 can be prepared using one or more of the following methods and variations as described in Schemes 1-12. R in compounds of Formulas 1-21 below 1 , R 2 , R 3 , R 4 , R 5 , m, n and R 6 is defined above in the Summary of the Invention unless otherwise indicated. Formulas 1a and 1b are subsets of Formula 1. The substituents for the subset formulas are as defined for their parent formulas unless otherwise indicated.

[0353] As shown in Scheme 1, compounds of formula 1 can be prepared by reacting a 5-aminopyrazole of formula 2 with a nitrophenyl compound of formula 3 (wherein L 1can be prepared by reaction with a leaving group such as a halogen (e.g., F, Cl, Br, I) or a sulfonate (e.g., mesylate, triflate, or p-toluenesulfonate). In some cases, the use of a metal catalyst in catalytic to superstoichiometric amounts can facilitate the desired reaction. Typical reaction conditions include, for example, carrying out the reaction in the presence of a metal catalyst such as a copper salt complex (e.g., CuI with N,N'-dimethylethylenediamine, proline, or bipyridyl), a palladium complex (e.g., tris(dibenzylideneacetone)dipalladium(0)), or a palladium salt (e.g., palladium acetate) with a ligand such as 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene, 2-dicyclohexylphosphino-2',4',6'-triisopropylbiphenyl, or 2,2'-bis(diphenylphosphino)1,1'-binaphthalene, with a base such as potassium carbonate, cesium carbonate, potassium phosphate, sodium phenoxide, or sodium tert-butoxide, and optionally with a solvent containing an alcohol such as ethanol, such as N,N-dimethylformamide, 1,2-dimethoxyethane, dimethyl sulfoxide, 1,4-dioxane, or toluene. For relevant references, see PCT Patent Publication No. WO 2013 / 126283, Synthetic Example 1, Step C; and WO 2010 / 020363, Example 2A. The method of Scheme 1 is also exemplified in this Example 1, Step C; Example 5, Step C; and Example 3. Compounds of Formula 3 are commercially available or their preparation is known in the art. [ka]

[0354] General methods useful for preparing 5-aminopyrazoles of formula 2 are well known in the art, see, for example, Journal für Practische Chemie (Leipzig) 1911, 83, 171 and J. Am. Chem. Soc. 1954, 76, 501. One such method is illustrated in Scheme 2 below, where 5-aminopyrazoles of formula 2 are prepared by condensing a compound of formula 4 with a hydrazine of formula 5 (e.g., methylhydrazine or ethylhydrazine) in a solvent such as ethanol or methanol, optionally in the presence of an acid such as acetic acid, according to general procedures known in the art; see, for example, PCT Patent Publication WO 2012 / 031061, Synthesis Example 1, Step A; and Synthesis Example 2, Step C. The method of Scheme 2 is also exemplified in this Example 1, Step B. [ka]

[0355] Alternatively, as shown in Scheme 3, 5-aminopyrazoles of formula 2 can be prepared by reacting 4-bromo- or 4-iodopyrazoles of formula 6 with boronic acid compounds of formula 7 using well-known transition metal-catalyzed cross-coupling reaction conditions. [ka]

[0356] Methods useful for preparing compounds of formula 6 are known in the art. 6Compounds of formula 8 (where R is H) can be prepared as shown in Scheme 4. In this method, compounds of formula 8 are condensed with hydrazines of formula 5 (e.g., methylhydrazine or ethylhydrazine) in a solvent such as ethanol or methanol, optionally in the presence of an acid or base catalyst, such as acetic acid, piperidine, or sodium methoxide, by general procedures known in the art. See PCT Patent Publication WO 2013 / 116251, Synthesis Example 1, Step C, and Example 2, Step B, for reaction conditions. Compounds of formula 8 (where R is H) can also be prepared as shown in Scheme 4. a is methyl) is exemplified in Example 2, Step C of the present invention. [ka]

[0357] As shown in Scheme 5, compounds of formula 8 can be prepared by reacting a ketene dithioacetal derivative of formula 9 with a compound of formula 10, optionally in the presence of a base such as sodium hydride or ethylmagnesium chloride, in a solvent such as toluene, tetrahydrofuran, or dimethoxymethane at a temperature ranging from about −10° C. to the boiling point of the solvent. For relevant references, see, for example, J. Heterocycl. Chem. 1975, 12(1), 139. Methods useful for preparing compounds of formula 9 are known in the art. [ka]

[0358] Additionally, as shown in Scheme 6, compounds of formula 8 (wherein R a is lower alkyl) (e.g., methyl, ethyl, n-propyl) and Formula 8a (i.e., R a

[0049] The tautomer of formula 8 (when t is H) can be prepared via a condensation reaction between an isothiocyanate compound of formula 11 and a carbonyl compound of formula 12 to give an intermediate compound of formula 13, which is a salt of a thioamide of formula 8a. The intermediate compound of formula 13 can be used in situ (as exemplified in WO 2013 / 116251, Synthesis Example 1, Step C; and this Example 2, Step C) or isolated (as exemplified in WO 2013 / 116251, Example 2, Step A). ​​Bases useful for preparing compounds of formula 13 include sodium or potassium hydrides, alkoxides, hydroxides, or carbonates, such as sodium hydride, potassium tert-butoxide, sodium ethoxide, potassium hydroxide, sodium hydroxide, or potassium carbonate. An amine base (e.g., triethylamine or N,N-diisopropylethylamine) can also be used to effect the condensation of compounds of formulas 11 and 12 to compounds of formula 13. A variety of solvents, such as tetrahydrofuran, diethyl ether, toluene, N,N-dimethylformamide, alcohols (e.g., ethanol), esters (e.g., ethyl acetate or isopropyl acetate), or mixtures thereof, are useful. As one skilled in the art will appreciate, the solvent is selected for its compatibility with the base. The reaction temperature can range from −78° C. to the boiling point of the solvent. One useful mixture of base and solvent combination is potassium tert-butoxide or potassium tert-pentoxide in tetrahydrofuran, to which can be added solutions of an isothiocyanate of formula 11 and a carbonyl compound of formula 12, either combined in one solution or added separately, preferably by addition of the carbonyl compound followed by the isothiocyanate. Typically, the reaction is carried out at −70 to 0° C. The salt of formula 13 may be acidified to form a ketothioamide compound of formula 8a, or R a X 1 (Formula 14) (where R a is lower alkyl (e.g., methyl, ethyl, n-propyl), and X 1can be alkylated with a nucleophilic leaving group (i.e., a nucleophilic leaving group, e.g., Br, I, OS(O)2CH3) to form the corresponding compound of formula 8. This general method is known in the chemical literature, see for example Zhurnal Organicheskoi Khimii 1982, 18(12), 2501. The intermediate compound of formula 13 (not isolated) can be converted to a compound of formula 8 (where R a The method of Scheme 6 for preparing (wherein R is methyl) is exemplified in Synthetic Example 1, Step C of PCT Patent Publication WO 2013 / 116251. Also, this Example 2, Step C illustrates the preparation of a compound of Formula 8. [ka]

[0359] Ketothioamides of formula 8a can also be prepared by reacting the corresponding ketoamide with a sulfurizing agent such as Lawesson's reagent or P2S5, see for example Helv. Chim. Act. 1998, 81(7), 1207.

[0360] As shown in Scheme 7, compounds of formula 1 can be prepared by reacting a 1H-pyrazole compound of formula 15 with a 1H-pyrazole compound of formula R in the presence of a base, such as 1,8-diazabicyclo[5.4.0]undec-7-ene, potassium carbonate or potassium hydroxide, and a solvent, such as N,N-dimethylformamide, tetrahydrofuran, toluene, or water. 1 -L 2 A methylating agent of formula (wherein R 1 is methyl or ethyl, and L 2can also be prepared by reacting with a leaving group such as a halogen (e.g., Cl, Br, I), a sulfonate (e.g., mesylate, triflate, or p-toluenesulfonate), or a phosphate (e.g., dimethyl phosphate). General procedures for this type of methylation are well known in the art and can be readily adapted to prepare the compounds of the present invention. Particularly useful methylating agents include diazomethane and iodomethane using general procedures known in the art, such as those described in Canadian Journal of Chemistry 1986, 64, 2211-2219 and Heterocycles 2000, 53(12), 2775-2780. [ka]

[0361] Compounds of formula 15 can be prepared by condensing compounds of formula 8 with hydrazine in a manner similar to that of Scheme 4. This method is described in Chemistry of Heterocyclic Compounds 2005, 41(1), 105-110.

[0362] In an alternative method, as shown in Scheme 8, compounds of formula 1 can be prepared by the reaction of a 4-bromo or 4-iodopyrazole of formula 16 with an organometallic compound of formula 17 in the presence of a suitable palladium, copper, or nickel catalyst under transition metal catalyzed cross-coupling reaction conditions. In this method, compounds of formula 17 can be prepared by the reaction of an organoboronic acid (e.g., M 1 is B(OH)), organic boronic acid esters (e.g., M 1 is B(-OC(CH2)3O-), organic trifluoroborate (e.g., M 1 is BF3K), organotin reagents (e.g., M 1 is Sn(n-Bu)3, Sn(Me)3), Grignard reagents (e.g., M 1 is MgBr or MgCl) or an organozinc reagent (e.g., M 1is ZnBr or ZnCl). Suitable metal catalysts include, but are not limited to, palladium(II) acetate, palladium(II) chloride, tetrakis(triphenylphosphine)palladium(0), bis(triphenylphosphine)palladium(II) dichloride, dichloro[1,1'-bis(diphenylphosphino)ferrocene]palladium(II), bis(triphenylphosphine)dichloronickel(II), and copper(I) salts (e.g., copper(I) iodide, copper(I) bromide, copper(I) chloride, copper(I) cyanide, or copper(I) triflate). Optimal conditions will depend on the catalyst and counterion (i.e., M) attached to the coupling reagent used, as will be understood by those skilled in the art. 1 ) In some cases, the addition of a ligand, such as a substituted phosphine or a substituted bisphosphinoalkane, promotes reactivity. Also, the presence of a base, such as an alkali carbonate, a tertiary amine, or an alkali fluoride, may be necessary for some reactions involving organoboron reagents of formula 17. For reviews of this type of reaction, see E. Negishi, Handbook of Organopalladium Chemistry for Organic Synthesis, John Wiley and Sons, Inc., New York, 2002; N. Miyaura, Cross-Coupling Reactions: A Practical Guide, Springer, New York, 2002; H. C. Brown et al., Organic Synthesis via Boranes, Vol. 3, Aldrich Chemical Co., Milwaukee, WI, 2002; Suzuki et al., Chemical Review 1995, 95, 2457-2483 and Molander et al., Accounts of Chemical Research 2007, 40, 275-286. The method of Scheme 8 is also exemplified in PCT Patent Publications WO 2010 / 101973 and WO 2012 / 031061. [ka]

[0363] As shown in Scheme 9, the pyrazole intermediate of formula 16 is readily prepared from the corresponding pyrazole of formula 18 by treatment with a halogenating agent. Suitable halogenating agents for this method include N-bromosuccinimide (NBS), N-iodosuccinimide (NIS), bromine, sodium bromite, thionyl chloride, oxalyl chloride, phenylphosphonic acid dichloride, or phosgene. Particularly useful are N-bromosuccinimide (NBS) and N-iodosuccinimide (NIS). Suitable solvents for this reaction include, for example, N,N-dimethylformamide, N,N-dimethylacetamide, dichloromethane, chloroform, chlorobutane, benzene, xylene, chlorobenzene, tetrahydrofuran, p-dioxane, acetonitrile, and the like. Optionally, an organic base, such as triethylamine, pyridine, N,N-dimethylaniline, and the like, can be added. Typical reaction temperatures range from about ambient temperature to 200°C. For representative procedures see Synthesis 2006, 17, 2855-2864; Journal of Medicinal Chemistry 2005, 48, 6843-6854; Journal of Medicinal Chemistry 2007, 50, 3086-3100 and Journal of Medicinal Chemistry 2005, 48, 4420-4431. [ka]

[0364] As shown in Scheme 10, compounds of formula 18 can be prepared from the corresponding compounds of formula 19 by procedures similar to those used for the method of Scheme 1. Compounds of formula 19 are commercially available or can be prepared by methods known in the art. [ka]

[0365] The compounds of Formula 1 described herein and intermediates thereto can be subjected to a variety of electrophilic, nucleophilic, organometallic, oxidation, and reduction reactions to add substituents or modify existing substituents, thus providing other functionalized compounds of Formula 1. For example, as shown in Scheme 11, compounds of Formula 1b (i.e., Formula 1, where (R 5 ) n is CH3), can be prepared by reacting a compound of formula 20 (where L is CH3) with a compound of formula 21 (where L is CH3) in the presence of a catalyst such as [1,1'-bis(diphenylphosphino)ferrocene]palladium chloride(II) dichloromethane adduct, preferably in the presence of a base such as 1,8-diazabicyclo[5.4.0]undec-7-ene, cesium carbonate or potassium hydroxide, in a solvent such as N,N-dimethylformamide, tetrahydrofuran, 1,4-dioxane, ethanol, toluene or water. 3 can be prepared by reaction of a leaving group, such as a halogen (e.g., Br, I) or a sulfonate (e.g., mesylate, triflate, p-toluenesulfonate), with a reagent such as 2,4,6-trimethylboroxine or tetramethylstannane. The method of Scheme 11 is exemplified in PCT Patent Publication WO 2013 / 192126, Example 4, Step A and Example 4, Step B.

[0366] Compounds of formula 20 can be prepared by the methods described in PCT Patent Publications WO 2010 / 101973 and WO 2012 / 031061. Those skilled in the art will recognize that, in some cases, preparation of an N-protected compound of formula 20 prior to functional group interconversion facilitates obtaining the desired product. The selection and use of appropriate N-protecting groups will be apparent to those skilled in the art; for representative examples, see T.W. Greene and P.G.M. Buts, Protective Groups in Organic Synthesis, 2nd ed.; Wiley: New York, 1991. Step A of this Example 4 also illustrates the preparation of an N-Boc-protected compound of formula 20. [ka]

[0367] Analogous to the method of Scheme 11, compounds of formula 20 can be treated with potassium (trifluoromethyl)trimethoxyborate to provide the trifluoromethyl analogs of formula 1b.

[0368] In another example, as shown in Scheme 12, a compound of Formula 1 (wherein R 6 is other than H) is R 6 and the corresponding compound of formula 1 (where R 6 is H). Typically, the reaction is carried out in the presence of a base, such as sodium hydride, and a polar solvent, such as N,N-dimethylformamide. In this context, the expression "R 6 Electrophiles containing nucleophiles (i.e., R 6 is H, the nitrogen atom in formula 1 is 6 refers to a compound to which the moiety can be transferred. Often, R 6 Electrophiles containing the formula R 6 X 2 wherein X 2 is a nucleophilic leaving group (i.e., a leaving group in a nucleophilic reaction). Typical nucleophilic leaving groups include halides (e.g., Br, Cl, I) or sulfonates (e.g., mesylate, triflate, p-toluenesulfonate). However, R 6 Some electrophiles, including those shown in Figure 1, do not contain a nucleophilic leaving group; an example is sulfur trioxide (SO3), which is a nucleophilic leaving group. 6 is H, deprotonation of the nitrogen atom in formula 1 (e.g., formula M + H - (In the formula, M + can be attached to the nitrogen atom as a -SO3M substituent after reaction with a base of ) which is a cation. [ka]

[0369] It is recognized that some of the reagents and reaction conditions described above for preparing compounds of Formula 1 may be incompatible with certain functional groups present in the intermediates. In these cases, the incorporation of protection / deprotection sequences into the synthesis or interconversion of functional groups will aid in obtaining the desired reaction products. The use and selection of protecting groups will be apparent to those skilled in the art of chemical synthesis (see, for example, T.W. Greene and P.G.M.Wuts, Protective Groups in Organic Synthesis, 2002). nd ed.; Wiley: New York, 1991). Those skilled in the art will recognize that in some cases, it may be necessary to perform additional conventional synthetic steps not specifically described after the introduction of a given reagent shown in any individual scheme to complete the synthesis of a compound of formula 1. Those skilled in the art will also recognize that it may be necessary to combine and perform the steps illustrated in the above schemes in an order other than the specific order presented to prepare a compound of formula 1.

[0370] Additionally, those skilled in the art will recognize that the compounds of Formula 1 and intermediates described herein can also be subjected to a variety of electrophilic, nucleophilic, radical, organometallic, oxidation, and reduction reactions to add substituents or modify existing substituents.

[0371] It is believed that one skilled in the art using the preceding description can, without undue effort, utilize the present invention to its fullest extent. Accordingly, the following examples are to be construed as merely illustrative and not limiting of the present disclosure in any way. The steps in the following examples describe the procedure for each step in the overall synthetic transformation, and the starting material for each step need not necessarily have been prepared by the particular preparative procedure whose procedure is described in another example or step. Percentages are by weight unless otherwise indicated, except in the case of chromatographic solvent mixtures, in which case parts and percentages are by volume unless otherwise specified. 1H NMR spectra are reported in ppm downfield from tetramethylsilane, where "s" means singlet, "d" means doublet, "t" means triplet, "m" means multiplet, "br s" means broad singlet, and "dd" means doublet of doublets. [Example]

[0372] Example 1 Preparation of 4-(2-chloro-4-fluorophenyl)-N-(2-fluoro-6-nitrophenyl)-1,3-dimethyl-1H-pyrazol-5-amine (Compound 112) Step A: Preparation of α-acetyl-2-chloro-4-fluorobenzeneacetonitrile A mixture of sodium methoxide solution (30% in methanol, 85 mL, 0.47 mol) in toluene (400 mL) was heated to 120 °C using a Dean-Stark trap for azeotropic removal of methanol. After cooling to 90 °C, 2-chloro-4-fluorobenzeneacetonitrile (40.0 g, 0.24 mol) in ethyl acetate (200 mL) was added dropwise to the reaction mixture. The reaction mixture was stirred at 90 °C for 1 hour, and then hydrochloric acid (1 N, 30 mL) was added. The resulting mixture was extracted with ethyl acetate (3 × 250 mL), and the combined organic extracts were dried over sodium sulfate, filtered, and concentrated under reduced pressure. The resulting material was purified by column chromatography on silica gel (eluting with 3:7 ethyl acetate-petroleum ether) to give the title compound as a white solid (35 g). 1 H NMR(CDCl3): δ7.49(dd,1H),7.24(dd,1H),7.14-7.09(m,1H),5.13(s,1H),2.36(s,3H).

[0373] Step B: Preparation of 4-(2-chloro-4-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine To a mixture of α-acetyl-2-chloro-4-fluorobenzeneacetonitrile (i.e., the product of Step A) (28 g, 0.13 mol) in ethanol (400 mL) was added methylhydrazine sulfate (28.6 g, 0.20 mol) and sodium acetate (21.7 g, 0.27 mol). The reaction mixture was heated at 120° C. for 12 hours and then concentrated under reduced pressure to remove the solvent. The resulting mixture was poured into ice water (500 mL) and filtered to collect a white solid. The solid was rinsed with water and pentane and then dried to give the title compound as an off-white solid (24 g). 1 H NMR(CDCl3): δ 7.45(dd,1H),7.27(t,1H),7.23-7.12(m,1H),4.89(s,2H),3.49(s,3H).

[0374] Step C: Preparation of 4-(2-chloro-4-fluorophenyl)-N-(2-fluoro-6-nitrophenyl)-1,3-dimethyl-1H-pyrazol-5-amine To a mixture of 4-(2-chloro-4-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine (i.e., the product of Step B) (1.2 g, 5.0 mmol) in tetrahydrofuran (40 mL) was added potassium tert-butoxide (1 M in THF, 10 mL, 10 mmol) portionwise at 0° C. The reaction mixture was stirred at 0° C. for 1 hour, and then 1,2-difluoro-3-nitrobenzene (0.85 g, 5.3 mmol) was added dropwise. After 30 minutes at 0° C., saturated aqueous ammonium chloride solution was added to the reaction mixture, and the resulting mixture was extracted with ethyl acetate (100 mL). The aqueous layer was further extracted with ethyl acetate (2×40 mL), and the combined organic extracts were washed with saturated sodium chloride solution, dried over sodium sulfate, filtered, and concentrated under reduced pressure. The material thus obtained was purified by column chromatography on silica gel (eluting with 40% ethyl acetate in petroleum ether) to give the title compound, a compound of the present invention, as a yellow solid (1.1 g). 1H NMR(CDCl3):δ 8.59(s,1H),7.59(d,1H),7.31(d,1H),7.2(d,1H),7.09(t,1H),7.04-7.01(m,1H),6.82-6.86(m,1H),3.74(s,3H),1.97(s,3H).

[0375] Example 2 Preparation of 3-chloro-4-[5-[(2-fluoro-6-nitrophenyl)amino]-1,3-dimethyl-1H-pyrazol-4-yl]benzonitrile (Compound 113) Step A: Preparation of 3-chloro-4-(2-oxopropyl)benzonitrile To a mixture of 4-amino-3-chlorobenzonitrile (50.0 g, 0.33 mol) in diethyl ether (500 mL) was added boron trifluoride diethyl etherate (61 mL, 0.50 mol) at −10° C. The reaction mixture was stirred at −10° C. for 10 minutes, and then tert-butyl nitrite (48 mL, 0.4 mol) was added. After 20 minutes at −10° C., the reaction mixture was warmed to room temperature, stirred for 2 hours, and then filtered to collect a white solid. The white solid was triturated with diethyl ether and pentane (1:1, 300 mL), filtered, and dried to give the intermediate compound 2-chloro-4-cyanobenzenediazonium tetrafluoroborate as an off-white solid (72 g).

[0376] To a mixture of 2-chloro-4-cyanobenzenediazonium tetrafluoroborate (72 g, 0.33 mol) in dimethylformamide (500 mL) was added isopropenyl acetate (354 mL, 3.2 mol) at −10° C. The reaction mixture was stirred at −10° C. for 20 minutes, and then 4-aminomorpholine (1.0 mL) in dimethyl sulfoxide (40 mL) was added. After 1 hour, ice-cold water (1000 mL) was added, and the resulting mixture was extracted with ethyl acetate (3×250 mL). The combined organic extracts were dried over sodium sulfate, filtered, and concentrated under reduced pressure. The resulting material was purified by column chromatography on silica gel (eluting with 1:4 ethyl acetate-petroleum ether) to give the title compound as a solid (52 g). 1 H NMR(CDCl3): δ 7.69(s,1H),7.53(d,1H),7.32(d,1H),3.93(s,2H),2.28(s,3H).

[0377] Step B: Preparation of 1-fluoro-2-isothiocyanato-3-nitrobenzene To a mixture of 2-fluoro-6-nitrobenzenamine (1.0 g, 6.4 mmol) in 1,2-dichlorobenzene (10 mL) at 0° C. was added two drops of dimethylformamide, followed by thiophosgene (1.46 mL, 19 mmol). The reaction mixture was heated at 160° C. for 1 hour, cooled to room temperature, and concentrated under reduced pressure. The resulting material was purified by column chromatography on silica gel (eluting with 1:9 ethyl acetate-petroleum ether) to give the title compound as an oil (0.91 g). 1 H NMR(CDCl3)δ 7.88(d,1H),7.46(t,1H),7.36(m,1H).

[0378] Step C: Preparation of 3-chloro-4-[5-[(2-fluoro-6-nitrophenyl)amino]-1,3-dimethyl-1H-pyrazol-4-yl]benzonitrile To a mixture of 3-chloro-4-(2-oxopropyl)benzonitrile (i.e., the product of Step A) (1.0 g, 5.2 mmol) in tetrahydrofuran (20 mL) was added potassium tert-butoxide (0.7 g, 6.2 mmol) at −10° C. After 30 minutes at −10° C., 1-fluoro-2-isothiocyanato-3-nitrobenzene (i.e., the product of Step B) (0.99 g, 5.0 mmol) in tetrahydrofuran (10 mL) was added to the reaction mixture, and stirring was continued for about 15 minutes to provide a reaction mixture containing the intermediate compound 4-[1-[[(2-chloro-6-nitrophenyl)amino]mercaptomethylene]-2-oxopropyl]-3-chloro-benzonitrile potassium salt, which is the potassium salt of α-acetyl-N-(2-chloro-6-nitrophenyl)-2-chloro-4-cyano-benzeneethanethioamide. Iodomethane (1.2 mL, 19 mmol) was added to the reaction mixture. After 20 minutes at -10°C, the reaction temperature was brought to 0°C, and acetic acid (5.0 mL) and methylhydrazine (85% in water, 0.5 g, 10 mmol) were added. The reaction mixture was warmed to room temperature and heated to reflux for 2 hours, then poured into ice-cold water (30 mL) and ethyl acetate (20 mL). The organic layer was separated, and the aqueous layer was extracted with ethyl acetate (2 x 10 mL). The combined organic extracts were washed with saturated sodium chloride solution (20 mL), dried over sodium sulfate, filtered, and concentrated under reduced pressure. The resulting material was purified by column chromatography on silica gel (eluting with 2:3 ethyl acetate-petroleum ether) to afford the title compound, a compound of the present invention, as a pale yellow solid (0.850 g). 1 H NMR(CDCl3)δ 8.71(d,1H),7.85(d,1H),7.64-7.58(m,2H),7.34-7.25(m,2H),6.87-6.81(m,1H),3.75(s,3H),1.99(s,3H).

[0379] Example 3 Preparation of N-(4-bromo-2-fluoro-6-nitrophenyl)-4-(2-chloro-4-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine (compound 61) To a mixture of 4-(2-chloro-4-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine (i.e., the product of Example 1, Step B) (0.5 g, 2.1 mmol) in tetrahydrofuran (30 mL) was added potassium tert-butoxide (1 M in THF, 4.2 mL, 4.2 mmol) portionwise at 0° C. The reaction mixture was stirred at 0° C. for 1 hour, and then 5-bromo-1,2-difluoro-3-nitrobenzene (0.54 g, 2.3 mmol) was added dropwise. After 30 minutes at 0° C., saturated aqueous ammonium chloride solution was added to the reaction mixture, and the resulting mixture was extracted with ethyl acetate (100 mL). The aqueous layer was further extracted with ethyl acetate (2×40 mL), and the combined organic extracts were washed with saturated sodium chloride solution, dried over sodium sulfate, filtered, and concentrated under reduced pressure. The material thus obtained was purified by column chromatography on silica gel (eluting with 40% ethyl acetate in petroleum ether) to give the title compound, a compound of the present invention, as a yellow solid (0.45 g). 1 H NMR(CDCl3): δ 8.69(br s,1H),7.77(t,1H),7.66(dd,1H),7.27(dd,2.0Hz,1H),7.09-7.06(m,2H),3.73(s,3H),1.97(s,3H).

[0380] Example 4 Preparation of 4-(2-chloro-4-fluorophenyl)-N-(2-fluoro-4-methyl-6-nitrophenyl)-1,3-dimethyl-1H-pyrazol-5-amine (compound 93) Step A: Preparation of 1,1-dimethylethyl N-(4-bromo-2-fluoro-6-nitrophenyl)-N-[4-(2-chloro-4-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-yl]carbamate To a mixture of N-(4-bromo-2-fluoro-6-nitrophenyl)-4-(2-chloro-4-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine (i.e., the product of Example 3) (1 g, 2.2 mmol) and triethylamine (1.24 mL, 8.9 mmol) in dichloromethane (20 mL) was added di-tert-butyl dicarbonate (1.46 g, 6.7 mmol) at 0 ° C. The reaction mixture was warmed to room temperature and stirred overnight, then diluted with water (20 mL) and extracted with dichloromethane (2 × 20 mL). The combined organic extracts were washed with saturated sodium chloride solution, dried over sodium sulfate, filtered, and concentrated under reduced pressure. The resulting material was purified by column chromatography on silica gel (eluting with 40% ethyl acetate in petroleum ether) to give the title compound as a yellow solid (750 mg). 1 H NMR(CDCl3):δ 7.85(s,1H),7.78(s,1H),7.52-7.47(m,1H),7.17-7.19(m,1H),6.97-6.88(m,1H),3.8(s,3H),1.96(s,3H),1.49(s,9H).

[0381] Step B: Preparation of 4-(2-chloro-4-fluorophenyl)-N-(2-fluoro-4-methyl-6-nitrophenyl)-1,3-dimethyl-1H-pyrazol-5-amine A mixture of 1,1-dimethylethyl N-(4-bromo-2-fluoro-6-nitrophenyl)-N-[4-(2-chloro-4-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-yl]carbamate (i.e., the product of Step A) (600 mg, 1.07 mmol), potassium carbonate (372 mg, 2.7 mmol), dichloro[1,1'-bis(diphenylphosphino)ferrocene]palladium(II) dichloromethane complex (1:1) (40 mg, 0.05 mmol), and trimethylboroxine (0.54 mL, 3.9 mmol) in 1,4-dioxane (20 mL) was heated to reflux for 3 hours. The reaction mixture was diluted with water (15 mL) and extracted with ethyl acetate (2 × 10 mL). The combined organic extracts were washed with saturated aqueous sodium chloride solution (3 × 5 mL), dried over sodium sulfate, filtered, and concentrated under reduced pressure. The resulting material was dissolved in dichloromethane and trifluoroacetic acid (3:1; 4 mL) and stirred at room temperature for 16 hours. The reaction mixture was concentrated under reduced pressure, and the resulting material was dissolved in dichloromethane (5 mL) and washed with saturated aqueous sodium bicarbonate (2 mL). The aqueous layer was further extracted with dichloromethane (3 × 10 mL). The combined organic extracts were washed with saturated sodium chloride solution, dried over sodium sulfate, filtered, and concentrated under reduced pressure. The resulting material was purified by column chromatography on silica gel (eluted with 40% ethyl acetate in petroleum ether) to give the title compound, a compound of the present invention, as a yellow solid (210 mg). 1 H NMR(CDCl3)δ 8.41(s,1H),7.45(s,1H),7.24-7.15(m,2H),7.1-7.01(m,2H),3.72(s,3H),2.15(s,3H),1.95(s,3H).

[0382] Example 5 Alternative preparation of 3-chloro-4-[5-[(2-fluoro-6-nitrophenyl)amino]-1,3-dimethyl-1H-pyrazol-4-yl]benzonitrile (compound 113) Step A: Preparation of 1-methyl-hydrazinecarbonitrile A solution of cyanogen bromide (13.5 g, 127.5 mmol) and dichloromethane (250 mL) was cooled to 0 °C, then a mixture of methylhydrazine (85% aqueous solution, 6.0 g, 127.5 mmol), sodium carbonate (7.5 g, 63.9 mmol), and water (60 mL) was added dropwise with vigorous stirring. After visible signs of gas evolution ceased, the aqueous layer was separated and extracted with dichloromethane (3x). The combined organic layers were dried over magnesium sulfate, filtered, and the filtrate was concentrated under reduced pressure to give the title compound as an oil (6.0 g).

[0383] Step B: Preparation of 4-(5-amino-1,3-dimethyl-1H-pyrazol-4-yl)-3-chlorobenzonitrile A mixture of 3-chloro-4-(2-oxopropyl)benzonitrile (13.7 g, 71.4 mmol) and 1-methylhydrazinecarbonitrile (i.e., the product of Step A) (6.0 g, 86 mmol) was heated with stirring at 60 °C. After 48 h, the reaction mixture was dissolved in dichloromethane (100 mL) and water (100 mL), the layers were separated, and the aqueous layer was extracted with dichloromethane (3x). The combined organic layers were dried over magnesium sulfate, filtered, and the filtrate was concentrated under reduced pressure. The resulting material was purified by column chromatography on silica gel (eluting with 60% ethyl acetate in petroleum ether) to afford the title compound as a pale yellow solid (8.1 g). LCMS:247(M+1)

[0384] Step C: Preparation of 3-chloro-4-[5-[(2-fluoro-6-nitrophenyl)amino]-1,3-dimethyl-1H-pyrazol-4-yl]benzonitrile To a mixture of 4-(5-amino-1,3-dimethyl-1H-pyrazol-4-yl)-3-chlorobenzonitrile (i.e., the product of Step B) (1.2 g, 4.8 mol) in tetrahydrofuran (40 mL) was added dropwise potassium tert-butoxide (9.7 mL, 1 M in tetrahydrofuran) at 0 °C. The reaction mixture was stirred at 0 °C for 1 hour, then 1,2-difluoro-3-nitrobenzene (0.85 g, 5.3 mmol) was added dropwise, and stirring was continued at 0 °C for an additional 30 minutes. The reaction mixture was diluted with saturated aqueous ammonium chloride and ethyl acetate (100 mL), and the layers were separated. The aqueous layer was extracted with ethyl acetate (40 mL × 2), and the combined organic extracts were washed with saturated aqueous sodium chloride, dried over magnesium sulfate, filtered, and the filtrate was concentrated under reduced pressure. The resulting material was purified by column chromatography on silica gel (eluting with 40% ethyl acetate in petroleum ether) to give a yellow solid. The yellow solid was crystallized from ethanol to give the title compound, a compound of the present invention, as a pale yellow solid (560 mg). 1 H NMR(CDCl3)δ 8.71(d,1H),7.85(d,1H),7.63-7.58(m,2H),7.33-7.25(m,2H),6.86-6.82(m,1H),3.75(s,3H),1.99(s,3H). LCMS: 386(M+1).

[0385] By the procedures described herein together with methods known in the art, the compounds disclosed in the following table can be prepared. The following abbreviations are used in the table below: Me means methyl, MeO means methoxy, EtO means ethoxy, and CN means cyano.

[0386] [Table 1]

[0387] This disclosure also includes Tables 1A-46A, each of which corresponds to the column heading in Table 1 (i.e., "R 2is CH3 and R 3 is Cl, (R 4 ) m It is structured the same as Table 1 above, except that the column headings are replaced with the column headings shown below.

[0388] [Table 2]

[0389] [Table 3]

[0390] Formulation / Practical Use The compounds of Formula 1 of the present invention (including their N-oxides and salts) or mixtures (i.e., compositions) comprising the compounds and at least one additional fungicidal compound described in the Summary of the Invention will generally be used as the fungicidal active ingredient in compositions, i.e., formulations, together with at least one additional ingredient selected from the group consisting of surfactants, solid diluents, and liquid diluents, which function as a carrier. The formulation or composition ingredients are selected to be consistent with the physical properties of the active ingredient, the application mode, and environmental factors such as soil type, moisture, and temperature.

[0391] Mixtures of component (a) (i.e., at least one compound of formula 1, its N-oxide or salt) with component (b) (e.g., selected from (b1)-(b54) above and salts thereof) and / or one or more other biologically active compounds or agents (i.e., insecticides, other fungicides, nematicides, miticides, herbicides and other biological agents) can be formulated in a number of ways, including the following: (i) component (a), component (b) and / or one or more other biologically active compounds or agents may be formulated separately and applied separately, or may be applied simultaneously in appropriate weight ratios, e.g., as a tank mix; or (ii) Component (a), component (b) and / or one or more other biologically active compounds or agents can be formulated together in a suitable weight ratio.

[0392] Useful formulations include both liquid and solid compositions. Liquid compositions include solutions (including emulsifiable concentrates), suspensions, emulsions (including microemulsions, oil-in-water emulsions, flowable concentrates, and / or suspoemulsions), which can optionally be concentrated into gels. Common types of aqueous liquid compositions include soluble concentrates, suspension concentrates, capsule suspensions, concentrated emulsions, microemulsions, oil-in-water emulsions, flowable concentrates, and suspoemulsions. Common types of non-aqueous liquid compositions are emulsifiable concentrates, microemulsifiable concentrates, dispersible concentrates, and oil dispersions.

[0393] Common types of solid compositions include dusts, powders, granules, pellets, prills, pastilles, tablets, and filled films (including seed coatings), which can be water-dispersible ("wettable") or water-soluble. Films and coatings formed from film-forming solutions or flowable suspensions are particularly useful for seed treatments. Active ingredients can be (micro)encapsulated and further formed into suspensions or solid formulations. Alternatively, the entire active ingredient formulation can be encapsulated (or "overcoated"). Encapsulation can control or delay the release of the active ingredient. Emulsifiable granules combine the advantages of both emulsifiable concentrate and dry granule formulations. High-strength compositions are primarily used as intermediates for further formulation.

[0394] Of note are composition embodiments in which granules of a solid composition comprising a compound of Formula 1 (or an N-oxide or salt thereof) are mixed with granules of a solid composition comprising component (b). These mixtures can be further mixed with granules comprising an additional agricultural protectant. Alternatively, two or more agricultural protectants (e.g., a component (a) (Formula 1) compound, a component (b) compound, an agricultural protectant other than component (a) or (b)) can be combined in a set of granules of a solid composition, which can then be mixed with one or more sets of granules of a solid composition comprising one or more additional agricultural protectants. These granule mixtures can conform to the general granule mixture disclosures of PCT Patent Publication WO 94 / 24861 or, more preferably, the homogeneous granule mixture teachings of U.S. Pat. No. 6,022,552.

[0395] Sprayable formulations are typically spread in a suitable medium before spraying. Such liquid and solid formulations are formulated to be easily diluted in another suitable medium, usually water, but sometimes an aromatic or paraffinic hydrocarbon or vegetable oil. Spray volumes can range from about one to several thousand liters per hectare, but more typically range from about 10 to several hundred liters per hectare. Sprayable formulations can be tank-mixed with water or other suitable medium for foliar treatment by aerial or ground application, or for application to the plant's growing medium. Liquid and dry formulations can be injected directly into drip irrigation systems or into furrows at planting. Liquid and solid formulations can be applied to seeds of crops and other desirable vegetation before planting as seed treatments to protect the developing roots and other underground plant parts and / or leaves by systemic absorption.

[0396] Formulations will typically contain active ingredients, diluents, and surfactants within the following approximate ranges, which add up to 100 weight percent:

[0397] [Table 4]

[0398] Examples of solid diluents include clays such as bentonite, montmorillonite, attapulgite, kaolin, gypsum, cellulose, titanium dioxide, zinc oxide, starch, dextrin, sugars (e.g., lactose, sucrose), silica, talc, mica, diatomaceous earth, urea, calcium carbonate, sodium carbonate and sodium bicarbonate, and sodium sulfate. Representative solid diluents are described in Watkins et al., Handbook of Insecticide Dust Diluents and Carriers, 2nd Ed., Dorland Books, Caldwell, New Jersey.

[0399] Examples of liquid diluents include water, N,N-dimethylalkanamides (e.g., N,N-dimethylformamide), limonene, dimethyl sulfoxide, N-alkylpyrrolidones (e.g., N-methylpyrrolidinone), alkyl phosphates (e.g., triethyl phosphate), ethylene glycol, triethylene glycol, propylene glycol, dipropylene glycol, polypropylene glycol, propylene carbonate, butylene carbonate, paraffins (e.g., white mineral oil, normal paraffin, isoparaffin), alkylbenzenes, alkylnaphthalenes, glycerin, glycerin triacetate, sorbitol, aromatic hydrocarbons, dearomatized aliphatic hydrocarbons, alkylbenzenes, alkylnaphthalenes, ketones such as cyclohexanone, 2-heptanone, isophorone, and 4-hydroxy-4-methyl-2-pentanone. Liquid diluents include saturated and unsaturated fatty acids (typically C6-C8), saturated and unsaturated fatty acids (typically C6-C8). 22Liquid diluents also include glycerol esters of vegetable oils (e.g., olive, castor, linseed, sesame, corn (maize), peanut, sunflower, grapeseed, safflower, cottonseed, soybean, rapeseed, coconut, and palm kernel oils), fats of animal origin (e.g., beef tallow, pork fat, lard, cod liver oil, fish oil), and mixtures thereof. Liquid diluents also include alkylated fatty acids (e.g., methylated, ethylated, butylated), where the fatty acids can be obtained by hydrolysis of glycerol esters from vegetable and animal sources and can be purified by distillation. Typical liquid diluents are described in Marsden, Solvents Guide, 2nd Ed., Interscience, New York, 1950.

[0400] The solid and liquid compositions of the present invention often contain one or more surfactants. When added to a liquid, surfactants (also known as "surface active agents") generally modify, and most often reduce, the surface tension of the liquid. Depending on the nature of the hydrophilic and lipophilic groups in the surfactant molecule, surfactants can be useful as wetting agents, dispersants, emulsifiers, or antifoaming agents.

[0401] Surfactants are classified as nonionic, anionic or cationic. Nonionic surfactants useful for the present compositions include, but are not limited to, alcohol alkoxylates, such as those based on natural and synthetic alcohols (which may be branched or linear) and prepared from alcohols and ethylene oxide, propylene oxide, butylene oxide or mixtures thereof; amine ethoxylates, alkanolamides and ethoxylated alkanolamides; alkoxylated triglycerides, such as ethoxylated soybean oil, castor oil and rapeseed oil; alkylphenol alkoxylates, such as octylphenol ethoxylate, nonylphenol ethoxylate, dinonylphenol ethoxylate and dodecylphenol ethoxylate (prepared from phenol and ethylene oxide, propylene oxide, butylene oxide or mixtures thereof); block polymers prepared from ethylene oxide or propylene oxide and reverse block copolymers in which the end blocks are prepared from propylene oxide. ethoxylated fatty acids; ethoxylated fatty esters and oils; ethoxylated methyl esters; ethoxylated tristyrylphenols (including those prepared from ethylene oxide, propylene oxide, butylene oxide or mixtures thereof); fatty acid esters, glycerol esters, lanolin-based derivatives, polyethoxylate esters such as polyethoxylated sorbitan fatty acid esters, polyethoxylated sorbitan fatty acid esters and polyethoxylated glycerol fatty acid esters; other sorbitan derivatives such as sorbitan esters; polymeric surfactants such as random copolymers, block copolymers, alkyl PEG (polyethylene glycol) resins, graft or comb polymers and star polymers; polyethylene glycol (PEG); polyethylene glycol fatty acid esters; silicone-based surfactants; and sugar derivatives such as sucrose esters, alkyl polyglycosides; and alkyl polysaccharides.

[0402] Useful anionic surfactants include, but are not limited to, alkylaryl sulfonic acids and their salts; carboxylated alcohol or alkylphenol ethoxylates; diphenyl sulfonic acid derivatives; lignin and lignin derivatives such as lignosulfonates; maleic acid or succinic acid or anhydrides; olefin sulfonates, phosphate esters such as phosphate esters of alcohol alkoxylates, phosphate esters of alkylphenol alkoxylates, and phosphate esters of styrylphenol ethoxylates; protein-based surfactants; sarcosine derivatives; styrylphenol ethers sulfates of alcohols; sulfates of ethoxylated alcohols; sulfonates of amines and amides such as N,N-alkyl taurates; sulfonates of benzene, cumene, toluene, xylene, and dodecyl and tridecyl benzene; sulfonates of condensed naphthalenes; sulfonates of naphthalene and alkyl naphthalenes; sulfonates of fractionated petroleum; sulfosuccinamates; and sulfosuccinates and their derivatives, such as dialkyl sulfosuccinate salts.

[0403] Useful cationic surfactants include, but are not limited to, amides and ethoxylated amides; amines such as N-alkylpropanediamines, tripropylenetriamine, and dipropylenetetramine; and ethoxylated amines, ethoxylated diamines, and propoxylated amines (prepared from amines and ethylene oxide, propylene oxide, butylene oxide, or mixtures thereof); amine salts such as amine acetates and diamine salts; quaternary ammonium salts such as quaternary salts, ethoxylated quaternary salts, and diquaternary salts; and amine oxides such as alkyldimethylamine oxides and bis-(2-hydroxyethyl)-alkylamine oxides.

[0404] Also useful in the compositions of the present invention are mixtures of nonionic and anionic surfactants or mixtures of nonionic and cationic surfactants. Nonionic, anionic, and cationic surfactants and their recommended uses are disclosed in various published references, including McCutcheon's Emulsifiers and Detergents, annual American and International Editions published by McCutcheon's Division, The Manufacturing Confectioner Publishing Co.; Sisely and Wood, Encyclopedia of Surface Active Agents, Chemical Publ. Co., Inc., New York, 1964; and A.S. Davidson and B. Milwidsky, Synthetic Detergents, Seventh Edition, John Wiley and Sons, New York, 1987.

[0405] The compositions of the present invention may also contain formulation aids and additives known to those skilled in the art as formulation aids. Such formulation aids and additives may control pH (buffering agents), foaming during processing (antifoaming agents such as polyorganosiloxanes (e.g., Rhodorsil® 416)), settling of active ingredients (suspending agents), viscosity (thixotropic thickeners), microbial growth in the container (antimicrobial agents), product freezing (antifreeze agents), color (dye / pigment dispersions (e.g., Rhodorsil® Colorant Red)), wash-off (film formers or stickers), evaporation (evaporation retardants), and other formulation properties. Film formers include, for example, polyvinyl acetate, polyvinyl acetate copolymers, polyvinylpyrrolidone-vinyl acetate copolymers, polyvinyl alcohol, polyvinyl alcohol copolymers, and waxes. Examples of formulation aids and additives include those described in McCutcheon's Volume 2: Functional Materials, annual International and North American editions published by McCutcheon's Division, The Manufacturing Confectioner Publishing Co.; and PCT Publication WO 03 / 024222.

[0406] The compound of Formula 1 and any other active ingredients are typically incorporated into the present compositions by dissolving the active ingredient in a solvent or milling it in a liquid or dry diluent. Solutions, including emulsifiable concentrates, can be prepared by simply mixing the ingredients. If the solvent of a liquid composition intended for use as an emulsifiable concentrate is not miscible with water, an emulsifier is typically added to emulsify the active-containing solvent upon dilution with water. Active ingredient slurries having particle sizes up to 2,000 μm can be wet-milled using a media mill to obtain particles with an average particle size of less than 3 μm. Aqueous slurries can be made into finished suspension concentrates (see, e.g., U.S. Pat. No. 3,060,084) or can be further processed by spray drying to form water-dispersible granules. Dry formulations typically require a dry-milling step, which results in an average particle size in the range of 2 to 10 μm. Dusts and powders can be prepared by blending and typically milling (e.g., hammer mills or fluid energy mills). Granules and pellets can be prepared by spraying the active material onto a preformed granular carrier or by agglomeration techniques. See Browning, "Agglomeration," Chemical Engineering, December 4, 1967, pp. 147-48; Perry's Chemical Engineer's Handbook, 4th Ed., McGraw-Hill, New York, 1963, pp. 8-57 et seq.; and WO 91 / 13546. Pellets can be prepared as described in U.S. Pat. No. 4,172,714. Water-dispersible and water-soluble granules can be prepared as taught in U.S. Pat. Nos. 4,144,050, 3,920,442, and German Patent No. 3,246,493. Tablets can be prepared as taught in U.S. Pat. Nos. 5,180,587, 5,232,701, and 5,208,030. Films can be prepared as taught in British Patent No. 2,095,558 and US Pat. No. 3,299,566.

[0407] One embodiment of the present invention relates to a method for controlling fungal pathogens, comprising diluting a fungicidal composition of the present invention (a compound of Formula 1 formulated with a surfactant, a solid diluent, and a liquid diluent, or a combined mixture of a compound of Formula 1 and at least one other fungicide) with water, optionally adding an adjuvant to form a diluted composition, and contacting the fungal pathogen or its environment with an effective amount of the diluted composition.

[0408] Although spray compositions formed by diluting a sufficient concentration of the fungicidal composition of the present invention with water are fully effective in controlling fungal pathogens, separately formulated adjuvant products can also be added to the spray tank mix. These additional adjuvants, commonly known as "spray adjuvants" or "tank-mix adjuvants," include any substance mixed in the spray tank to improve pesticide performance or alter the physical properties of the spray mixture. Adjuvants can be anionic or nonionic surfactants, emulsifiers, petroleum-based crop oils, crop-derived seed oils, acidifiers, buffers, thickeners, or antifoaming agents. Adjuvants are used to improve efficacy (e.g., bioavailability, adhesion, penetration, uniformity of coverage, and durability of protection) or to minimize or eliminate spray problems related to incompatibility, foaming, drift, evaporation, volatilization, and decomposition. To achieve optimal performance, adjuvants are selected based on the characteristics of the active ingredient, formulation, and target (e.g., crop, pest).

[0409] The amount of adjuvant added to the spray mixture generally ranges from about 2.5% to 0.1% by volume. The application rate of adjuvants added to the spray mixture is generally about 1 to 5 L per hectare. Representative examples of spray adjuvants include Adigor® (Syngenta) 47% methylated rapeseed oil liquid hydrocarbon, Silwet® (Helena Chemical Company) polyalkylene oxide-modified heptamethyltrisiloxane, and Assist® (BASF) 17% surfactant blend in 83% paraffin-based mineral oil.

[0410] One method of seed treatment involves spraying or dusting the seeds with the compound of the present invention (i.e., as a formulated composition) before sowing. Seed treatment compositions generally contain a film former or adhesive. Thus, the seed coating composition of the present invention typically contains a biologically effective amount of a compound of Formula 1 and a film former or adhesive. Seeds can be coated by spraying a flowable suspension concentrate directly onto a tumbling bed of seeds and then allowing the seeds to dry. Alternatively, other formulation types, such as wettable powders, solutions, suspoemulsions, emulsifiable concentrates, and emulsions in water, can be sprayed onto the seeds. This process is particularly useful for applying film coatings to seeds. A variety of coating machines and processes are available to those skilled in the art. Suitable processes include those described in P. Kosters et al., Seed Treatment: Progress and Prospects, 1994 BCPC Monograph No. 57, and references cited therein.

[0411] For further information on formulation techniques, see T. Swoods, "The Formulator's Toolbox - Product Forms for Modern Agriculture," in Pesticide Chemistry and Bioscience, The Food-Environment Challenge, T. Brooks and T. R. Roberts, Eds., Proceedings of the 9th International Congress on Pesticide Chemistry, The Royal Society of Chemistry, Cambridge, 1999, pp. 120-133. See also U.S. Pat. No. 3,235,361, column 6, lines 16-7, line 19, and Examples 10-41; U.S. Pat. No. 3,309,192, column 5, lines 43-7, line 62, and Examples 8, 12, 15, 39, 41, 52, 53, 58, 132, 138-140, 162-164, 166, 167, and 169-182; U.S. Pat. No. 2,891,855, column 3, lines 66-5, line 17, and Examples 1-4; Klingman, Weed Control as a Science, John Wiley and Sons, Inc., New York, 1961, pp. 81-96; Hance et al., Weed Control Handbook, 8th Ed., Blackwell Scientific Publications, Oxford, 1989; and Developments in Formulation Technology, PJB See also, Publications, Richmond, UK, 2000.

[0412] In the following examples, all percentages are by weight and all formulations are prepared in the usual manner. Compound numbers refer to compounds in Index Tables A-B. Without further elaboration, it is believed that one skilled in the art using the preceding description can utilize the present invention to its fullest extent. Accordingly, the following examples are to be construed as merely illustrative and not as limiting the present disclosure in any way.

[0413] Example A high strength concentrate Compound 60 98.5% Silica aerogel 0.5% Synthetic amorphous fine silica 1.0%

[0414] Example B Wettable powder Compound 68 65.0% Dodecylphenol polyethylene glycol ether 2.0% Sodium lignosulfonate 4.0% Sodium silicoaluminate 6.0% Montmorillonite (calcined) 23.0%

[0415] Example C Granules Compound 72 10.0% Attapulgite Granules (Low Volatility, 0.71 / 0.30 mm; USS No. 25-50 Sieve) 90.0%

[0416] Example D Extruded pellets Compound 93 25.0% Anhydrous sodium sulfate 10.0% Crude calcium lignosulfonate 5.0% Sodium alkylnaphthalene sulfonate 1.0% Calcium / Magnesium Bentonite 59.0%

[0417] Example E emulsifiable concentrate Compound 112 10.0% Polyoxyethylene sorbitol hexaoleate 20.0% C6~C 10 Fatty acid methyl ester 70.0%

[0418] Example F Microemulsion Compound 118 5.0% Polyvinylpyrrolidone-vinyl acetate copolymer 30.0% Alkyl polyglycoside 30.0% Glyceryl monooleate 15.0% Water 20.0%

[0419] Example G Seed treatment Compound 60 20.00% Polyvinylpyrrolidone-vinyl acetate copolymer 5.00% Montan Acid Wax 5.00% Calcium lignosulfonate 1.00% Polyoxyethylene / Polyoxypropylene Block Copolymer 1.00% Stearyl alcohol (POE20) 2.00% Polyorganosilane 0.20% Colorant: Red dye 0.05% Water 65.75%

[0420] Example H Fertilizer sticks Compound 68 2.50% Pyrrolidone-styrene copolymer 4.80% Tristyrylphenyl 16-ethoxylate 2.30% Talc 0.80% Corn starch 5.00% Sustained Release Fertilizer 36.00% Kaolin 38.00% Water 10.60%

[0421] Example I Suspension concentrate Compound 72 35% Butyl polyoxyethylene / polypropylene block copolymer 4.0% Stearic acid / polyethylene glycol copolymer 1.0% Styrene acrylic polymer 1.0% Xanthan gum 0.1% Propylene glycol 5.0% Silicone-based antifoam agent 0.1% 1,2-benzisothiazolin-3-one 0.1% Water 53.7%

[0422] Example J emulsion in water Compound 93 10.0% Butyl polyoxyethylene / polypropylene block copolymer 4.0% Stearic acid / polyethylene glycol copolymer 1.0% Styrene acrylic polymer 1.0% Xanthan gum 0.1% Propylene glycol 5.0% Silicone-based antifoam agent 0.1% 1,2-benzisothiazolin-3-one 0.1% Aromatic Petroleum-Based Hydrocarbons 20.0 Water 58.7%

[0423] Example K oil dispersion Compound 112 25% Polyoxyethylene sorbitol hexaoleate 15% Organically modified bentonite clay 2.5% Fatty acid methyl esters 57.5%

[0424] Example L Suspo Emulsion Compound 118 10.0% Imidacloprid 5.0% Butyl polyoxyethylene / polypropylene block copolymer 4.0% Stearic acid / polyethylene glycol copolymer 1.0% Styrene acrylic polymer 1.0% Xanthan gum 0.1% Propylene glycol 5.0% Silicone-based antifoam agent 0.1% 1,2-benzisothiazolin-3-one 0.1% Aromatic petroleum-based hydrocarbons 20.0% Water 53.7%

[0425] Water-soluble and water-dispersible formulations are typically diluted with water to form aqueous compositions before application. Aqueous compositions for direct application to plants or parts thereof (e.g., spray tank compositions) typically contain at least about 1 ppm or more (e.g., 1 ppm to 100 ppm) of a compound of the invention.

[0426] Seeds are typically treated at a rate of about 0.001 g (more typically about 0.1 g) to about 10 g per kg of seed (i.e., about 0.0001 to 1% by weight of the seed before treatment). Flowable suspensions formulated for seed treatment typically contain about 0.5 to about 70% active ingredient, about 0.5 to about 30% film-forming adhesive, about 0.5 to about 20% dispersant, about 0 to about 5% thickener, 0 to about 5% pigment and / or dye, 0 to about 2% antifoaming agent, 0 to about 1% preservative, and 0 to about 75% volatile liquid diluent.

[0427] The compounds of the present invention are useful as plant disease control agents. Accordingly, the present invention further includes a method for controlling plant diseases caused by fungal plant pathogens, comprising applying an effective amount of a compound of the present invention or a fungicidal composition containing said compound to a plant or part thereof to be protected, or to a plant seed to be protected. The compounds and / or compositions of the present invention provide control of diseases caused by a wide range of fungal plant pathogens in the Ascomycota, Basidiomycota, Zygomycota, and fungus-like Oomycota classes. They are effective in controlling a wide range of plant diseases, particularly foliar pathogens of ornamental, turf, vegetable, field, cereal, and fruit crops. These pathogens include, but are not limited to, those listed in Table 1-1. For Ascomycota and Basidiomycota, the names of both the sexual / teleomorph / complete stage and the asexual / anamorph / complete stage (in parentheses) are listed where known. Synonymous names of pathogens are indicated by an equal sign, e.g., the name of the sexual / teleomorph / complete stage, Phaeoshaeria nodorum, followed by the corresponding name of the asexual / anamorph / incomplete stage, Stagonospora nodorum, and the synonymous, older name, Septoria nodorum.

[0428] [Table 5]

[0429] [Table 6]

[0430] In addition to fungicidal activity, the compositions or combinations also have activity against bacteria such as Erwinia amylovora, Xanthomonas campestris, Pseudomonas syringae, and other related species. By controlling harmful microorganisms, the compounds of the present invention are useful for improving (i.e., increasing) the ratio of beneficial to harmful microorganisms in contact with crop plants or their propagation materials (e.g., seeds, corms, bulbs, tubers, cuttings) or the agricultural environment of crop plants or their propagation materials.

[0431] The compounds of the present invention are useful for treating all plants, plant parts, and seeds. Plant and seed varieties and cultivars can be obtained by conventional propagation and breeding methods or by genetic engineering methods. A transgenic plant or seed (transgenic plant or seed) is one in which a heterologous gene (transgene) has been stably integrated into the genome of the plant or seed. A transgene defined by its specific location in the plant genome is called a transformation or transformation event.

[0432] Transgenic plant cultivars that can be treated according to the present invention include those that are tolerant to one or more biotic stresses (pests such as nematodes, insects, mites, fungi, etc.) or abiotic stresses (drought, low temperature, soil salinity, etc.) or contain other desirable traits. Plants can be genetically modified to exhibit, for example, herbicide tolerance, insect resistance, improved oil profile, or drought tolerance characteristics.

[0433] By treating transgenic plants and seeds with the compounds of the invention, superadditive or enhanced effects can be obtained, such as reduced application rates, broadened spectrum of activity, increased resistance to biotic / abiotic stresses, or improved storage stability, which may be greater than would be expected from a simple additive effect of applying the compounds of the invention to transgenic plants and seeds.

[0434] The compounds and compositions of the present invention are useful in seed treatments to protect seeds from plant diseases. For the purposes of this disclosure and claims, treating seeds means contacting the seeds with a biologically effective amount of a compound of the present invention, typically formulated as a composition of the present invention. This seed treatment protects the seeds from soil-borne disease pathogens and generally also protects the roots and other plant parts that come into contact with the soil of seedlings that emerge from the germinated seeds. This seed treatment can also provide foliar protection through translocation of the compound of the present invention or a second active ingredient within the developing plant. Seed treatments can be applied to all types of seeds, including seeds from which germinated plants have been genetically transformed to express specific traits. Representative examples include those expressing proteins toxic to invertebrate pests, such as Bacillus thuringiensis toxin, or herbicide resistance, such as glyphosate acetyltransferase, which confers tolerance to glyphosate. Seed treatment with the compounds of the present invention can also increase the vigor of plants grown from the seeds.

[0435] The compounds of the present invention and compositions thereof, alone and in combination with other fungicides, nematicides and insecticides, are particularly useful in seed treatments for crops including, but not limited to, corn or maize, soybeans, cotton, cereals (e.g., wheat, oats, barley, rye and rice), potatoes, vegetables and oilseed rape.

[0436] Furthermore, the compounds of the present invention are useful for treating postharvest diseases of fruits and vegetables caused by fungi and bacteria. These infections can occur before, during, and after harvest. For example, infections can occur before harvest and then remain dormant until a certain point during ripening (e.g., the host begins to change tissue in a way that allows infection to progress); infections can also occur from superficial wounds caused by machinery or insect damage. In this regard, the compounds of the present invention can reduce losses (i.e., losses due to quantity and quality) due to postharvest diseases that can occur any time between harvest and consumption. Treatment of postharvest diseases with the compounds of the present invention can increase the period during which fresh edible plant parts (e.g., fruits, seeds, leaves, stems, bulbs, tubers) can be stored refrigerated or unrefrigerated after harvest, remain edible, and are free from significant or harmful deterioration or contamination by fungi or other microorganisms. Treatment of edible plant parts before or after harvest with the compounds of the present invention can also reduce the production of toxic metabolites of fungi or other microorganisms, such as mycotoxins, such as aflatoxins.

[0437] Control of plant diseases is typically achieved by applying an effective amount of the compounds of the present invention to the parts of the plant to be protected, such as roots, stems, leaves, fruits, seeds, tubers, or bulbs, or to the medium (soil or sand) in which the plant to be protected is growing, either before or after infection. The compounds can also be applied to seeds to protect the seeds and the seedlings that emerge from them. The compounds can also be applied to treat plants through irrigation water. Control of postharvest pathogens that infect produce before harvest is typically achieved by field application of the compounds of the present invention; when infection occurs after harvest, the compounds can be applied to the harvested crop as a dip, spray, fumigant, treatment wrap, or box liner.

[0438] The compounds can also be applied using unmanned aerial vehicles (UAVs) to distribute the compositions disclosed herein over the planted area. In some embodiments, the cultivated area is an area containing crops. In some embodiments, the crop is selected from monocotyledonous or dicotyledonous plants. In some embodiments, the crop is selected from rice, corn, barley, buckwheat, wheat, vegetables, tobacco, tea plants, fruit trees, and sugarcane. In some embodiments, the compositions disclosed herein are formulated for spraying at ultra-low volumes. Products applied by drones can use water or oil as the spray carrier. Typical spray volumes (including product) used worldwide for drone application are 5.0 liters / hectare to 100 liters / hectare (approximately 0.5 to 10 gpa). This ranges from ultra-low spray volume (ULV) to low spray volume (LV). Although not common, there may be situations where even lower spray volumes, such as 1.0 liter / ha (0.1 gpa), are used.

[0439] Suitable application rates (e.g., fungicidally effective amounts) of component (a) (i.e., at least one compound selected from the compound of Formula 1, its N-oxides, and salts) and mixtures and compositions containing component (a) according to the present invention (e.g., biologically effective amounts, fungicidally effective amounts, or insecticidally effective amounts) are influenced by factors such as the plant disease to be controlled, the plant species to be protected, the population structure of the pathogen to be controlled, ambient moisture, and temperature, and should be determined under actual use conditions. Those skilled in the art can easily determine the fungicidally effective amount required for the desired level of plant disease control through simple experiments. Protection of leaves is usually possible when treated at a rate of less than about 1 g / ha to about 5,000 g / ha of active ingredient. Protection of seeds and seedlings is usually possible when treated at a rate of about 0.001 g (more typically about 0.1 g) to about 10 g per kg of seed. Those skilled in the art can readily determine by simple experimentation the application rates of component (a) and mixtures and compositions thereof containing the particular combination of active ingredients according to the present invention required to provide the desired spectrum of plant protection and control of plant diseases and, optionally, other plant pests.

[0440] The compounds and compositions of the present invention may also be useful for increasing the vigor of crop plants. This method involves contacting a crop plant (e.g., leaves, flowers, fruits, or roots) or a seed from which the crop plant grows with a composition containing a compound of Formula 1 in an amount sufficient to achieve the desired plant vigor effect (i.e., a biologically effective amount). Typically, the compound of Formula 1 is applied in a formulated composition. While the compound of Formula 1 is often applied directly to the crop plant or its seed, it can also be applied to the locus of the crop plant, i.e., to a portion of the environment of the crop plant, particularly one sufficiently close to the crop plant for the compound of Formula 1 to be translocated to the crop plant. The locus relevant to this method most commonly includes the growth medium in which the plant is cultivated (i.e., the medium that provides nutrients to the plant), typically soil. Thus, treating a crop plant to increase its vigor involves contacting the crop plant, the seed from which the crop plant grows, or the locus of the crop plant with a biologically effective amount of a compound of Formula 1.

[0441] Increased crop vigor can result in one or more of the following observed effects: (a) optimal crop growth as indicated by superior seed germination, crop emergence, and crop stand; (b) improved crop growth as indicated by rapid and robust leaf growth (e.g., as measured by leaf area index), plant height, number of tillers (e.g., in the case of rice), root mass, and total dry weight of the growing parts of the crop; (c) improved crop yield as indicated by time to flowering, flowering duration, number of flowers, total biomass accumulation (i.e., yield), and / or marketability of the fruit or grain grade of the product (i.e., yield quality); (d) improved ability of crops to resist or prevent infection by plant diseases and arthropod, nematode, or mollusk pests; and (e) improved ability of crops to tolerate environmental stresses, such as extreme temperatures, suboptimal moisture, or exposure to phytotoxic chemicals.

[0442] The compounds and compositions of the present invention can increase the vigor of treated plants compared to untreated plants by preventing and / or curing plant diseases caused by fungal plant pathogens in the plant's environment. In the absence of such plant disease control, the disease reduces plant vigor by consuming plant tissue or sap or transmitting plant pathogens such as viruses. Even in the absence of fungal plant pathogens, the compounds of the present invention can increase plant vigor by modifying plant metabolism. Generally, the vigor of crop plants will be most significantly increased by treating them with the compounds of the present invention when the plants are grown in a non-ideal environment, i.e., an environment that contains one or more aspects unfavorable for the plant to achieve its full genetic potential in an ideal environment.

[0443] Of note are methods for increasing the vigor of crop plants grown in an environment that includes a plant disease caused by a fungal plant pathogen. Also of note are methods for increasing the vigor of crop plants grown in an environment that does not include a plant disease caused by a fungal plant pathogen. Also of note are methods for increasing the vigor of crop plants grown in an environment that includes an amount of moisture that is not ideal for supporting crop plant growth.

[0444] The compounds and compositions of the present invention can be mixed with one or more other biologically active compounds or agents, including fungicides, insecticides, nematicides, bactericides, acaricides, herbicides, herbicide antidotes, growth regulators, such as insect molting inhibitors and root stimulators, chemical hemostats, semi-chemicals, repellents, attractants, pheromones, feeding stimulants, plant nutrients, other biologically active compounds, or insect pathogenic bacteria, viruses, or fungi, to form multi-component insecticides that provide an even broader spectrum of agricultural protection. Thus, the present invention also relates to compositions comprising (a fungicidally effective amount of) a compound of Formula 1 and (a biologically effective amount of) at least one additional biologically active compound or agent, which may further comprise at least one surfactant, solid diluent, or liquid diluent. Other biologically active compounds or agents can be formulated in compositions that include at least one surfactant, solid diluent, or liquid diluent. With respect to the mixtures of the present invention, one or more other biologically active compounds or agents can be formulated together with the compound of Formula 1 to form a premix, or one or more other biologically active compounds or agents can be formulated separately from the compound of Formula 1, with the formulations being combined together (e.g., in a spray tank) prior to application or alternatively applied sequentially.

[0445] As noted in the Summary of the Invention, one aspect of the present invention is a fungicidal composition (i.e., mixture or combination) comprising a compound of Formula 1, its N-oxide or salt (i.e., component a), and at least one other fungicide (i.e., component b). Of note are such combinations in which the other fungicidal active ingredient has a different site of action than the compound of Formula 1. In certain instances, combinations with at least one other fungicidal active ingredient having a similar spectrum of control but a different site of action are particularly advantageous for resistance management. Thus, the compositions of the present invention can further comprise a fungicidally effective amount of at least one additional fungicidal active ingredient having a similar spectrum of control but a different site of action.

[0446] Examples of component (B) fungicides include acibenzolar-S-methyl, aldimorph, ametocladine, amisulbrom, anilazine, azaconazole, azoxystrobin, benalaxyl (including benalaxyl-M), benodanil, benomyl, benciavalicarb (including benciavalicarb-isopropyl), benzovindiflupyr, befoxadine, binapacryl, biphenyl, bitertanol, bixafen, blasticidin-S, boscalid, bromuconazole, bupirimate, buthiobate, captafol, captan, carbendazim, and carboxymethyl. phenanthrene, carpropamid, chloroneb, chlorothalonil, chlozolinate, clotrimazole, copper hydroxide, copper oxychloride, copper sulfate, cumoxystrobin, cyazofamid, cyflufenamid, cymoxanil, cyproconazole, cyprodinil, dichlofluanid, diclocymet, diclomedine, dicloran, diethofencarb, difenoconazole, diflumetrim, dimethirimol, dimethomorph, dimoxystrobin, diniconazole (including diniconazole-M), dinocap, dithianon, dithiolane, dodemorph, dodine, dipimethitron, econa Zol, edifenphos, enoxastrobin (also known as enestroburin), epoxiconazole, etaconazole, ethaboxam, esilimol, etridiazole, famoxadone, fenamidone, fenarimol, phenaminestrobin, fenbuconazole, fenfuram, fenhexamid, fenoxanil, fenpiclonil, fenpropidin, fenpropimorph, fenprirazaamine, fentin acetate, fentin chloride, fentin hydroxide, ferbam, ferimzone, flometoquin, florylpicoxamide, fluazinam, fludio Xonil, flufenoxystrobin, fluindapyr, flumorph, fluopicolide, fluopimomide, fluopyram, fluuromimide, floxastrobin, fluquinconazole, flusilazole, flusulfamide, flutianil, flutolanil, flutriafol, fluxapyroxad, folpet, phthalide, fuberidazole, furalaxyl, furametpyr, guazatine, hexaconazole, hymexazole, imazalil, imibenconazole, iminoctadine albesilate, iminoctadine triacetate, iodocarb, ipconazole,Ipfentrifluconazole, iprobenfos, iprodione, iprovalicarb, isoconazole, isofenamide, isoprothiolane, isoflucipram, isopyrazam, isotianil, kasugamycin, kresoxim-methyl, mancozeb, mandepropamide, mandestrobin, maneb, mepanipyrim, mepronil, meptyldinocap, metalaxyl (including metalaxylyl-M / mefenoxam), mefentrifluconazole, meconazole, metasulfocarb, metiram, metronostrobin, metrafenone, miconazole Myclobutanil, naftifine, neo-asozin, nuarimol, octhilinone, ofurase, orysastrobin, oxadixyl, oxathiapiprolin, oxolinic acid, oxpoconazole, oxycarboxin, oxytetracycline, pefurazoate, penconazole, pencycuron, perflufen, penthiopyrad, phosphoric acid (including its salts, e.g., fosetyl-aluminum), picarbutrazox, picoxystrobin, piperalin, polyoxins, probenazole, prochloraz, procymidone, propamacarb, propiconazole , propineb, proquinazid, prothiocarb, prothioconazole, pyraclostrobin, pyrametostrobin, pyraoxystrobin, pyrazophos, pyribencarb, pyributicarb, pyrifenox, pyrimethanil, pyriophenone, pyrisoxazole, pyroquilon, pyrrolnitrin, quinconazole, quinofumelin (registration number 861647-84-9), quinomethionate, quinoxyfen, quintozene, sedaxane, silthiofam, simeconazole, spiroxamine, streptomycin, sulfur, tebuconazole, tebufloquine, teclomethionate Futaram, tecnazene, terbinafine, tetraconazole, thiabendazole, thifluzamide, thiophanate, thiophanate-methyl, thiram, tiadinil, tolclofos-methyl, tolnifanide, tolprocarb, trifluanid, triadimefon, triadimenol, triarimol, triticonazole, triazoxide, tribasic copper sulfate, tricyclazole, triclopiricarb, tridemorph, trifloxystrobin, triflumizole, triforine, trimorphamide, uniconazole, uniconazole-P, validamycin,Valifenalate (also known as Valifenal), vinclozolin, zineb, ziram, zoxamide, N-[2-(1S,2R)-[1,1'-bicyclopropyl]-2-ylphenyl]-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide, α-(1-chlorocyclopropyl)-α-[2-(2,2-dichlorocyclopropyl)ethyl]-1H-1,2,4-triazole-1-ethanol, (αS)-[3-(4-chloro-2-fluorophenyl)-5-(2,4-difluorophenyl)-4-isoxazolyl] -3-Pyridinemethanol, rel-1-[[(2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)-2-oxiranyl]methyl]-1H-1,2,4-triazole, rel-2-[[(2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)-2-oxiranyl]methyl]-1,2-dihydro-3H-1,2,4-triazole-3-thione, rel-1-[[(2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)-2-oxiranyl]methyl]-1,2-dihydro-3H-1,2,4-triazole-3-thione ]methyl]-5-(2-propen-1-ylthio)-1H-1,2,4-triazole, N-[2-[4-[[3-(4-chlorophenyl)-2-propyn-1-yl]oxy]-3-methoxyphenyl]ethyl]-3-methyl-2-[(methylsulfonyl)amino]butanamide, N-[2-[4-[[3-(4-chlorophenyl)-2-propyn-1-yl]oxy]-3-methoxyphenyl]ethyl]-3-methyl-2-[(ethylsulfonyl)amino]butanamide, N'-[4-[4-chloro-3-(trifluoromethyl)furan [phenyloxy]-2,5-dimethylphenyl]-N-ethyl-N-methylmethanimidamide, N-[[(cyclopropylmethoxy)amino][6-(difluoromethoxy)-2,3-difluorophenyl]methylene]benzeneacetamide, N-[2-(2,4-dichlorophenyl)-2-methoxy-1-methylethyl]-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide, N-(3',4'-difluoro[1,1'-biphenyl]-2-yl)-3-(trifluoromethyl)-2-pyrazinecarboxamide,3-(Difluoromethyl)-N-(2,3-dihydro-1,1,3-trimethyl-1H-inden-4-yl)-1-methyl-1H-pyrazole-4-carboxamide, 5,8-difluoro-N-[2-[3-methoxy-4-[[4-(trifluoromethyl)-2-pyridinyl]oxy]phenyl]ethyl]-4-quinazolinamine, 1-[4-[4-[5R-[(2,6-difluorophenoxy)methyl]-4,5-dihydro-3-isoxazolyl]-2-thiazolyl]-1-piperdinyl]-2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]ethanone, 4-fluorophenyl N-[1-[[[1

[0013] Examples of suitable antimicrobial compounds include 5-fluoro-2-[(4-cyanophenyl)ethyl]sulfonyl]methyl]propyl]carbamate, 5-fluoro-2-[(4-fluorophenyl)-methoxy]-4-pyrimidinamine, α-(methoxyimino)-N-methyl-2-[[[1-[3-(trifluoromethyl)phenyl]ethoxy]imino]methyl]-benzeneacetamide, and [[4-methoxy-2-[[[(3S,7R,8R,9S)-9-methyl-8-(2-methyl-1-oxopropoxy)-2,6-dioxo-7-(phenylmethyl)-1,5-dioxonan-3-yl]amino]carbonyl]-3-pyridinyl]oxy]methyl 2-methylpropanoate. Therefore, of note is a fungicidal composition comprising as component (a) a compound of formula 1 (or its N-oxide or salt) and as component (b) at least one fungicide selected from the above list.

[0447] Of particular note are compounds of Formula 1 (or an N-oxide or salt thereof) (i.e., component (a) in the composition) in combination with aminopyrifen (Registry No. 1531626-08-0), azoxystrobin, benzovindiflupyr, bixafen, captan, carpropamid, chlorothalonil, copper hydroxide, copper oxychloride, copper sulfate, cymoxanil, cyproconazole, cyprodinil, diclobenthiazox (Registry No. 957144-77-3), diethofencarb, difenoconazole, dimethomorph, epoxiconazole, ethaboxam, fenarimol, fluoxamer ... Fenhexamide, fluazinam, fludioxonil, fluindapir, fluopyram, flusilazole, flutianil, flutriafol, fluxapyroxad, folpet, ipflufenoquine (Registration number 1314008-27-9), iprodione, isofetamide, isofulcipram, isopyrazam, kresoxim-methyl, mancozeb, mandestrobin, meptyldinocap, metalaxyl (including metalaxyl-M / mefenoxam), mefentrifluconazole, metconazole, metrafenone, methyltetraprole (Registration number 1472649-01-6), myclobutanil, oxathiapiprolin, penflufen, penthiopyrad, phosphorous acid (including its salts, e.g., fosetyl-aluminum), picoxystrobin, propiconazole, proquinazid, prothioconazole, pyridaclomethyl (Registration No. 1358061-55-8), pyraclostrobin, pyrapropoin (Registration No. 1803108-03-3), pyrimethanil, sedaxane, spiroxamine, sulfur, tebuconazole, thiophanate-methyl, trifloxystrobin, zoxamide, α-(1-chloroisothiazolinone), methylparaben, ... cyclopropyl)-α-[2-(2,2-dichlorocyclopropyl)ethyl]-1H-1,2,4-triazole-1-ethanol, 2-[2-(1-chlorocyclopropyl)-4-(2,2-dichlorocyclopropyl)-2-hydroxybutyl]-1,2-dihydro-3H-1,2,4-triazole-3-thione, N-[2-(2,4-dichlorophenyl)-2-methoxy-1-methylethyl]-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide, 3-(difluoromethyl)-N-(2,3-dihydro-1,1,3-Trimethyl-1H-inden-4-yl)-1-methyl-1H-pyrazole-4-carboxamide, 1-[4-[4-[5R-(2,6-difluorophenyl)-4,5-dihydro-3-isoxazolyl]-2-thiazolyl]-1-piperidinyl]-2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]ethanone, 1,1-dimethylethyl N-[6-[[[[(1-methyl-1H-tetrazol-5-yl)phenylmethylene]amino]oxy]methyl]-2-pyridinyl]carbamate, dipimethitrone, 5-fluoro-2-[(4-fluorophenyl)methoxy]-4-pyrimidinamine, 5-fluoro-2-[(4-methylphenyl)methoxy]-4-pyrimidinamine, (αS)-[3-(4-chloro-2-fluorophenyl)-5- and a component (b) compound selected from (2,4-difluorophenyl)-4-isoxazolyl]-3-pyridinemethanol, rel-1-[[(2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)-2-oxiranyl]methyl]-1H-1,2,4-triazole, rel-2-[[(2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)-2-oxiranyl]methyl]-1,2-dihydro-3H-1,2,4-triazole-3-thione, and rel-1-[[(2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)-2-oxiranyl]methyl]-5-(2-propen-1-ylthio)-1H-1,2,4-triazole (i.e., as component (b) in the composition).

[0448] Of particular note are combinations of a compound of Formula 1 (or an N-oxide or salt thereof) (i.e., component (a) in the composition) with aminopyrifen (Registration No. 1531626-08-0), azoxystrobin, benzovindiflupyr, bixafen, captan, carpropamid, chlorothalonil, copper hydroxide, copper oxychloride, copper sulfate, cymoxanil, cyproconazole, cyprodinil, diclobenthiazox (Registration No. 957144-77-3), diethofencarb, difenoconazole, dimethomorph, dipimethitron, epoxiconazole, ethaboxam, Fenarimol, fenhexamid, fluazinam, fludioxonil, fluindapyr, fluopyram, flusilazole, flutianil, flutriafol, fluxapyroxad, folpet, ipflufenoquine (registration number 1314008-27-9), iprodione, isofetamide, isoflucipram, isopyrazam, kresoxim-methyl, mancozeb, mandestrobin, meptyldinocap, metalaxyl (including metalaxyl-M / mefenoxam), mefentrifluconazole, metconazole, metrafenone, methyltetrapro ol (Registration No. 1472649-01-6), myclobutanil, oxathiapiprolin, penflufen, penthiopyrad, phosphorous acid (including its salts, e.g., fosetyl-aluminium), picoxystrobin, propiconazole, proquinazid, prothioconazole, pyridaclomethyl (Registration No. 1358061-55-8), pyraclostrobin, pyrapropoin (Registration No. 1803108-03-3), pyrimethanil, sedaxane, spiroxamine, sulfur, tebuconazole, thiophanate-methyl, trifloxystrobin, zoxamide, α- (1-chlorocyclopropyl)-α-[2-(2,2-dichlorocyclopropyl)ethyl]-1H-1,2,4-triazole-1-ethanol, N-[2-(2,4-dichlorophenyl)-2-methoxy-1-methylethyl]-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide, 3-(difluoromethyl)-N-(2,3-dihydro-1,1,3-trimethyl-1H-inden-4-yl)-1-methyl-1H-pyrazole-4-carboxamide, 1-[4-[4-[5R-(2,6-difluorophenyl)-4,5-Dihydro-3-isoxazolyl]-2-thiazolyl]-1-piperidinyl]-2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]ethanone, 1,1-dimethylethyl N-[6-[[[[(1-methyl-1H-tetrazol-5-yl)phenylmethylene]amino]oxy]methyl]-2-pyridinyl]carbamate, 5-fluoro-2-[(4-fluorophenyl)methoxy]-4-pyrimidinamine, (αS)-[3-(4-chloro-2-fluorophenyl)-5-(2,4-difluorophenyl)-4-isoxazolyl]-3-pyridinemethanol, rel-1-[[(2R,3S)-3-(2- and a component (b) compound selected from rel-2-[[(2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)-2-oxiranyl]methyl]-1H-1,2,4-triazole, rel-2-[[(2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)-2-oxiranyl]methyl]-1,2-dihydro-3H-1,2,4-triazole-3-thione, and rel-1-[[(2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)-2-oxiranyl]methyl]-5-(2-propen-1-ylthio)-1H-1,2,4-triazole (i.e., as component (b) in the composition).

[0449] Generally, for better control of plant diseases caused by fungal plant pathogens (e.g., lower use rates or a broader spectrum of controlled plant pathogens) or resistance management, preferred are combinations of a compound of Formula 1, its N-oxide or salt with amisulbrom, azoxystrobin, benzovindiflupyr, bixafen, boscalid, carbendazim, carboxin, chlorothalonil, copper hydroxide, cymoxanil, cyproconazole, difenoconazole, dimetamorph, dimoxystrobin, epoxiconazole, fenpropidin, fenpropimorph, flurylpicoxamide, fluazinam, fludioxonil, flufenoxystrobin, fluindapyr, fluquinconazole, flupicolide. , fluoxastrobin, flutriafol, fluxapyroxad, ipconazole, ipfentrifluconazole, iprodione, kresoxim-methyl, mancozeb, metalaxyl, mefenoxam, mefentrifluconazole, metconazole, metominostrobin, myclobutanil, paclobutrazol, penflufen, picoxystrobin, prothioconazole, pydiflumetofen, pyraclostrobin, pyrametostrobin, pyroxystrobin, pyriophenone, sedaxane, silthiofam, tebuconazole, thiabendazole, thiophanate-methyl, thiram, trifloxystrobin and triticonazole.

[0450] In the fungicidal compositions of the present invention, component (a) (i.e., at least one compound selected from the compound of Formula 1, its N-oxides, and salts) and component (b) are present in fungicidally effective amounts. The weight ratio of component (a) to component (b) (i.e., one or more additional fungicidal compounds) is generally about 1:3000 to about 3000:1, more typically about 1:500 to about 500:1. Of note are compositions in which the weight ratio of component (a) to component (b) is about 125:1 to about 1:125. Of particular note are compositions in which the weight ratio of component (a) to component (b) is about 25:1 to about 1:25 or about 5:1 to about 1:5. One skilled in the art can determine the weight ratio and application rate of the fungicidal compounds required for the desired area of ​​fungicidal protection and control by simple experimentation. It is apparent that the inclusion of additional fungicidal compounds in component (b) can expand the spectrum of plant diseases controlled beyond that controlled by component (a) alone. Further, exemplary weight ratios for combinations of fungicidal compounds of the present invention are provided below in Tables A1-A15 and C1-C15. Table B1 below lists typical, more typical, and most typical ranges of ratios involving particular fungicidal compounds of component (b).

[0451] Table A1 discloses specific mixtures of component (a) compounds and component (b) compounds. The component (a) compounds are identified by their compound numbers; see Index Tables A-B for compound descriptions. The entries under the heading "Exemplary Ratios" disclose three specific weight ratios of component (a) to component (b) for the disclosed mixtures. For example, the first row of Table A1 discloses mixtures of Compound 1 of the present invention and acibenzolar-S-methyl, where the weight ratio of Compound 1 to acibenzolar-S-methyl is 1:1, 1:4, or 1:18.

[0452] [Table 7]

[0453] [Table 8]

[0454] [Table 9]

[0455] [Table 10]

[0456] [Table 11]

[0457] [Table 12]

[0458] [Table 13]

[0459] Tables A2-A15 are each structured identically to Table A1 above, except that the entries under the "Component (a)" column heading are replaced with the respective Component (a) column entries shown below. Thus, for example, in Table A2, the entries under the "Component (a)" column heading all list "Compound 18." Thus, the first entry in Table A2 specifically discloses a mixture of Compound 18 and acibenzolar-S-methyl. Tables A3-A15 are structured similarly.

[0460] [Table 14]

[0461] Table B1 lists combinations of component (b) compounds and component (a) compounds that are illustrative of the mixtures, compositions, and methods of the present invention. The first column of Table B1 lists the specific component (b) compound (e.g., "acibenzolar-S-methyl" is the first entry). The second, third, and fourth columns of Table B1 list a series of weight ratios for the rate at which component (a) compounds are typically applied to outdoor-grown crops relative to component (b). Thus, for example, the first row of Table B1 discloses that combinations of component (a) compounds and acibenzolar-S-methyl are typically applied in a weight ratio of component (a) to component (b) of 2:1 to 1:180, more typically 1:1 to 1:60, and most typically 1:1 to 1:18. The remaining rows of Table B1 are interpreted similarly. Of particular note are compositions comprising a mixture of any one of the compounds listed as component (a) in embodiment 97 with a compound listed in the component (b) column of Table B1, in the weight ratios disclosed in Table B1. Table B1 thus supplements the specific ratios disclosed in Tables A1-A15 with a series of ratios for these combinations.

[0462] [Table 15]

[0463] [Table 16]

[0464] [Table 17]

[0465] [Table 18]

[0466] [Table 19]

[0467] [Table 20]

[0468] [Table 21]

[0469] [Table 22]

[0470] As previously noted, the present invention includes embodiments in which a composition comprises components (a) and (b), wherein component (b) comprises at least one fungicidal compound from each of two groups selected from (b1) through (b54). Table C1 lists specific mixtures illustrating embodiments in which component (b) comprises at least one fungicidal compound from each of two groups selected from (b1) through (b54). Table C1 discloses mixtures of Compound 1 of the present invention with at least two component (b) compounds. The entries under the heading "Exemplary Ratios" disclose three specific weight ratios of component (a) to each component (b) compound. For example, the first row discloses a mixture of Compound 1 with cyproconazole and azoxystrobin, listing weight ratios of Compound 1 to cyproconazole and azoxystrobin of 1:1:1, 2:1:1, or 3:1:1.

[0471] [Table 23]

[0472] [Table 24]

[0473] [Table 25]

[0474] [Table 26]

[0475] [Table 27]

[0476] Tables C2-C15 are each structured identically to Table C1 above, except that the entries under the "Component (a)" column heading are replaced with the respective Component (a) column entries shown below. Thus, for example, in Table C2, the entries under the "Component (a)" column heading all list "Compound 18." Thus, the first entry in Table C2 specifically discloses a mixture of Compound 18 with cyproconazole and azoxystrobin, with exemplary weight ratios of Compound 18 to cyproconazole and azoxystrobin being 1:1:1, 2:1:1, and 3:1:1. Tables C3-C15 are similarly structured.

[0477] [Table 28]

[0478] Of note are compositions of the present invention comprising a compound of Formula 1 (or an N-oxide or salt thereof) together with at least one other fungicidal compound having a different site of action than the compound of Formula 1. In certain instances, the combination with at least one other fungicidal compound having a similar control spectrum but a different site of action is particularly advantageous with respect to resistance management. Thus, the compositions of the present invention can advantageously contain at least one fungicidal compound having a similar control spectrum but a different site of action selected from the group consisting of (b1) to (b54) above.

[0479] The composition of component (a) or the composition of components (a) and (b) can be further mixed with one or more other biologically active compounds or agents, including insecticides, nematicides, fungicides, acaricides, herbicides, herbicide antidotes, growth regulators, such as insect molting inhibitors and root stimulators, chemical hemostats, semi-chemicals, repellents, attractants, pheromones, feeding stimulants, plant nutrients, other biologically active compounds, or insect pathogenic bacteria, viruses, or fungi, to form multi-component insecticides that provide an even broader spectrum of agricultural protection. Accordingly, the present invention also relates to compositions comprising a fungicidally effective amount of component (a) or a mixture of components (a) and (b) and a biologically effective amount of at least one additional biologically active compound or agent, which may further comprise at least one surfactant, solid diluent, or liquid diluent. The other biologically active compound or agent can also be formulated separately in a composition that comprises at least one surfactant, solid diluent, or liquid diluent. With respect to the compositions of the present invention, one or more other biologically active compounds or agents can be formulated with one or both of components (a) and (b) to form a premix, or one or more other biologically active compounds or agents can be formulated separately from components (a) and (b), with the formulations being combined together prior to application (e.g., in a spray tank) or alternatively applied sequentially.

[0480] Examples of such biologically active compounds or agents with which the composition of component (a) or the composition of components (a) and (b) may be formulated include insecticides such as abamectin, acephate, acequinocyl, acetamiprid, acrinathrin, acinonapyr, afidopiropen, amidoflumet, amitraz, avermectin, azadirachtin, azinphosmethyl, benfuracarb, bensultap, benzpirimoxan, bifenthrin, kappa-bifenthrin, bifenazate, bistrifluron, borate, broflanilide, buprofen, and the like. Ezin, cadusafos, carbaryl, carbofuran, cartap, carzol, chlorantraniliprole, chlorfenapyr, chlorfluazuron, chlorprallethrin, chlorpyrifos, chlorpyrifos-e, chlorpyrifos-methyl, chromafenozide, clofentezine, chlorprallethrin, clothianidin, cyantraniliprole, cyclaniliprole, cycloprothrin, cycloxapride, cyenopyrafen, cyflumetofen, cyfluthrin, beta-cyfluthrin, cyhalodiamide, cyhalothrin, gamma-cyhalothrin, lambda-cyhalothrin Halothrin, cypermethrin, alpha-cypermethrin, zeta-cypermethrin, cyromazine, deltamethrin, diafenthiuron, diazinon, dichloromethiaz, dieldrin, diflubenzuron, dimefluthrin, dimehypo, dimethoate, dinpropylidaz, dinotefuran, diofenolan, emamectin, emamectin benzoate, endosulfa, esfenvalerate, ethiprole, etofenprox, epsilon-metofluthrin, etoxazole, fenbutatin oxide, fenitrothion, fenothiocarb, feno Xicarb, fenpropathrin, fenvalerate, fipronil, flometoquin, flonicamid, fluazaindolizine, flubendiamide, flucythrinate, flufenerim, flufenoxuron, flufenoxystrobin, fluensulfone, fluhexafon, fluopyram, flupiprole, flupyradifuron, flupirimine, fluvalinate, tau-fluvalinate, fluxamethamide, fonofos, formetanate, fosthiazate, gamma-cyhalothrin, halofenozide, heptafluthrin, hexaflumuron, hexythiazox,Hydramethylnon, imidacloprid, indoxacarb, insecticidal soap, isofenphos, isocycloceram, kappa-tefluthrin, lambda-cyhalothrin, lufenuron, malathion, meperfluthrin, metaflumizone, metaldehyde, methamidophos, methidathion, methiocarb, methomyl, methoprene, methoxychlor, metofluthrin, methoxyfenozide, epsilon-metofluthrin, epsilon -Monfluorotrin, monocrotophos, monofluorotrin, nicotine, nitenpyram, nithiazine, novaluron, noviflumuron, oxamyl, oxazosulfil, parathion, parathion-methyl, permethrin, phorate, phosalone, phosmet, phosphamidon, pirimicarb, profenofos, profluthrin, propargite, protrifenbut, piflubumid, pymetrozine, pyrafluprole, pyrethrins , pyridaben, pyridalyl, pyrifluquinazone, pyriminostrobin, pyriprole, pyriproxyfen, rotenone, ryanodine, silafluofen, spinetoram, spinosad, spirodiclofen, spiromesifen, spiropydione, spirotetramat, sulprofos, sulfoxaflor, tebufenozide, tebufenpyrad, teflubenzuron, tefluthrin, kappa-tefluthrin, terbufos, tetrachlorantraniliprole, tetrachlorvinphos, tetramethrin, tetramethylfluthrin, tetraniliprole, thiacloprid, thiamethoxam, thiodicarb, thiosultap-sodium, thioxazafen, tolfenpyrad, tralomethrin, triazamate, trichlorfon, triflumezopyrim, triflumuron, cyclopyrazoflurane, zeta-cypermethrin, Bacillus thuringiensis (Bacillus thuringiensis) delta-endotoxin, entomopathogenic fungi, entomopathogenic viruses, or entomopathogenic fungi.

[0481] General references for these agricultural protection agents (i.e. insecticides, fungicides, nematicides, acaricides, herbicides and biological agents) include The Pesticide Manual, 13th Edition, CDS Tomlin, Ed., British Crop Protection Council, Farnham, Surrey, UK, 2003 and The BioPesticide Manual, 2nd Edition, L.G. Copping, Ed., British Crop Protection Council, Farnham, Surrey, UK, 2001.

[0482] For embodiments in which one or more of these various mixing partners are used, the weight ratio (total) of these various mixing partners to component (a) or the mixture of components (a) and (b) is generally from about 1:3000 to about 3000:1. Of note are weight ratios of from about 1:100 to about 3000:1 or from about 1:30 to about 300:1 (e.g., ratios of from about 1:1 to about 30:1). It will be apparent that the inclusion of these additional components can expand the spectrum of diseases controlled beyond that controlled by component (a) or the mixture of components (a) and (b).

[0483] Component (a) compounds and / or component (b) compounds and / or combinations thereof with one or more other biologically active compounds or agents can be applied to plants genetically engineered to express proteins toxic to invertebrate pests (such as Bacillus thuringiensis delta-endotoxins). The effect of exogenously applied component (a) of the present invention, alone or in combination with component (b), can be synergistic with the expressed toxin protein.

[0484] Of note are combinations or compositions comprising component (a) or components (a) and (b) as described in the Summary of the Invention, which further comprise at least one invertebrate pest control compound or agent (e.g., insecticide, acaricide). Of particular note are compositions comprising component (a) and at least one (i.e., one or more) invertebrate pest control compound or agent, which can then be combined with component (b) to provide a composition comprising components (a) and (b) and one or more invertebrate pest control compounds or agents. Alternatively, a biologically effective amount of a composition comprising component (a) and at least one invertebrate pest control agent can be applied to a plant or plant seed (directly or through the plant's or plant seed's environment) without first mixing with component (b) to protect the plant or plant seed from diseases caused by fungal pathogens and damage caused by invertebrate pests.

[0485] Of note, in addition to the compounds of component (a) alone or in combination with component (b), abamectin, acetamiprid, acrinathrin, acinonapyr, afidopiropen, amitraz, avermectin, azadirachtin, benfuracarb, bensultap, bifenthrin, buprofezin, brofuranilide, cadusafos, carbaryl, cartap, chlorantraniliprole, chlorprallethrin, chlorfenapyr, chlorpyrifos, clothianidin, cyantraniliprole, cyclaniliproxene, cyfluthrin, beta-cyfluthrin, cyclopropyltrimonium chloride ... Phosphorus, cyhalothrin, gamma-cyhalothrin, lambda-cyhalothrin, cypermethrin, alpha-cypermethrin, zeta-cypermethrin, cyromazine, deltamethrin, dieldrin, dinotefuran, diofenolan, emamectin, endosulfan, epsilon-metofluthrin, esfenvalerate, ethiprole, etofenprox, etoxazole, fenitrothion, fenothiocarb, fenoxycarb, fenvalerate, fipronil, flometoquin, fluxamethamide, flonicamid, flubendiamide, fluen Sulfone, flufenoxuron, flufenoxystrobin, flufensulfone, flupiprole, flupirimine, flupyradifurone, fluvalinate, formetanate, fosthiazate, gamma-cyhalothrin, heptafluthrin, hexaflumuron, hydramethylnon, imidacloprid, indoxacarb, isocycloceram, kappa-tefluthrin, lambda-cyhalothrin, lufenuron, meperfluthrin, metaflumizone, methiodicarb, methomyl, methoprene, methoxyfenozide, mesofluthrin, monofluorothrin, nitenpi Ram, nithiazine, novaluron, oxamyl, piflubumid, pymetrozine, pyrethrins, pyridaben, pyridalyl, pyriminostrobin, pyriproxyfen, ryanodine, spinetoram, spinosad, spirodiclofen, spiromesifen, spirotetramat, sulfoxaflor, tebufenozide, tetramethrin, tetramethylfluthrin, thiacloprid, thiamethoxam, thiodicarb, thiosultap-sodium, tralomethrin, triazamate, triflumezopyrim, triflumuron, cyclopyrazofluran, zeta-cypermethrin,The composition of the present invention comprises at least one invertebrate pest control compound or agent selected from the group consisting of Bacillus thuringiensis delta-endotoxin, all strains of Bacillus thuringiensis, and all strains of nucleopolyhedrosis virus.

[0486] In some cases, the combination of the component (a) compound of the present invention, alone or in a mixture with component (b), with other biologically active (especially fungicidal) compounds or agents (i.e., active ingredients) can produce a greater than additive effect (i.e., a synergistic effect).While ensuring effective pest control, it is always desirable to reduce the amount of active ingredient released into the environment.If the enhancing effect of the fungicidal active ingredient occurs at an application rate that provides an agriculturally satisfactory level of fungal control, such a combination can be advantageous in terms of reducing crop production costs and reducing environmental impact.

[0487] Table D1 lists specific combinations of invertebrate pest control agents with Compound 1 (the compound numbers refer to compounds in Index Tables A-B) as exemplary component (a) compounds of mixtures and compositions containing these active ingredients according to the present invention, as well as methods of using them. Column 2 of Table D1 lists specific invertebrate pest control agents (e.g., "Abamectin" in the first row). Column 3 of Table D1 lists the mechanism of action (if known) or chemical class of the invertebrate pest control agent. Column 4 of Table D1 lists embodiments of weight ratio ranges for the rate at which the invertebrate pest control agent is typically applied to Compound 1 alone or in combination with component (b) (e.g., 50:1 to 1:50 weight ratios of abamectin to Compound 1). Thus, for example, row 1 of Table D1 specifically discloses that a combination of Compound 1 and abamectin is typically applied in a weight ratio of 50:1 to 1:50. The remaining rows of Table D1 are similarly structured.

[0488] [Table 29]

[0489] [Table 30]

[0490] [Table 31]

[0491] Tables D2 to D15 are each structured similarly to Table D1 above, except that the items following the "Component (a)" column heading are replaced with the respective component (a) column items shown below. Thus, for example, in Table D2, all items following the "Component (a)" column heading list "Compound 18," and the first line following the column heading in Table D2 specifically discloses a mixture of Compound 18 and abamectin. Tables D3 to D15 are structured similarly.

[0492] [Table 32]

[0493] Compositions containing a compound of Formula 1 useful for seed treatment may further include bacteria and fungi capable of providing protection from the harmful effects of plant pathogenic fungi or bacteria and / or soil-borne animals, such as nematodes. Nematicidal bacteria may include, but are not limited to, Bacillus firmus, Bacillus cereus, Bacillus subtilis, and Pasteuria penetrans. A suitable Bacillus firmus strain is the CNCM I-1582 (GB-126) strain, commercially available under the trademark BioNem™. A suitable Bacillus cereus strain is the NCMM I-1592 strain. Both Bacillus strains are disclosed in U.S. Patent No. 6,406,690. Other suitable nematicidal bacteria include B. amyloliquefaciens IN937a and B. subtilis strain GB03. Bactericidal bacteria may include, but are not limited to, B. pumilus strain GB34. Nematicidal fungi may include, but are not limited to, Myrothecium verrucaria, Paecilomyces lilacinus, and Purpureocillium lilacinum.

[0494] The seed treatment may also include one or more naturally occurring nematicides, such as an elicitor protein called a harpin, isolated from certain bacterial plant pathogens, such as fire blight (Erwinia amylovora). One example is Harpin-N-Tek seed treatment technology, available as N-Hibit™ Gold CST.

[0495] Seed treatments may also include one or more microsymbiotic nitrogen-fixing bacteria, such as legume nodulating bacteria (Bradyrhizobium japonicum). These inoculants may optionally include one or more lipochitooligosaccharides (LCOs), which are nodulation factors produced by rhizobia at the initiation of nodulation on legume roots. For example, Optimize® brand seed treatment technology incorporates LCO Promoter Technology™ in combination with the inoculant.

[0496] Seed treatments can also include one or more isoflavones that can increase the level of root colonization by mycorrhizal fungi. Mycorrhizal fungi improve plant growth by enhancing root uptake of nutrients such as water, sulfate, nitrate, phosphate, and metals. Examples of isoflavones include, but are not limited to, genistein, biochanin A, formononetin, daidzein, glycitein, hesperetin, naringenin, and pratensein. Formononetin is available as an active ingredient in mycorrhizal inoculant products such as PHC Colonize® AG.

[0497] The seed treatment may also include one or more plant activators that induce systemic acquired resistance in the plant after contact with the pathogen. One example of a plant activator that induces such a protective mechanism is acibenzolar-S-methyl.

[0498] In the fungicidal composition, the compound of Formula 1 as component (a) can act synergistically with the additional fungicidal compound as component (b) to provide beneficial results such as broadening the spectrum of plant diseases controlled, extending the duration of preventative and curative protection, and suppressing the growth of resistant fungal pathogens. In certain embodiments, the present invention provides compositions comprising ratios of components (a) and (b) that are particularly useful for controlling certain fungal diseases (e.g., Alternaria solani, Blumeria graminis f.sp. tritici, Botrytis cinerea, Puccinia recondita f.sp. tritici, Rhizoctonia solani, Septoria nodorum, and Septoria tritici).

[0499] Also, mixtures of fungicides can provide significantly better disease control than would be predicted based on the activity of the individual components. Synergy has been described as "the cooperative action of two components of a mixture, the total effect of which is greater or longer-lasting than the sum of the effects of the two (or more) components taken independently" (see PM L Tames, Neth. J. Plant Pathology 1964, 70, 73-80). In methods of providing synergistic plant disease control from combinations of active ingredients (e.g., fungicidal compounds) applied to plants or seeds, the active ingredients are applied in synergistic weight ratios and synergistic (i.e., synergistically effective) amounts. Measures of disease control, suppression, and prevention cannot exceed 100%. Thus, to achieve substantial synergistic effects, it is typically necessary to use application rates of the active ingredients such that the active ingredients individually provide much less than 100% efficacy, and to allow for the possibility of increased efficacy due to synergy, the additive effect must be substantially less than 100%. On the other hand, an application rate of the active ingredients that is too low may result in a mixture that is less active, even if there is a synergistic benefit. Those skilled in the art can easily identify and optimize the weight ratios and application rates (i.e., amounts) of the fungicidal compounds that produce a synergistic effect by simple experimentation.

[0500] The existence of a synergistic effect between two active ingredients was established using the Colby equation (see Colby, SR, "Calculating Synergistic and Antagonistic Responses of Herbicide Combinations", Weeds, (1967), 15, 20-22).

number

[0501] Using Colby's method, the existence of a synergistic interaction between two active ingredients is established by first calculating the predicted activity, p, of the mixture based on the activity of the two ingredients when applied alone. If p is lower than the experimentally established efficacy, then a synergistic effect has occurred. In the above formula, A is the fungicidal activity in % control of one ingredient applied alone at rate x. The B term is the fungicidal activity in % control of the second ingredient applied at rate y. The formula estimates p, the predicted fungicidal activity of a mixture of A at rate x and B at rate y, if the effects are strictly additive and no interaction occurs.

[0502] The seed treatment may also include one or more plant activators that induce systemic acquired resistance in plants following contact with pathogens. One example of a plant activator that induces such a protective mechanism is acibenzolar-S-methyl.

[0503] The following tests demonstrate the control efficacy of the compounds of the present invention against specific pathogens. However, the pathogen control protection afforded by the compounds is not limited to these species. See Index Tables A-B below for compound descriptions. The following abbreviations are used in Index Table A: Me means methyl, i-Pr means isopropyl, MeO means methoxy, and -NO2 means nitro. The abbreviation "Cmpd." stands for "Compound," and the abbreviation "Ex." stands for "Example," followed by a number indicating in which example the compound is prepared. In Index Table A, the substituent R 4 and R 5 The locant numbers listed for are as shown in the structure above the table. 4 and R 5 The order in which the substituents R are listed may differ from the Chemical Abstracts naming system if the difference does not affect the meaning. For example, compound 1 in Index Table A is 5is at the 6-position (i.e., 6-F), while the CAS name for Compound 1 is 4-(2-bromo-4,6-difluorophenyl)-N-(2-fluoro-6-nitrophenyl)-1,3-dimethyl-1H-pyrazol-5-amine. + The number reported in "(M+1)" is the H to the molecule with the highest isotopic abundance (i.e., M). + (molecular weight of 1) is the molecular weight of the observed molecular ion formed by the addition of - The values ​​reported in "(M-1)" are the H from the molecule with the highest isotopic abundance (i.e., M). + is the molecular mass of the observed molecular ion formed by the loss of (the molecular mass of 1). 37 Cl, 81 The presence of molecular ions containing Br is not reported. The reported M+1 and M-1 peaks were observed by mass spectrometry using electrospray ionization (ESI) or atmospheric pressure chemical ionization (APCI).

[0504] [Table 33]

[0505] [Table 34]

[0506] [Table 35]

[0507] [Table 36]

[0508] [Table 37]

[0509] [Table 38]

[0510] [Table 39]

[0511] Biological Examples of the Invention General protocol for preparing test suspensions for Tests A-F: Test compounds were first dissolved in acetone in an amount equal to 3% of the final volume, then suspended at the desired concentration (in ppm) in acetone and purified water (50 / 50 mix by volume) containing 250 ppm of the surfactant PEG 400 (polyhydric alcohol ester). The resulting test suspensions were used for Tests A-F.

[0512] Test A The test solution was sprayed onto wheat seedlings until dripping. The next day, the seedlings were inoculated with a spore suspension of Septoria tritici (the causal agent of wheat leaf blight) and incubated at 24°C in a saturated atmosphere for 48 hours, then transferred to a growth chamber at 20°C for 17 days, after which time disease assessments were made.

[0513] Test B The test solution was sprayed onto wheat seedlings to a runoff level. The next day, the seedlings were inoculated with a spore suspension of Puccinia recondita f.sp. tritici (the causal agent of wheat leaf rust) and incubated at 20°C in a saturated atmosphere for 24 hours. After incubation, the seedlings were transferred to a growth chamber at 20°C for 7 days, after which disease evaluation was performed.

[0514] Test C The test suspension was sprayed onto wheat seedlings to dripping. The next day, the seedlings were inoculated with spore powder of Blumeria graminis f.sp. tritici (also known as Erysiphe graminis f.sp. tritici, the causal agent of wheat powdery mildew) and incubated in a growth chamber at 20°C for 8 days, after which time visual disease assessments were made.

[0515] Test D The test solution was sprayed onto soybean seedlings to dripping. The next day, the seedlings were inoculated with a spore suspension of Phakopsora pachyrhizi (the causal agent of Asian soybean rust), incubated at 22°C in a saturated atmosphere for 24 hours, and then transferred to a growth chamber at 22°C for 8 days, after which time visual disease assessment was made.

[0516] Test E The test suspension was sprayed onto tomato seedlings until dripping. The next day, the seedlings were inoculated with a spore suspension of Botrytis cinerea (the causal agent of tomato botrytis disease) and incubated at 20°C in a saturated atmosphere for 48 hours, then transferred to a growth chamber at 24°C for 3 days, after which time visual disease assessment was made.

[0517] Test F The test suspension was sprayed onto tomato seedlings until dripping. The next day, the seedlings were inoculated with a spore suspension of Alternaria solani (the causal agent of early blight of tomato) and incubated at 27°C in a saturated atmosphere for 48 hours, then transferred to a growth chamber at 20°C for 3 days, after which time visual disease assessment was made.

[0518] The results for Tests A through F are shown in Table A below. A rating of 100 indicates 100% disease control and a rating of 0 indicates no disease control (vs. control). A dash (-) indicates that the compound was not tested.

[0519] [Table 40]

[0520] [Table 41]

[0521] [Table 42]

[0522] [Table 43]

[0523] [Table 44]

[0524] [Table 45]

[0525] [Table 46]

[0526] The test results presented above in Table A for compounds of Formula 1 illustrate the fungicidal activity of component (a) that results in the plant disease control utility of compositions comprising component (a) in combination with component (b) and, optionally, at least one additional fungicidal compound according to the present invention.

[0527] Biological comparison example General protocol for preparing test suspensions for Tests A1-F1: The test compound is first dissolved in acetone in an amount equal to 3% of the final volume, and then suspended at the desired concentration (ppm) in acetone and purified water (50 / 50 mix by volume) containing 250 ppm of the surfactant PEG 400 (polyhydric alcohol ester). The test suspension thus obtained is then used in Tests A1-F1.

[0528] Test A1 The test solution was sprayed onto wheat seedlings until dripping. The next day, the seedlings were inoculated with a spore suspension of Septoria tritici (the causal agent of wheat leaf blight) and incubated at 24°C in a saturated atmosphere for 48 hours, then transferred to a growth chamber at 20°C for 17 days, after which time disease assessments were made.

[0529] Exam B1 The test solution was sprayed onto wheat seedlings until dripping. The next day, the seedlings were inoculated with a spore suspension of Puccinia recondita f.sp. tritici (the causal agent of wheat leaf rust) and incubated at 20°C in a saturated atmosphere for 24 hours, then transferred to a growth chamber at 20°C for 7 days, after which time disease assessment was carried out.

[0530] Test C1 The test suspension was sprayed onto wheat seedlings to dripping. The next day, the seedlings were inoculated with spore powder of Blumeria graminis f.sp. tritici (also known as Erysiphe graminis f.sp. tritici, the causal agent of wheat powdery mildew) and incubated in a growth chamber at 20°C for 8 days, after which time visual disease assessments were made.

[0531] Test E1 The test suspension was sprayed onto tomato seedlings until dripping. The next day, the seedlings were inoculated with a spore suspension of Botrytis cinerea (the causal agent of tomato botrytis disease) and incubated at 20°C in a saturated atmosphere for 48 hours, then transferred to a growth chamber at 24°C for 3 days, after which time visual disease assessment was made.

[0532] Test F1 The test suspension was sprayed onto tomato seedlings until dripping. The next day, the seedlings were inoculated with a spore suspension of Alternaria solani (the causal agent of early blight of tomato) and incubated at 27°C in a saturated atmosphere for 48 hours, then transferred to a growth chamber at 20°C for 3 days, after which time visual disease assessment was made.

[0533] The results for tests A1 to F1 are shown in Table B below. A rating of 100 indicates 100% disease control and a rating of 0 indicates no disease control (vs. control). Data are presented for the following compounds: [ka]

[0534] [Table 47]

Claims

1. 1. A fungicidal composition comprising: (a) Formula 1: 【Chemistry 1】 a compound selected from the group consisting of the compounds of formula (I) and N-oxides and salts thereof; (b) at least one additional fungicidal compound selected from the group consisting of: (b3) triforine, buthiobate, pyrifenox, pyrisoxazole, fenarimol, nuarimol, triarimol, econazole, imazalil, oxpoconazole, pefurazoate, prochloraz, triflumizole, azaconazole, bitertanol, bromuconazole, cyproconazole, difenoconazole, diniconazole (including diniconazole-M), epoxiconazole, etaconazole, fenbuconazole, fluquinconazole, flusilazole a demethylation inhibitor (DMI) fungicide selected from flutriafol, hexaconazole, imibenconazole, ipconazole, mefentrifluconazole, metconazole, myclobutanil, penconazole, propiconazole, prothioconazole, ipfentrifluconazole, quinconazole, simeconazole, tebuconazole, tetraconazole, triadimefon, triadimenol, triticonazole, uniconazole and uniconazole-P; (b5) amine / morpholine fungicides selected from aldimorph, dodemorph, fenpropimorph, tridemorph, trimorphamide, fenpropidin, piperaline, and spiroxamine; (b7) succinate dehydrogenase inhibitor (SDHI) fungicides selected from benodanil, flutolanil, mepronil, isofetamide, fluopyram, fenfuram, carboxin, oxycarboxin, thifluzamide, benzovindiflupyr, bixafen, fluindapyr, fluxapyroxad, furametpyr, inpirfluxam, isopyrazam, penflufen, penthiopyrad, pyrapropoin, sedaxane, fluventeram, isofetamide, pydiflumetofen, boscalid, and pyraziflumid; (b9) anilinopyrimidine (AP) fungicides selected from cyprodinil, mepanipyrim, and pyrimethanil; (b11) quinone outside inhibitor (QoI) fungicides selected from azoxystrobin, cumoxystrobin, enoxastrobin, flufenoxystrobin, picoxystrobin, pyraoxystrobin, mandestrobin, pyraclostrobin, pyrametostrobin, triclopyricarb, kresoxim-methyl, trifloxystrobin, dimoxystrobin, phenaminestrobin, metominostrobin, orysastrobin, fluoxastrobin, famoxadone, fenamidone, and pyribencarb; (b12) a phenylpyrrole fungicidal compound selected from fenpiclonil and fludioxonil; (b13) an azanaphthalene fungicide selected from quinoxyfen and proquinazid; (b16b) melanin biosynthesis inhibitor-polyketide synthase (MBI-P) fungicides selected from tolprocarb; (b17) a ketoreductase inhibitor (KRI) fungicide selected from fenhexamid, fenpyrazamine, quinofumelin, and ipflufenoquin; (b21) a quinone inside inhibitor (QiI) fungicide selected from cyazofamid, amisulbrom, and fenpicoxamid; (b52) multi-site active fungicides selected from copper oxychloride, copper sulfate, copper hydroxide, Bordeaux composition, elemental sulfur, ferbam, mancozeb, maneb, metiram, propineb, thiram, zinc thiazole, zineb, ziram, folpet, captan, captafol, chlorothalonil, dichlofluanid, trifluanid, guazatine, iminoctadine albesilate, iminoctadine triacetate, anilazine, dithianon, chinomethionate, and fluoroimide; and (b54) Florylpicoxamide, methyltetraprole, pyridaclomethyl, aminopyrifen, methyl N-[[5-[1-[2,6-difluoro-4-(1-methylethyl)phenyl]-1H-pyrazol-3-yl]-2-methylphenyl]methyl]carbamate, and N-(2,2,2-trifluoroethyl)-2-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-4-oxazolecarboxamide A disinfectant composition comprising:

2. 10. The composition of claim 1, wherein component (b) comprises at least one fungicidal compound selected from (b3).

3. 10. The composition of claim 1, wherein component (b) comprises at least one fungicidal compound selected from (b7).

4. 10. The composition of claim 1, wherein component (b) comprises at least one fungicidal compound selected from (b21).

5. 10. The composition of claim 1, wherein component (b) comprises at least one fungicidal compound from each of two different groups selected from (b3), (b5), (b7), (b9), (b11), (b12), (b13), (b16b), (b17), (b21), (b52), and (b54).

6. 2. The composition of claim 1, wherein component (b) comprises at least one compound selected from azoxystrobin, benzovindiflupyr, bixafen, chlorothalonil, copper hydroxide, cyproconazole, epoxiconazole, fenpropidin, fenpropimorph, fluindapyr, flutriafol, fluxapyroxad, mancozeb, metominostrobin, picoxystrobin, prothioconazole, pydiflumetofen, pyraclostrobin, tebuconazole, and trifloxystrobin.

7. Component (b) is azoxystrobin, benzovindiflupyr, bixafen, chlorothalonil, copper hydroxide, cyproconazole, difenoconazole, dimoxystrobin, epoxiconazole, famoxadone, fenpropidin, fenpropimorph, fluindapyr, flusilazole, flutriafol, fluxapyroxad, kresoximmethyl, mancozeb, metconazole, metominostrobin, myclobutanil, penthiopyrad, picoxystrobin, propiconazole, proquinazide, prothioconazole, pydiflumetofen, pyraclostrobin ...

10. The composition of claim 1, comprising at least one fungicidal compound selected from metostrobin, pyraoxystrobin, quinoxyfen, tebuconazole, trifloxystrobin, triticonazole, methyl N-[[5-[1-[2,6-difluoro-4-(1-methylethyl)phenyl]-1H-pyrazol-3-yl]-2-methylphenyl]methyl]carbamate, and N-(2,2,2-trifluoroethyl)-2-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-4-oxazolecarboxamide.

8. Component (b) is azoxystrobin, benzovindiflupyr, bixafen, chlorothalonil, copper hydroxide, cyproconazole, difenoconazole, epoxiconazole, fenpropidin, fenpropimorph, fluindapyr, flutriafol, fluxapyroxad, mancozeb, metominostrobin, picoxystrobin, prothioconazole, pydiflumetofen, pyraclostrobin, tebuconazole, trifloxystrobin, metomino ...

8. The composition of claim 7, comprising at least one fungicidal compound selected from N-[[5-[1-[2,6-difluoro-4-(1-methylethyl)phenyl]-1H-pyrazol-3-yl]-2-methylphenyl]methyl]carbamate, and N-(2,2,2-trifluoroethyl)-2-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-4-oxazolecarboxamide.

9. 9. The composition of claim 8, wherein component (b) comprises at least one fungicidal compound selected from azoxystrobin, benzovindiflupyr, bixafen, chlorothalonil, copper hydroxide, cyproconazole, epoxiconazole, fenpropidin, fenpropimorph, fluindapyr, flutriafol, fluxapyroxad, mancozeb, metominostrobin, picoxystrobin, prothioconazole, pydiflumetofen, pyraclostrobin, tebuconazole, and trifloxystrobin.

10. 10. The composition of claim 1, wherein component (b) comprises at least one fungicidal compound selected from florylpicoxamide, methyltetraprole, pyridaclomethyl, and aminopyrifen.

11. The composition according to any one of claims 1 to 10, wherein the weight ratio of component (a) to component (b) is from 125:1 to 1:

125.

12. 12. The composition according to claim 11, wherein the weight ratio of component (a) to component (b) is from 25:1 to 1:

12.

13. The composition according to claim 12, wherein the weight ratio of component (a) to component (b) is from 5:1 to 1:

5.

14. A composition comprising the composition of claim 1 and at least one additional component selected from the group consisting of surfactants, solid diluents, and liquid diluents.

15. 15. A method for protecting a plant or plant seed from disease caused by a fungal pathogen, the method comprising applying to said plant or plant seed a fungicidally effective amount of a composition according to any one of claims 1 to 14.

16. 16. The method of claim 15, wherein the fungal pathogen is selected from Alternaria solani, Blumeria graminis f.sp. tritici, Botrytis cinerea, Puccinia recondita f.sp. tritici, Rhizoctonia solani, Septoria nodorum, and Septoria tritici.

Images